ELENCO CONTRIBUTI INVIATI


ID Autore Titolo
37 Abbracchio MP. Multiple sclerosis and depressio... Visualizza
38 Abbracchio MP. GPR17-expressing oligodendrocyte... Visualizza
39 Abdo S. Effects of ethanolic extracts of... Visualizza
40 Abete L. Antiviral and antioxidant activi... Visualizza
3024 Abete L. Effects of the metronomic treatm... Visualizza
3487 Abete L. ë_-Caryophyllene oxide as a new... Visualizza
41 Aboufares El Alaoui A. PPARγ Acti vati on reduces alco... Visualizza
42 Accattatis F. LIPIDOMICS AS A TOOL TO UNRAVEL ... Visualizza
3025 Accattatis F. LIPID CONTENT OF HUMAN TUMOR EXO... Visualizza
43 Acciarini S. PPARγ Acti vati on reduces alco... Visualizza
44 Achatz-straussberger G. IMMUNOSURVEILLANCE OF TUMORS: IG... Visualizza
45 Acquaviva T. POTENTIAL MECHANISMS LINKING DEF... Visualizza
46 Adamo A. Proatherosclerotic effect of tri... Visualizza
47 Adamo EB. Cadmium and its role in brain dy... Visualizza
48 Adamo F. GLUCOCORTICOID-INDUCED LEUCINE Z... Visualizza
3488 Adamo F. GLUCOCORTICOID-INDUCED LEUCINE Z... Visualizza
3026 Adesso S. Intestine as a Source of Inflamm... Visualizza
3027 Adesso S. NIVALENOL AND DEOXYNIVALENOL IND... Visualizza
49 Adorni MP. Vitamin D replacement in pre-men... Visualizza
4239 Agapito G. Identification and validation of... Visualizza
50 Agnelli FA. SAFETY AND EFFICACY OF GLP-1 REC... Visualizza
51 Agosti F. Hedonic eating in Prader-Willi s... Visualizza
52 Agostinis P. A NEW SYNTHETIC ISOTHIOCYANATE D... Visualizza
53 Aguilar M.A. AN EXTRACT OF HYPERICUM PERFORAT... Visualizza
54 Aiello A. Access to the market of medicine... Visualizza
55 Aiello E. PHARMACOLOGICAL EFFECT OF PERAMP... Visualizza
56 Airoldi C. REAL-LIFE SAFETY AND EFFECTIVENE... Visualizza
3489 Aitta-aho T. Dopamine D3 receptor-dependent c... Visualizza
3490 Alberti M. Intracellular chloride accumulat... Visualizza
57 Alberti S. PLATELET-DEPENDENT ACTIVATION OF... Visualizza
58 Albertini B. Development of microparticles fo... Visualizza
3491 Albini E. The proteasome inhibitor bortezo... Visualizza
3492 Albini E. REINSTALLING IMMUNE REGULATORY T... Visualizza
59 Alboni S. LYMNAEA STAGNALIS AS A NEW MODEL... Visualizza
4105 Alboni S. Fluoxetine counteracts the oppos... Visualizza
63 Aliquò F. WHITE-TO-BROWN ADIPOSE TRANSDIFF... Visualizza
64 Aliquò G. Intravitreal anti-VEGF injection... Visualizza
65 Aliquò G. EVALUATION OF HEALTH DIRECT COST... Visualizza
66 Aliquò G. GENDER SPECIFIC DRUG USE IN PEDI... Visualizza
3493 Allardyce C. RNA-SEQ ANALYSIS OF DIFFERENTIAL... Visualizza
3028 Allegri L. Tacrolimus Therapeutic Drug Moni... Visualizza
67 Alllegra A. Curcumin Ameliorates the In Vitr... Visualizza
68 Altamura C. DEVELOPMENT OF NEW BENZOTHIAZOLA... Visualizza
3029 Altamura C. SEARCHING FOR NOVEL DRUGS IN MYO... Visualizza
69 Altavilla D. MODELING ROS1 TRANSLOCATION IN L... Visualizza
70 Altavilla D. ADENOSINE 2A RECEPTOR STIMULATIO... Visualizza
71 Altavilla D. Activation of the EPOR-b common ... Visualizza
72 Altavilla D. WHITE-TO-BROWN ADIPOSE TRANSDIFF... Visualizza
73 Altavilla D. CURCUMIN POTENTIATES THE ANTI-IN... Visualizza
74 Altavilla D. Cadmium and its role in brain dy... Visualizza
75 Altavilla D. HIGH VARIABILITY IN TACROLIMUS B... Visualizza
76 Altavilla D. Survivin and NAIP in Human Benig... Visualizza
3494 Altavilla D. FLAVONOIDS CONTAINED IN FLAVOCOX... Visualizza
3495 Altavilla D. LACK OF THE NLRP3 INFLAMMASOME I... Visualizza
4235 Altomare E. Identification and validation of... Visualizza
4203 Alvarado P. Experience of risk communication... Visualizza
4216 Alvaro D. Obeticholic acid in primary bili... Visualizza
77 Amadio M. MODULATION OF OXIDATIVE AND INFL... Visualizza
78 Amadio P. Environmental Chronic Stress Ind... Visualizza
3030 Amadio P. Carbaprostacyclin prevents venou... Visualizza
79 Amato M. A PRIORI-DEFINED MEDITERRANEAN-L... Visualizza
3031 Amato M. CAROTID PLAQUE-THICKNESS AND COM... Visualizza
80 Ambra AA. INVESTIGATION OF A PUTATIVE NICO... Visualizza
81 Ambrosi A. IMMUNOSURVEILLANCE OF TUMORS: IG... Visualizza
82 Ambrosiani L. PSYCHOTROPIC MEDICATIONS IN MOOD... Visualizza
83 Ambrosino P. STARGAZIN REGULATES THE BIOCHEMI... Visualizza
84 Ambrosino P. Compound heterozygosis in the kc... Visualizza
85 Amisano G. ANTIPROLIFERATIVE, ANTIOXIDANT A... Visualizza
86 Ammazzalorso A. CM554, A NEW POTENT AND SELECTIV... Visualizza
87 Amodeo G. ROLE OF PROKINETICIN SYSTEM IN A... Visualizza
3032 Amodeo G. THERAPEUTIC EFFECT OF SYSTEMIC I... Visualizza
88 Amodio N. EFFECTS OF HISTONE DEACETYLASE I... Visualizza
89 Amoroso C. TRANSPLANTATION OF MENINGEAL-DER... Visualizza
90 Amoroso R. CM554, A NEW POTENT AND SELECTIV... Visualizza
91 Amoroso S. INVOLVEMENT OF NCX IN GLUTAMATE-... Visualizza
3496 Amoroso S. PIVOTAL ROLE OF NCX1 IN GLUTAMAT... Visualizza
93 Anderson iii DA. PROTECTIVE ROLE OF CONVENTIONAL ... Visualizza
94 Andrea A. Targeting nicotinamide phosphory... Visualizza
3034 Andriani L. CARDIOVASCULAR SAFETY OF MACROLI... Visualizza
95 Anfuso CD. Sulodexide prevents high glucose... Visualizza
98 Angelelli M. IRREVERSIBLE BK CHANNEL BLOCKING... Visualizza
3035 Angelelli M. IN VITRO AND EX-VIVO EFFECTS OF ... Visualizza
99 Angelici L. CYP27A1 GENETIC POLYMORPHISM IN ... Visualizza
100 Angelinetta C. AN ALTERNATIVE METHOD FOR EVALUA... Visualizza
101 Angelini J. OBSERVATIONAL, PROSPECTIVE CLINI... Visualizza
3036 Angelini J. The importance of Integrated Car... Visualizza
4023 Angelini J. Insulin analogue glargine 300 U/... Visualizza
102 Angelini JA. SAFETY AND EFFICACY OF GLP-1 REC... Visualizza
103 Angelini S. MIR-139-5P AND MIR-455-5P AS POT... Visualizza
104 Angelini S. DNA METHYLATION: GENE PROFILING ... Visualizza
3037 Angelini S. TARGETING THE CANCER RESISTOME T... Visualizza
4117 Angelini S. microRNA (miRNA) deregulation as... Visualizza
105 Angius A. CONVERGENT ANALYSIS OF GENOME-WI... Visualizza
4165 Annicchiarico G. The role of regional coordinatio... Visualizza
108 Anniciello AM. COX-2 EXPRESSION IN MALIGNANT ME... Visualizza
109 Annovazzi L. SOLID LIPID NANOPARTICLES CARRYI... Visualizza
110 Annunziata C. PALMITOYLETAHNOLAMIDE ATTENUATES... Visualizza
3038 Annunziata C. N-(1-CARBAMOYL-2-PHENYLETHYL) BU... Visualizza
3497 Annunziata C. BUTYRATE REDUCES VALPROATE-INDUC... Visualizza
111 Annunziato L. IDENTIFICATION OF TRANSCRIPTION ... Visualizza
1685 annunziato L. SYNERGISTIC ASSOCIATION OF VALPR... Visualizza
112 Antinori A. Pharmacokinetics of darunavir/co... Visualizza
113 Antognoni F. Effects of ethanolic extracts of... Visualizza
3039 Antonazzo IC. Occurrence of Liver Injury with ... Visualizza
114 Antoniazzi S. On the possible relationship bet... Visualizza
115 Antonioli L. EFFECTS OF L-DOPA/BENSERAZIDE CO... Visualizza
116 Antonioli L. Bifidobacterium Longum and Lacto... Visualizza
117 Antonioli L. Alteration of visceral sensitivi... Visualizza
118 Antonioli L. Enteric glia is involved in colo... Visualizza
119 Antonioli L. APIGENIN SUPPLEMENTATION PREVENT... Visualizza
3498 Antonioli L. COMPARATIVE PRE-CLINICAL STUDY O... Visualizza
4118 Antonioli L. Obesity and related enteric neur... Visualizza
120 Antoniotti C. Colon cancer therapy beyond tumo... Visualizza
3499 Antonucci F. KCC2 is a key target of oxytocin... Visualizza
121 Apicella C. In vitro and in vivo antibacteri... Visualizza
122 Appendino G. The antimigraine butterbur ingre... Visualizza
123 Aprea G. TRPM8 and experimental colorecta... Visualizza
124 Aquino RP. EFFECT OF ULTRAFINE PARTICLE MAT... Visualizza
125 Aragno M. EFFECT OF VITAMIN D ON INSULIN S... Visualizza
126 Aragno M. THE AGEs INHIBITOR PYRIDOXAMINE ... Visualizza
127 Aragno M. TOXICOLOGICAL IMPACT OF HIGH FRU... Visualizza
3500 Aragno M. THE ANTI-INFLAMMATORY PROTEIN AN... Visualizza
128 Aragones G. Proatherosclerotic effect of tri... Visualizza
129 Arancio O. cGMP MODULATES LONG-TERM POTENTI... Visualizza
130 Arancio O. GEBR-32A, A NEW PROMISING PDE4D ... Visualizza
4227 Arbitrio M. Identification and validation of... Visualizza
131 Arcadu F. SPRUE-LIKE ENTEROPATHY ASSOCIATE... Visualizza
4206 Arcangeli A. hERG1 Channels: from antitargets... Visualizza
132 Arcoraci V. HIGH VARIABILITY IN TACROLIMUS B... Visualizza
133 Arcoraci V. CURCUMIN POTENTIATES THE ANTI-IN... Visualizza
134 Arcoraci V. ADVERSE DRUG REACTIONS IN EMERGE... Visualizza
3501 Arcoraci V. LACK OF THE NLRP3 INFLAMMASOME I... Visualizza
4155 Arcoraci V. Antiosteoporotic drugs use reduc... Visualizza
135 Ardau R. CONVERGENT ANALYSIS OF GENOME-WI... Visualizza
3502 Argenziano M. Megalin and Sodium-Hydrogen Exch... Visualizza
3040 Ariaudo A. A NEW UHPLC-MS/MS METHOD FOR THE... Visualizza
3503 Aringhieri S. Clozapine as the most efficaciou... Visualizza
136 Armando AA. Targeting nicotinamide phosphory... Visualizza
137 Armogida C. Modulation of the inflammatory r... Visualizza
138 Armogida C. COX-2 EXPRESSION IN MALIGNANT ME... Visualizza
3041 Armogida C. ACETYL DEACYLASADISULFIDE, A NAT... Visualizza
3504 Armogida CA. KEY PATHWAYS AND EMERGING PLAYER... Visualizza
139 Arnaboldi L. Recombinant LCAT rescues defecti... Visualizza
140 Arnaboldi L. LIPID CONTENT OF HUMAN TUMOR EXO... Visualizza
141 Arnaboldi L. LIPIDOMICS AS A TOOL TO UNRAVEL ... Visualizza
3042 Arnaboldi L. UNRAVELING THE MECHANISM OF ACTI... Visualizza
3505 Aroni S. EFFECTS OF THE PPAR-ALPHA AGONIS... Visualizza
3043 Arrigoni E. The ABCB1 pharmacogenetics of R-... Visualizza
142 Artudi F. MONITORING SAFETY AND USE OF OLD... Visualizza
143 Arturi F. VILDAGLIPTIN IMPROVES ANIMAL BEH... Visualizza
144 Arzenton E. VIGINETWORK: A COMMUNITY PHARMAC... Visualizza
3506 Asteriti E. In vitro effects of mediators de... Visualizza
3507 Asth L. NOP RECEPTOR AND FUNCTIONAL SELE... Visualizza
4158 Atteritano M. Antisclerostin Antibody... Visualizza
3044 Auricchio F. ANALYSIS OF THE ADVERSE DRUG REA... Visualizza
145 Autore G. NIVALENOL AND DEOXYNIVALENOL IND... Visualizza
146 Autore G. Intestine as a Source of Inflamm... Visualizza
147 Avagliano C. PHARMACOLOGICAL EFFECT OF PERAMP... Visualizza
3045 Avagliano C. BUTYRATE ATTENUATES MOTOR DEFICI... Visualizza
148 Avola R. ROSMARINUS OFFICINALIS EXTRACT P... Visualizza
149 Awada K. Alteration of visceral sensitivi... Visualizza
150 Awada K. A PRECLINICAL SET UP OF A RAT MO... Visualizza
151 Awada K. Studying the mechanism of rat ad... Visualizza
152 Awada K. Development of an in vitro model... Visualizza
153 Awada K. Into the unexplored pathophysiol... Visualizza
154 Azari EK. EFFECTS OF SUBDIAPHRAGMATIC DEAF... Visualizza
155 Bagadia P. PROTECTIVE ROLE OF CONVENTIONAL ... Visualizza
3046 Baggiani G. PSYCHOTROPIC MEDICATIONS IN MOOD... Visualizza
156 Bagini L. EFFECTS OF CLONIDINE ON HIPPOCAM... Visualizza
157 Baiula M. ANTIALLERGIC ACTIVITY OF A NOVEL... Visualizza
3047 Baiula M. EFFECTS OF RGD LIGANDS ON INTEGR... Visualizza
158 Balbi M. PRESYNAPTIC GLP-1 RECEPTORS ENHA... Visualizza
159 Balbi M. cGMP MODULATES LONG-TERM POTENTI... Visualizza
3048 Balbi M. GEBR-32A, A NEW PROMISING PDE4D ... Visualizza
160 Balboni G. Involvement of the Prokineticin ... Visualizza
161 Baldan F. Tacrolimus Therapeutic Drug Moni... Visualizza
3049 Baldan V. Phytochemical Investigation and ... Visualizza
3050 Baldan V. HPLC-MS Analysis of Glucosinolat... Visualizza
162 Baldassarre D. CAROTID PLAQUE-THICKNESS AND COM... Visualizza
3051 Baldassarre D. A PRIORI-DEFINED MEDITERRANEAN-L... Visualizza
163 Baldassarri S. Subcutaneous slow-release metfor... Visualizza
4131 Balducci C. Neuroinflammation and Alzheimer'... Visualizza
164 Balducci S. SEDENTARY-TIME: EFFECT ON PRO- A... Visualizza
165 Balestra B. AN ALTERNATIVE METHOD FOR EVALUA... Visualizza
166 Ballabeni V. PHARMACOLOGICAL CHARACTERIZATION... Visualizza
167 Ballabeni V. BENEFICIAL EFFECTS OF PHARMACOLO... Visualizza
168 Ballabeni V. EFFECTS OF L-DOPA/BENSERAZIDE CO... Visualizza
169 Ballantini F. Retrospective study on ItaliaN A... Visualizza
3052 Ballerini P. Targeting platelet purinergic si... Visualizza
3053 Ballerini P. Conditioned medium of human peri... Visualizza
4024 Balzarotti G. PCSK9 (PROPROTEIN CONVERTASE SUB... Visualizza
170 Baragetti A. Apolipoprotein E modulates adapt... Visualizza
171 Baraldo M. Tacrolimus Therapeutic Drug Moni... Visualizza
172 Baraldo M. CLINICAL PHARMACOLOGICAL ADVICE ... Visualizza
2669 baraldo S. ALPHA-1 ANTITRYPSIN (AAT) POLYME... Visualizza
173 Barbagallo A. NABILONE AND THC/CBD FOR THE TRE... Visualizza
174 Barbetta B. Characterization of adipokines s... Visualizza
175 Barbieri F. PRION PROTEIN SIGNALLING CONTROL... Visualizza
176 Barbieri F. Subcutaneous slow-release metfor... Visualizza
3054 Barbieri F. bFGF/FGFR1 SIGNALING IS THE MAIN... Visualizza
177 Barbieri M. ADVERSE DRUG REACTIONS ASSOCIATE... Visualizza
3293 Barbieri M.A. Safety profile of antipsychotic ... Visualizza
178 Barbieri SS. Carbaprostacyclin prevents venou... Visualizza
179 Barbieri SS. Environmental Chronic Stress Ind... Visualizza
180 Barca E. STATIN THERAPY: CLC-1 CHLORIDE C... Visualizza
181 Bardelli F. Utilization of biological drugs ... Visualizza
182 Barge A. VANADIUM COMPOUNDS INHIBIT CELL ... Visualizza
183 Barocelli E. PHARMACOLOGICAL CHARACTERIZATION... Visualizza
184 Barocelli E. BLOCKADE OF EPHB-EPHRINB SIGNALL... Visualizza
185 Barocelli E. BENEFICIAL EFFECTS OF PHARMACOLO... Visualizza
186 Barocelli E. EFFECTS OF L-DOPA/BENSERAZIDE CO... Visualizza
3508 Barocelli E. DUAL TARGETING OF EPH-EPHRIN SYS... Visualizza
187 Baronchelli F. ACTIVITY OF ALOE ARBORESCENS LEA... Visualizza
188 Barone E. BEHAVIOURAL AND NEUROPATHOLOGICA... Visualizza
189 Barreca D. IN VITRO EVALUATION OF ANTIOXIDA... Visualizza
3509 Barresi M. Chronic treatment with fluoxetin... Visualizza
190 Bartolini C. NSAIDs utilization in a large co... Visualizza
191 Bartolini C. Utilization of biological drugs ... Visualizza
192 Basc, J. EFFECTS OF CLONIDINE ON HIPPOCAM... Visualizza
193 Bashllari R. In Vitro Protective Effects of C... Visualizza
3055 Bashllari R. Curcumin Potentiates Antitumor A... Visualizza
3510 Bashllari R. Alpha-Lipoic Acid, But Not Dihyd... Visualizza
3511 Basili S. Results from an e-learning cours... Visualizza
194 Basilico N. Cutaneous hypoxia: effect of oxy... Visualizza
195 Bassetti M. CLINICAL PHARMACOLOGICAL ADVICE ... Visualizza
196 Bassi FD. Inhibition of SIRT1 Deacetylase ... Visualizza
197 Basta G. Prevention of diabetes in NOD mi... Visualizza
198 Bastioli G. INVOLVEMENT OF NCX IN GLUTAMATE-... Visualizza
199 Battaglia G. PHARMACOLOGICAL CHARACTERIZATION... Visualizza
200 Battaglia L. SOLID LIPID NANOPARTICLES CARRYI... Visualizza
201 Battista DR. ANTI-ATHEROSCLEROTIC EFFECTS OF ... Visualizza
3056 Battista S. Proatherosclerotic effect of tri... Visualizza
202 Battistello E. A2B adenosine receptors stimulat... Visualizza
203 Baumann I. OVER-EXPRESSION OF MIR-574-5P IN... Visualizza
3512 Baumann I. MICRORNA-574-5P MODULATES MICROS... Visualizza
1091 Bazzan E. ALPHA-1 ANTITRYPSIN (AAT) POLYME... Visualizza
3057 Bazzani L. PGE2 SIGNALING INDUCES EGFR NUCL... Visualizza
3513 Bazzu G. Real-time detection of ethanol i... Visualizza
4224 Bazzu G. Real-time monitoring of MPTP-ind... Visualizza
204 Bedini A. Identification of a novel, funct... Visualizza
3058 Bedini A. Morphine differently influences ... Visualizza
4025 Beggiato S. Gestational cannabinoid exposure... Visualizza
3059 Begni V. LONG-LASTING EFFECTS OF STRESS I... Visualizza
205 Belardo C. D-ASPARTIC ACID AMELIORATES COGN... Visualizza
206 Belardo C. PALMITOYLETHANOLAMIDE, VIA PPAR-... Visualizza
3060 Belardo C. Palmitoylethanolamide Reduces Ne... Visualizza
207 Belisario A. A multiple approach allowed unve... Visualizza
3514 Belladonna M.L. The proteasome inhibitor bortezo... Visualizza
208 Bellani G. EFFECTS OF HEXARELIN IN A MODEL ... Visualizza
3515 Bellavista E. EFFECTS OF THROMBIN CLEAVAGE OF ... Visualizza
209 Belleudi V. Real world data about biosimilar... Visualizza
3061 Bellin A. HEPATITIS C VIRUS (HCV) INFECTIO... Visualizza
210 Bellini T. BIVALENT LIGANDS DISCLOSE GPCR D... Visualizza
211 Bellocco E. IN VITRO EVALUATION OF ANTIOXIDA... Visualizza
212 Belluomini L. LIQUID BIOPSY: A REAL CLINICAL P... Visualizza
213 Belperio D. THE PROGESTIN DESOGESTREL AFFECT... Visualizza
214 Belperio D. NEWLY IDENTIFIED PHOX2B TARGET G... Visualizza
4176 Beltrami A. P. Mechanotransduction in cardiovas... Visualizza
215 Belvedere R. Effects of Prisma® Skin dermal ... Visualizza
216 Belvedere R. Hypoxia regulates ANXA1 expressi... Visualizza
4026 Belvedere R. ANNEXIN A1 CONTRIBUTES TO PANCRE... Visualizza
1795 benarese M. SYNERGISTIC ASSOCIATION OF VALPR... Visualizza
217 Benatti C. THE ROLE OF SNPs ANALYSIS IN NEU... Visualizza
3062 Benatti C. LYMNAEA STAGNALIS AS A NEW MODEL... Visualizza
218 Bencivenni S. A2B adenosine receptors stimulat... Visualizza
219 Benemei S. The antimigraine butterbur ingre... Visualizza
220 Benemei SB. Aromatase inhibitor-evoked pain ... Visualizza
3063 Benetti E. EFFECT OF VITAMIN D ON INSULIN S... Visualizza
3064 Benetti E. SEDENTARY-TIME: EFFECT ON PRO- A... Visualizza
221 Beneventano M. THE CONTRIBUTION OF MICROGLIA TO... Visualizza
222 Benfante R. THE PROGESTIN DESOGESTREL AFFECT... Visualizza
223 Benfante R. NEWLY IDENTIFIED PHOX2B TARGET G... Visualizza
4027 Benfante R. THE ACETYLCHOLINESTERASE DONEPEZ... Visualizza
224 Benfatto G. Ensure patients access to invest... Visualizza
225 Benfatto G. Off-label drug use and safety of... Visualizza
226 Benfatto G. Off-label drug use at the Policl... Visualizza
227 Benfatto G. Off-label drug use at the Univer... Visualizza
228 Bennardo L. ADVERSE DRUG REACTIONS WITH BIOL... Visualizza
229 Bennardo L. ADVERSE DRUG REACTIONS BY BIOLOG... Visualizza
230 Benvenuti F. ACTIVATION OF PPAR_ AS A NEW PHA... Visualizza
231 Benvenuti L. Bifidobacterium Longum and Lacto... Visualizza
232 Benvenuti L. Enteric glia is involved in colo... Visualizza
233 Benvenuti L. APIGENIN SUPPLEMENTATION PREVENT... Visualizza
234 Benvenuti L. EFFECTS OF L-DOPA/BENSERAZIDE CO... Visualizza
4028 Benvenuti L. COMPARATIVE PRE-CLINICAL STUDY O... Visualizza
235 Bereshchenko O. THE EFFECT OF ARA-C TREATMENT ON... Visualizza
236 Bereshchenko O. GLUCOCORTICOID-INDUCED LEUCINE Z... Visualizza
4029 Bereshchenko O. GLUCOCORTICOID-INDUCED LEUCINE Z... Visualizza
237 Bergamini BM. THE ROLE OF SNPs ANALYSIS IN NEU... Visualizza
238 Bergamo A. TARGETING THE CANCER RESISTOME T... Visualizza
4030 Bergamo A. RNA-SEQ ANALYSIS OF DIFFERENTIAL... Visualizza
239 Bernardi F.F. ANALYSIS OF THE ADVERSE DRUG REA... Visualizza
240 Bernardi P. The Impact Of ALDH-2 Activity On... Visualizza
241 Bernardini C. Effects of ethanolic extracts of... Visualizza
3516 Bernardini C. In vitro effects of mediators de... Visualizza
242 Bernardini N. Enteric glia is involved in colo... Visualizza
243 Bernardini N. APIGENIN SUPPLEMENTATION PREVENT... Visualizza
244 Bernardini N. EFFECTS OF L-DOPA/BENSERAZIDE CO... Visualizza
245 Bernardini S. ANTIOXIDANT EFFECTS OF A HYDROXY... Visualizza
246 Bernini DR. ANTI-ATHEROSCLEROTIC EFFECTS OF ... Visualizza
247 Bernini F. Proatherosclerotic effect of tri... Visualizza
248 Bernini F. Vitamin D replacement in pre-men... Visualizza
3065 Bernini SK. Characterization of adipokines s... Visualizza
249 Berretta M. Next generation sequencing for i... Visualizza
250 Berretta M. COST-EVALUATION OF FLUOROPYRIMID... Visualizza
251 Berretta N. VULNERABILITY TO SEIZURES AND AS... Visualizza
252 Berrino L. Ranolazine attenuates adverse my... Visualizza
253 Berrino L. Effects of lung resident mesench... Visualizza
3517 Berrino L. Cardio-renal positive effects of... Visualizza
254 Berruti A. IN VITRO ASSESSMENT OF CABAZITAX... Visualizza
255 Berruti A. In vitro identification of molec... Visualizza
256 Berry SE. IN VITRO AND IN VIVO MODELING OF... Visualizza
257 Bertini M. ESTIMATING INCIDENCE RATES OF AD... Visualizza
258 Bertini M. ROSACEA DURING FINGOLIMOD THERAP... Visualizza
3066 Bertini M. SAFETY OF NEW DIRECT-ACTING ANTI... Visualizza
259 Berton V. TRANSPLANTATION OF MENINGEAL-DER... Visualizza
260 Bertoni S. BENEFICIAL EFFECTS OF PHARMACOLO... Visualizza
3067 Bertoni S. BLOCKADE OF EPHB-EPHRINB SIGNALL... Visualizza
261 Bettiol A. Risk of bone fractures among use... Visualizza
262 Bettiol A. Adverse drug reactions in paedia... Visualizza
263 Bettiol A. Drug-utilization of new oral ant... Visualizza
264 Bettiol A. Pharmacoutilization of Antidiabe... Visualizza
265 Bettiol A. FREQUENCY AND CHARACTERISTICS OF... Visualizza
266 Bettiol A. HEPATITIS C VIRUS (HCV) INFECTIO... Visualizza
3068 Bettiol A. MANAGING CHRONIC MYELOID LEUKEMI... Visualizza
4031 Biagioli M. The bile acid receptor GPBAR1 re... Visualizza
3518 Bianchi R. The proteasome inhibitor bortezo... Visualizza
267 Bianco S. Pathological gambling new therap... Visualizza
3069 Bianco S. IMPORTANCE OF ADHERENCE TO TREAT... Visualizza
268 Biasco E. DETECTION OF AR-V7 IN PLASMA-DER... Visualizza
269 Biasibetti E. SOLID LIPID NANOPARTICLES CARRYI... Visualizza
270 Biasotta A. ADVERSE DRUG REACTIONS ASSOCIATE... Visualizza
271 Bibic L. BIVALENT LIGANDS DISCLOSE GPCR D... Visualizza
272 Bifari F. FATTY ACIDS RESTORE IN VITRO ANG... Visualizza
273 Bifari F. SEX-DEPENDENT EXPRESSION AND FUN... Visualizza
274 Bifari F. TRANSPLANTATION OF MENINGEAL-DER... Visualizza
275 Bifari F. MENINGEAL NEURAL PRECURSORS CONT... Visualizza
276 Bifulco G. DOWN REGULATION OF PRO-INFLAMMAT... Visualizza
277 Bifulco M. RIMONABANT KILLS COLON CANCER ST... Visualizza
278 Bigagli E. Effects of NO and H2S releasing ... Visualizza
3070 Bigagli E. Effects of electronic cigarette ... Visualizza
3071 Bigagli E. AN IN VITRO MODEL FOR SCREENING ... Visualizza
3519 Bigagli E. Nutraceutical properties of Arth... Visualizza
279 Bignucolo A. COST-EVALUATION OF FLUOROPYRIMID... Visualizza
280 Bignucolo A. GENETIC MARKERS IN NUCLEAR RECEP... Visualizza
281 Bilancia R. SEX BIAS IN LIPID MEDIATOR BIOSY... Visualizza
282 Bilel S. Acute behavioral and molecular e... Visualizza
283 Binaschi A. Sestrin 3 as a regulator of pro-... Visualizza
284 Binello A. ANTIPROLIFERATIVE, ANTIOXIDANT A... Visualizza
285 Bini S. Hedonic eating in Prader-Willi s... Visualizza
3072 Bini S. DRUGS PRESCRIPTION AS A MEASURE ... Visualizza
286 Bini V. INHIBITION OF 5-ALPHA REDUCTASE ... Visualizza
3520 Biondi N. Nutraceutical properties of Arth... Visualizza
870 biondini D. ALPHA-1 ANTITRYPSIN (AAT) POLYME... Visualizza
287 Bisecco A. ROSACEA DURING FINGOLIMOD THERAP... Visualizza
288 Bisignano C. IN VITRO EVALUATION OF ANTIOXIDA... Visualizza
289 Bisignano C. IN VITRO AND IN VIVO MODELING OF... Visualizza
290 Bitonto V. THE AGEs INHIBITOR PYRIDOXAMINE ... Visualizza
291 Bitonto V. TOXICOLOGICAL IMPACT OF HIGH FRU... Visualizza
292 Bitto A. CURCUMIN POTENTIATES THE ANTI-IN... Visualizza
293 Bitto A. HIGH VARIABILITY IN TACROLIMUS B... Visualizza
294 Bitto A. MODELING ROS1 TRANSLOCATION IN L... Visualizza
295 Bitto A. Cadmium and its role in brain dy... Visualizza
296 Bitto A. WHITE-TO-BROWN ADIPOSE TRANSDIFF... Visualizza
297 Bitto A. Survivin and NAIP in Human Benig... Visualizza
3073 Bitto A. Activation of the EPOR-b common ... Visualizza
3521 Bitto A. PROTECTIVE EFFECT OF NDP-_-MSH O... Visualizza
3522 Bitto A. LACK OF THE NLRP3 INFLAMMASOME I... Visualizza
4032 Bitto A. FLAVONOIDS CONTAINED IN FLAVOCOX... Visualizza
4156 Bitto A. Adenosine receptor stimulation i... Visualizza
298 Biundo FB. Inhibition of inflammasome activ... Visualizza
299 Biundo FB. PEA/PLD ASSOCIATION, REDUCE INFL... Visualizza
300 Bizzarro V. Effects of Prisma® Skin dermal ... Visualizza
3074 Bizzarro V. Hypoxia regulates ANXA1 expressi... Visualizza
3523 Bizzarro V. ANNEXIN A1 CONTRIBUTES TO PANCRE... Visualizza
301 Blandina P. THE FAT SENSING MOLECULE OLEOYLE... Visualizza
302 Blandina P. An Omega-3 PUFA/Vitamin A enrich... Visualizza
303 Blandini F. EFFECTS OF L-DOPA/BENSERAZIDE CO... Visualizza
304 Blandizzi C. Bifidobacterium Longum and Lacto... Visualizza
305 Blandizzi C. Alteration of visceral sensitivi... Visualizza
306 Blandizzi C. Enteric glia is involved in colo... Visualizza
307 Blandizzi C. APIGENIN SUPPLEMENTATION PREVENT... Visualizza
308 Blandizzi C. EFFECTS OF L-DOPA/BENSERAZIDE CO... Visualizza
309 Blandizzi C. ADVERSE DRUG REACTIONS IN ONCOLO... Visualizza
310 Blandizzi C. A CLINICIAN NETWORK FOR SHARING ... Visualizza
311 Blandizzi C. INTENSIVE MONITORING PROGRAM OF ... Visualizza
3524 Blandizzi C. COMPARATIVE PRE-CLINICAL STUDY O... Visualizza
4120 Blandizzi C. Functional intestinal dysmotilit... Visualizza
312 Blescia S. Angiotensin-II activates p-38 an... Visualizza
313 Blom J. THE ROLE OF SNPs ANALYSIS IN NEU... Visualizza
314 Bluher M. OLFACTORY RECEPTOR 984 A NEW TAR... Visualizza
315 Boccella S. Palmitoylethanolamide Reduces Ne... Visualizza
3075 Boccella S. PALMITOYLETHANOLAMIDE, VIA PPAR-... Visualizza
3525 Boccella S. DIMETHYL FUMARATE REDUCES TACTIL... Visualizza
316 Bocchetta A. PSYCHOTROPIC MEDICATIONS IN MOOD... Visualizza
317 Bocci G. Colon cancer therapy beyond tumo... Visualizza
318 Bocci G. Melanocortin receptor-4 as a nov... Visualizza
319 Boffa L. ANTIPROLIFERATIVE, ANTIOXIDANT A... Visualizza
3526 Boggio E. EFFECTS OF THROMBIN CLEAVAGE OF ... Visualizza
320 Boglione L. A NEW UHPLC-MS/MS METHOD FOR THE... Visualizza
321 Bolcato J. MANAGING CHRONIC MYELOID LEUKEMI... Visualizza
322 Bolcato J. HEPATITIS C VIRUS (HCV) INFECTIO... Visualizza
323 Bolego C. Anti-angiogenic effect of therap... Visualizza
324 Bolego C. G-protein coupled estrogen recep... Visualizza
325 Bolego C. Effects of digitoxin on cell mig... Visualizza
326 Bollati V. CYP27A1 GENETIC POLYMORPHISM IN ... Visualizza
327 Bonacina F. ACTIVITY-BASED ANOREXIA ALTERS N... Visualizza
3076 Bonacina F. Apolipoprotein E modulates adapt... Visualizza
3077 Bonacina F. Fatty acid synthesis is crucial ... Visualizza
328 Bonaldo G. Reporting of adverse drug reacti... Visualizza
329 Bonaldo G. CARDIOVASCULAR SAFETY OF MACROLI... Visualizza
3078 Bonaldo G. DRUGS - INDUCED DISSEMINATED INT... Visualizza
330 Bonanni D. INDOMETHACIN INHIBITS PROLIFERAT... Visualizza
331 Bonanno G. Altered Mechanisms Underlying th... Visualizza
332 Bonanno G. THE DOWN REGULATION OF MGLUR5 AT... Visualizza
333 Bonanno G. Prophylactic versus Therapeutic ... Visualizza
334 Bonanno G. IN-VIVO EFFECTS OF KNOCKING-DOWN... Visualizza
4175 Bonci A. From single synapses to clinical... Visualizza
3079 Bondi H. SALMETEROL, A SELECTIVE AND LONG... Visualizza
335 Bonfiglio T. PHARMACOLOGICAL CHARACTERIZATION... Visualizza
336 Bonfiglio T. Prophylactic versus Therapeutic ... Visualizza
3080 Bonfiglio T. ENVIRONMENTAL TRAINING AMELIORAT... Visualizza
337 Bonifacino T. IN-VIVO EFFECTS OF KNOCKING-DOWN... Visualizza
338 Bonifacino T. THE DOWN REGULATION OF MGLUR5 AT... Visualizza
3081 Bonifacino T. Altered Mechanisms Underlying th... Visualizza
339 Bonifacio A. Surfaced-enhanced Raman spectros... Visualizza
340 Bonifazi D. Failures to further developing o... Visualizza
341 Bonifazi F. Failures to further developing o... Visualizza
342 Bonomi A. CAROTID PLAQUE-THICKNESS AND COM... Visualizza
343 Bordano V. EFFECT OF VITAMIN D ON INSULIN S... Visualizza
344 Bordi P. Monitoring of Epidermal Growth F... Visualizza
345 Bordin F. HOSPICE PALLIATIVE CARE MEDICATI... Visualizza
346 Borea P. A2B adenosine receptors stimulat... Visualizza
347 Borea PA. PULSED ELECTROMAGNETIC FIELDS TR... Visualizza
348 Borea PA. ANTI-NOCICEPTIVE EFFECTS OF NOVE... Visualizza
1 Borrelli F. TRPM8 and experimental colorecta... Visualizza
349 Borrelli F. A COMPARISON BETWEEN A CANNABIS ... Visualizza
350 Borrelli F. ENDOCANNABINOID SYSTEM AND MOUSE... Visualizza
351 Borroni AP. Inhibition of SIRT1 Deacetylase ... Visualizza
3082 Borruto AM. ACTIVATION OF PPAR_ AS A NEW PHA... Visualizza
3527 Borruto AM. TARGETING THE NOCICEPTINE/ORPHAN... Visualizza
352 Borsani E. THERAPEUTIC EFFECT OF SYSTEMIC I... Visualizza
353 Bortolato M. INHIBITION OF 5-ALPHA REDUCTASE ... Visualizza
354 Bortolotto V. SALMETEROL, A SELECTIVE AND LONG... Visualizza
355 Bortolotto V. CONTRIBUTION OF ASTROCYTES TO NE... Visualizza
356 Bortolozzo K. HEPATITIS C VIRUS GENOTYPE 3H: T... Visualizza
357 Bortolozzo K. CLINICAL VALIDATION OF THE REALQ... Visualizza
358 Bortone AS. POTENTIAL MECHANISMS LINKING DEF... Visualizza
359 Boscaro C. Effects of digitoxin on cell mig... Visualizza
3083 Boscaro C. G-protein coupled estrogen recep... Visualizza
360 Boscaro V. INDOMETHACIN INHIBITS PROLIFERAT... Visualizza
361 Boscaro V. VANADIUM COMPOUNDS INHIBIT CELL ... Visualizza
3084 Boscaro V. ANTIPROLIFERATIVE, ANTIOXIDANT A... Visualizza
362 Bosco BF. Sildenafil improves cardiac func... Visualizza
363 Bosco F. Early up-regulation of hepatic m... Visualizza
364 Bosco F. HYPERCHOLESTEROLEMIA MODULATES M... Visualizza
365 Bosello O. A prospective observational stud... Visualizza
366 Bosone E. Failures to further developing o... Visualizza
367 Bossert JM. ROLE OF DORSOMEDIAL STRIATUM NEU... Visualizza
368 Bossi S. IN-VIVO EFFECTS OF KNOCKING-DOWN... Visualizza
4230 Botta C. Identification and validation of... Visualizza
3528 Botta M. High density lipoproteins inhibi... Visualizza
369 Botti G. COX-2 EXPRESSION IN MALIGNANT ME... Visualizza
370 Bottoni U. ADVERSE DRUG REACTIONS WITH BIOL... Visualizza
371 Bouchè A. MENINGEAL NEURAL PRECURSORS CONT... Visualizza
372 Bova G. NABILONE AND THC/CBD FOR THE TRE... Visualizza
373 Bove G. SPA THERAPY: SULPHUROUS MINERAL ... Visualizza
3085 Bove M. STUDYING SOCIAL WITHDRAWAL IN A ... Visualizza
374 Braegger FE. ROLE OF THE AREA POSTREMA IN THE... Visualizza
375 Braida D. BIVALENT LIGANDS DISCLOSE GPCR D... Visualizza
376 Braida D. PROSOCIAL AND ANXIOLYTIC EFFECT ... Visualizza
377 Bramanti P. Growth inhibition, cell-cycle ar... Visualizza
4033 Brambilla M. Vitamin D levels and Tissue Fact... Visualizza
378 Branca J. Into the unexplored pathophysiol... Visualizza
379 Brancaleone V. THE H2S-DONOR, 4-CPI, PROMOTES A... Visualizza
4034 Brancaleone V. DIFFERENT EFFECT OF HYDROGEN SUL... Visualizza
4145 Brancato A. Vesicular glutamate transporter ... Visualizza
380 Breda M. SCREENING OF HUMAN SULFOTRANSFER... Visualizza
381 Breschi M. THE H2S-DONOR, 4-CPI, PROMOTES A... Visualizza
3481 Breschi M.C. NARINGENIN PROTECTS MYOCARDIUM A... Visualizza
382 Breschi MC. Potential relationship between t... Visualizza
383 Breschi MC. MYOCARDIAL ANTI-AGEING EFFECTS O... Visualizza
384 Breschi MC. Role of miR-34a as biomarker and... Visualizza
3529 Breschi MC. ANTICANCER EFFECTS OF NOVEL LDH-... Visualizza
3530 Breschi MC. ANTI-CANCER PROPERTIES OF ERUCIN... Visualizza
385 Bresciani E. miRNA-218 TARGETS LIPIN-1 AND GL... Visualizza
386 Bresciani E. EFFECTS OF HEXARELIN IN A MODEL ... Visualizza
387 Bressanello D. SEDENTARY-TIME: EFFECT ON PRO- A... Visualizza
36 Brini A.T. ASC-DERIVED CONDITIONED MEDIUM (... Visualizza
388 Brini AT. Bisphosphonates modulate bone bi... Visualizza
389 Brini AT. THERAPEUTIC EFFECT OF SYSTEMIC I... Visualizza
390 Brini AT. IMMUNOSURVEILLANCE OF TUMORS: IG... Visualizza
391 Brise1o CG. PROTECTIVE ROLE OF CONVENTIONAL ... Visualizza
3086 Brivio P. INFLUENCE OF CHRONIC STRESS EXPO... Visualizza
3531 Briz O. ë_-Caryophyllene oxide as a new... Visualizza
392 Bronzuoli MR. EFFECT OF ULTRAMICRONIZED-PALMYT... Visualizza
3087 Bronzuoli MR. EFFECT OF PALMYTOILETHANOLAMIDE ... Visualizza
393 Brovedani V. GENETIC IDENTIFICATION OF Na+/K+... Visualizza
394 Brullo C. GEBR-32A, A NEW PROMISING PDE4D ... Visualizza
395 Brunello N. LYMNAEA STAGNALIS AS A NEW MODEL... Visualizza
396 Brunetti L. Peripheral RVD-hemopressin(_) ad... Visualizza
397 Brunetti L. Effects of Growth Hormone-Releas... Visualizza
398 Brunetti L. HARPAGOPHYTUM PROCUMBENS AQUEOUS... Visualizza
3532 Brunetti L. Emotional Disorders Induced by H... Visualizza
399 Bruno A. PLATELET-DEPENDENT ACTIVATION OF... Visualizza
400 Bruno A. Conditioned medium of human peri... Visualizza
401 Bruno A. NEWER LONG-ACTING INJECTABLE ANT... Visualizza
3088 Bruno A. OVER-EXPRESSION OF MIR-574-5P IN... Visualizza
405 Bruno O. GEBR-32A, A NEW PROMISING PDE4D ... Visualizza
406 Brunori G. ACTIVATION OF PPAR_ AS A NEW PHA... Visualizza
407 Brusco S. SAFETY OF NEW DIRECT-ACTING ANTI... Visualizza
3089 Brusco S. ESTIMATING INCIDENCE RATES OF AD... Visualizza
3090 Brusco S. ROSACEA DURING FINGOLIMOD THERAP... Visualizza
408 Bruscoli S. THE EFFECT OF ARA-C TREATMENT ON... Visualizza
3091 Bruscoli S. GLUCOCORTICOID-INDUCED LEUCINE Z... Visualizza
3533 Bruscoli S. GLUCOCORTICOID-INDUCED LEUCINE Z... Visualizza
4133 Bruscoli S. Blucocorticoid and B lymphocytes... Visualizza
409 Bucci M. Kv7 channels are involved in hum... Visualizza
410 Bucci M. THE H2S-DONOR, 4-CPI, PROMOTES A... Visualizza
411 Bucci M. S1PR1, S1PR3 and FTY720 in vascu... Visualizza
3534 Bucci M. DIFFERENT EFFECT OF HYDROGEN SUL... Visualizza
3535 Buckhardt R. Sphingosine 1-Phosphate And Athe... Visualizza
412 Bucolo C. Structure based approach for sea... Visualizza
413 Bucolo C. Effects of Taurine in dry eye mo... Visualizza
414 Bucolo C. Autoregulation of retinal gangli... Visualizza
415 Bucolo C. PALMITOYLETHANOLAMIDE LOADED IN ... Visualizza
416 Bucolo C. Role of TGF-_1 in age-related ma... Visualizza
417 Bucolo C. Sulodexide prevents high glucose... Visualizza
3092 Bucolo C. Small molecules to treat diabeti... Visualizza
3093 Bucolo C. Role of P2X7 receptor in early d... Visualizza
3536 Bucolo C. Buspirone rescues MK-801-induced... Visualizza
3537 Bucolo C. Dopamine D3 receptor-dependent c... Visualizza
4035 Bucolo C. Retinal bioavailability of curcu... Visualizza
4036 Bucolo C. VEGF EXACERBATES DAMAGE INDUCED ... Visualizza
418 Buda S. Healthcare resources use in pati... Visualizza
419 Buda S. Burden of comorbidities in HCV p... Visualizza
420 Bulotta S. Anti-proliferative effects of Cy... Visualizza
421 Buonadonna A. Next generation sequencing for i... Visualizza
422 Buonadonna A. COST-EVALUATION OF FLUOROPYRIMID... Visualizza
423 Buonadonna A. GENETIC MARKERS IN NUCLEAR RECEP... Visualizza
424 Buono L. ENDOCANNABINOID SYSTEM AND MOUSE... Visualizza
425 Burke LK. Hypothalamic Circuit Mediates Th... Visualizza
426 Burrai C. PSYCHOTROPIC MEDICATIONS IN MOOD... Visualizza
427 Buscaglia E. Gamma-hydroxybutyrate intoxicati... Visualizza
428 Buscaglia E. Antidote treatment in Viper enve... Visualizza
3094 Buscaglia E. Analytically confirmed post-inje... Visualizza
3095 Buscaglia E. Methotrexate therapeutic error i... Visualizza
3096 Busnelli M. BIVALENT LIGANDS DISCLOSE GPCR D... Visualizza
4037 Busnelli M. KCC2 is a key target of oxytocin... Visualizza
429 Butelman ER. EFFECTS OF A NOVEL SELECTIVE SHO... Visualizza
3097 Buzzella A. AN ALTERNATIVE METHOD FOR EVALUA... Visualizza
432 Caberlotto L. Cross-Disease Analysis of Alzhei... Visualizza
433 Cacciola F. Evaluation of protective effect ... Visualizza
434 Caccuri AM. SCREENING OF HUMAN SULFOTRANSFER... Visualizza
435 Cadamuro S. VANADIUM COMPOUNDS INHIBIT CELL ... Visualizza
3538 Caderni G. INHIBITION OF SPONTANEOUS COLON ... Visualizza
3539 Caderni G. Potential of a flavonoid-rich ex... Visualizza
436 Cadossi M. PULSED ELECTROMAGNETIC FIELDS TR... Visualizza
437 Cadossi R. PULSED ELECTROMAGNETIC FIELDS TR... Visualizza
438 Caffino L. ACTIVITY-BASED ANOREXIA ALTERS N... Visualizza
439 Caffino L. REPEATED EXPOSURE TO COCAINE DUR... Visualizza
3098 Caffino L. Acute behavioral and molecular e... Visualizza
4038 Caffino L. POST-SYNAPTIC GLUTAMATE DYSFUNCT... Visualizza
4151 Caffino L. Adolescent exposure to cocaine i... Visualizza
4178 Caffo M. Role of dickkopf-related protein... Visualizza
4039 Caiazzo E. A ROLE FOR FIBROBLAST GROWTH FAC... Visualizza
441 Calabrese F. INFLUENCE OF CHRONIC STRESS EXPO... Visualizza
1168 calabrese F. ALPHA-1 ANTITRYPSIN (AAT) POLYME... Visualizza
442 Calabresi L. Recombinant LCAT rescues defecti... Visualizza
3541 Calabresi L. High density lipoproteins inhibi... Visualizza
443 Calabro' M. In search of biological substant... Visualizza
444 Calafiore R. Prevention of diabetes in NOD mi... Visualizza
445 Calapai F. NABILONE AND THC/CBD FOR THE TRE... Visualizza
446 Calapai F. PHYTO.VIG.GEST: "VIGILANCE ON US... Visualizza
447 Calapai G. NABILONE AND THC/CBD FOR THE TRE... Visualizza
448 Calapai G. PHYTO.VIG.GEST: "VIGILANCE ON US... Visualizza
4198 Calapai G. Nutraceuticals pre-clinical rese... Visualizza
449 Calcabrini C. Creatine preserves the myogenic ... Visualizza
450 Calcabrini C. A NEW SYNTHETIC ISOTHIOCYANATE D... Visualizza
3542 Calcabrini C. NON THERMAL PLASMA AS INNOVATIVE... Visualizza
3099 Calcagnini S. BEHAVIOURAL AND NEUROPATHOLOGICA... Visualizza
451 Calcagno E. cGMP MODULATES LONG-TERM POTENTI... Visualizza
452 Calcagno E. GEBR-32A, A NEW PROMISING PDE4D ... Visualizza
453 Caldeira G. STARGAZIN REGULATES THE BIOCHEMI... Visualizza
454 Calderaro A. IN VITRO EVALUATION OF ANTIOXIDA... Visualizza
455 Calderone V. MYOCARDIAL ANTI-AGEING EFFECTS O... Visualizza
456 Calderone V. Kv7 channels are involved in hum... Visualizza
457 Calderone V. 3-Mercaptopyruvate relaxes aorta... Visualizza
458 Calderone V. THE H2S-DONOR, 4-CPI, PROMOTES A... Visualizza
3486 Calderone V. NARINGENIN PROTECTS MYOCARDIUM A... Visualizza
3543 Calderone V. ANTICANCER EFFECTS OF NOVEL LDH-... Visualizza
3544 Calderone V. ANTI-CANCER PROPERTIES OF ERUCIN... Visualizza
459 Calevro A. STUDY ON PROTECTIVE ACTION OF HY... Visualizza
3545 Calevro A. PROTECTIVE EFFECT OF NDP-_-MSH O... Visualizza
460 Calignano A. THE FAT SENSING MOLECULE OLEOYLE... Visualizza
461 Calignano A. Hypothalamic Circuit Mediates Th... Visualizza
462 Calignano A. N-(1-CARBAMOYL-2-PHENYLETHYL) BU... Visualizza
463 Calignano A. BUTYRATE ATTENUATES MOTOR DEFICI... Visualizza
464 Calignano A. PALMITOYLETAHNOLAMIDE ATTENUATES... Visualizza
465 Calignano A. Behavioral and Metabolic Charact... Visualizza
466 Calignano A. DOWN REGULATION OF PRO-INFLAMMAT... Visualizza
467 Calignano A. PHARMACOLOGICAL EFFECT OF PERAMP... Visualizza
3546 Calignano A. BUTYRATE REDUCES VALPROATE-INDUC... Visualizza
468 Calissano P. Involvement of bradykinin B2 rec... Visualizza
440 Calò G. PHARMACOLOGICAL CHARACTERIZATION... Visualizza
469 Calvani M. Enhancement of cardiac different... Visualizza
3540 Cal˜ G. NOP RECEPTOR AND FUNCTIONAL SELE... Visualizza
3547 Cameli M. REMODELING OF ATRIAL REPOLARIZAT... Visualizza
3548 Camera M. Vitamin D levels and Tissue Fact... Visualizza
3549 Camera M. Shedding light on PCSK9 function... Visualizza
3100 Camerino C. COLD STRESS CHALLENGE IS ASSOCIA... Visualizza
4150 Camerino G. M. Correlation between long-lasting... Visualizza
470 Camerino GM. GROWTH HORMONE SECRETAGOGUES PRE... Visualizza
471 Camerino GM. NEW BIOMARKERS IN ALS ETIOLOGY: ... Visualizza
472 Camerino GM. Gender-dependent involvement of ... Visualizza
473 Camerino GM. DEVELOPMENT OF NOVEL LACTATE-NA2... Visualizza
474 Camerino GM. SKELETAL MUSCLE CLC-1 CHANNEL: F... Visualizza
475 Camerino GM. EFFECT OF A LONG TERM TREATMENT ... Visualizza
476 Camerino GM. IN VIVO AND IN VITRO PRECLINICAL... Visualizza
3101 Camerino GM. STATIN THERAPY: CLC-1 CHLORIDE C... Visualizza
477 Camero S. THE EPHRIN RECEPTOR KINASE INHIB... Visualizza
3102 Cammarota S. Increasing trend in admission ra... Visualizza
478 Campanella F. IRREVERSIBLE BK CHANNEL BLOCKING... Visualizza
479 Campiglia P. PALMITOYLETHANOLAMIDE LOADED IN ... Visualizza
480 Campisi M. CYP27A1 GENETIC POLYMORPHISM IN ... Visualizza
481 Campolo M. Intestine as a Source of Inflamm... Visualizza
482 Campolo M. Dimethyl fumarate attenuates neu... Visualizza
483 Campolo M. Multiple mechanisms of dimethyl ... Visualizza
484 Campolo M. Absence of TLR4 reduces neuroinf... Visualizza
485 Campolo MC. Inhibition of inflammasome activ... Visualizza
486 Campolongo P. AMPHETAMINE AND THE "BATH SALT" ... Visualizza
487 Campolongo P. Involvement of the Prokineticin ... Visualizza
3550 Camussi G. Megalin and Sodium-Hydrogen Exch... Visualizza
488 Can, PD. Chronic Oleoylethanolamide Treat... Visualizza
489 Canalini F. STUDY ON PROTECTIVE ACTION OF HY... Visualizza
4040 Canalini F. PROTECTIVE EFFECT OF NDP-_-MSH O... Visualizza
490 Cananzi P. Trends in Spontaneous Adverse Dr... Visualizza
491 Cananzi P. Access to the market of medicine... Visualizza
492 Cananzi P. Intravitreal anti-VEGF injection... Visualizza
493 Cananzi P. EVALUATION OF HEALTH DIRECT COST... Visualizza
494 Cananzi P. Real world data about biosimilar... Visualizza
495 Canazza I. Acute behavioral and molecular e... Visualizza
3551 Cancedda L. Intracellular chloride accumulat... Visualizza
3552 Canciani B. Shedding light on PCSK9 function... Visualizza
3553 Candeletti S. N/OFQ and CRF systems dysregulat... Visualizza
496 Candelletti S. Selective dynorphin and nocicept... Visualizza
497 Canevini MP. OVERTREATMENT IN PHARMACORESISTA... Visualizza
498 Canistro D. Effects of electronic cigarette ... Visualizza
499 Canistro D. The chemopreventive effects of i... Visualizza
500 Canistro D. Development of microparticles fo... Visualizza
3103 Canistro D. E-CIGARETTES INDUCE TOXICOLOGICA... Visualizza
4240 Cannataro M. Identification and validation of... Visualizza
501 Cannataro R. Therapeutic benefits of methylxa... Visualizza
502 Cannavò S. Real world data about biosimilar... Visualizza
4041 Cannella N. TARGETING THE NOCICEPTINE/ORPHAN... Visualizza
503 Cannizzaro L. UNRAVELING THE MECHANISM OF ACTI... Visualizza
504 Canonico PL. SALMETEROL, A SELECTIVE AND LONG... Visualizza
505 Canonico PL. The pharmacogenetics of the resp... Visualizza
506 Cantalupo A. S1PR1, S1PR3 and FTY720 in vascu... Visualizza
507 Cantatore P. GROWTH HORMONE SECRETAGOGUES PRE... Visualizza
508 Cantile C. SAFETY OF NEW DIRECT-ACTING ANTI... Visualizza
509 Cantile C. ESTIMATING INCIDENCE RATES OF AD... Visualizza
510 Cantoni AM. BENEFICIAL EFFECTS OF PHARMACOLO... Visualizza
511 Cantoni AM. BLOCKADE OF EPHB-EPHRINB SIGNALL... Visualizza
3554 Canzano P. Vitamin D levels and Tissue Fact... Visualizza
512 Caparrotta L. GLUCOSE-6-PHOSPHATE DEHYDROGENAS... Visualizza
3104 Capasso A. HYPERPROLACTINEMIA INDUCED BY AN... Visualizza
3105 Capasso A. DO CANNABINOIDS CONFER NEUROPROT... Visualizza
3106 Capasso A. THE PSYCHOBIOLOGY OF ENDOCANNABI... Visualizza
3107 Capasso A. BENEFICAL EFFECTS OF POLYPHENOLS... Visualizza
3108 Capasso A. PROTECTIVE EFFECT OF HDAC INHIBI... Visualizza
3109 Capasso A. CANNABINOIDS INVOLVEMENT IN NEUR... Visualizza
513 Capasso C. Role of miR-34a as biomarker and... Visualizza
514 Capasso R. A COMPARISON BETWEEN A CANNABIS ... Visualizza
515 Capogrosso RF. EFFECT OF A LONG TERM TREATMENT ... Visualizza
516 Capogrosso RF. A LONG TERM TREATMENT WITH TAURI... Visualizza
517 Capogrosso RF. IN VIVO AND IN VITRO PRECLINICAL... Visualizza
518 Capogrosso sansone A. INTENSIVE MONITORING PROGRAM OF ... Visualizza
519 Capogrosso sansone A. ADVERSE DRUG REACTIONS IN ONCOLO... Visualizza
520 Capogrosso-sansone A. A CLINICIAN NETWORK FOR SHARING ... Visualizza
3555 Capone ML. REDUCED VARIABILITY TO ASPIRIN A... Visualizza
521 Caporarello N. Sulodexide prevents high glucose... Visualizza
522 Capovilla G. OVERTREATMENT IN PHARMACORESISTA... Visualizza
523 Cappetta D. Ranolazine attenuates adverse my... Visualizza
524 Cappetta D. Effects of lung resident mesench... Visualizza
4042 Cappetta D. Cardio-renal positive effects of... Visualizza
525 Caprioli D. ROLE OF DORSOMEDIAL STRIATUM NEU... Visualizza
3556 Caprodossi A. Platelet-derived microparticles ... Visualizza
526 Capuano A. ROSACEA DURING FINGOLIMOD THERAP... Visualizza
527 Capuano A. ANALYSIS OF THE ADVERSE DRUG REA... Visualizza
528 Capuano A. ESTIMATING INCIDENCE RATES OF AD... Visualizza
529 Capuano A. SAFETY OF NEW DIRECT-ACTING ANTI... Visualizza
530 Capuano A. LONG TERM DRUG SAFETY IN CHILDRE... Visualizza
531 Capuano A. GENDER SPECIFIC DRUG USE IN PEDI... Visualizza
4125 Capuano A. Orphan drugs: post-marketing sur... Visualizza
4195 Capuano A. Monitoring of psychiatric drugs ... Visualizza
532 Capucchio MT. SOLID LIPID NANOPARTICLES CARRYI... Visualizza
4114 Caputi F. F. Addictive drugs and epigenetic r... Visualizza
535 Caputi FF. Selective dynorphin and nocicept... Visualizza
4043 Caputi FF. N/OFQ and CRF systems dysregulat... Visualizza
533 Caputi V. Antibiotic-induced dysbiosis aff... Visualizza
534 Caputi V. Changes of small bowel inhibitor... Visualizza
536 Caputi V. EFFECT OF ANTIBIOTIC-INDUCED DYS... Visualizza
537 Caputi V. Enteric glia is involved in colo... Visualizza
3110 Caputi V. Involvement of catechol-O-methyl... Visualizza
3557 Caraci F. Buspirone rescues MK-801-induced... Visualizza
3558 Caraci F. Dopamine D3 receptor-dependent c... Visualizza
4141 Caraci F. b-Amyloid and cell cycle activat... Visualizza
538 Caramuscio R. Retrospective study on ItaliaN A... Visualizza
3115 carbone C. DIFFERENTIAL CONTRIBUTION OF IH ... Visualizza
539 Carbone M. Analytically confirmed post-inje... Visualizza
3111 Carboni L. Cross-Disease Analysis of Alzhei... Visualizza
4044 Carboni L. Rat Nicotine Sensitization Modul... Visualizza
540 Carcieri C. A NEW UHPLC-MS/MS METHOD FOR THE... Visualizza
541 Cardani S. NEWLY IDENTIFIED PHOX2B TARGET G... Visualizza
3112 Cardani S. THE PROGESTIN DESOGESTREL AFFECT... Visualizza
3559 Cardani S. THE ACETYLCHOLINESTERASE DONEPEZ... Visualizza
542 Cardellicchio M. Tryptophan 2,3-dioxygenase inhib... Visualizza
543 Cardenia V. E-CIGARETTES INDUCE TOXICOLOGICA... Visualizza
544 Cardia L. NABILONE AND THC/CBD FOR THE TRE... Visualizza
545 Cardile V. ROSMARINUS OFFICINALIS EXTRACT P... Visualizza
4135 Cardinale D. Cardiotoxicity-induced by antitu... Visualizza
3113 Cargnin S. The pharmacogenetics of the resp... Visualizza
3114 Cari L. Prevention of diabetes in NOD mi... Visualizza
3560 Cari L. GLUCOCORTICOID-INDUCED LEUCINE Z... Visualizza
546 Carini M. UNRAVELING THE MECHANISM OF ACTI... Visualizza
3561 Carino A. The bile acid receptor GPBAR1 re... Visualizza
3562 Carli M. Clozapine as the most efficaciou... Visualizza
547 Carmeliet P. MENINGEAL NEURAL PRECURSORS CONT... Visualizza
548 Carnovale C. MARKAR survey: influence of dire... Visualizza
3116 Carnovale C. On the possible relationship bet... Visualizza
4205 Carnovale C. Management of therapy in a pedia... Visualizza
4115 Carola V. Exposure to childhood maltreatme... Visualizza
549 Caroleo MC. Myotrophin and miR-375 as pharma... Visualizza
550 Carozzi V. Understanding the pathogenesis o... Visualizza
551 Carpi S. Potential relationship between t... Visualizza
552 Carpi S. APIGENIN SUPPLEMENTATION PREVENT... Visualizza
3117 Carpi S. Role of miR-34a as biomarker and... Visualizza
553 Carradori S. HARPAGOPHYTUM PROCUMBENS AQUEOUS... Visualizza
554 Carrara M. Antiproliferative effect of Cuba... Visualizza
555 Carratù M. COLD STRESS CHALLENGE IS ASSOCIA... Visualizza
3 Carratù M.R. SEARCHING FOR NOVEL DRUGS IN MYO... Visualizza
556 Carratù MR. DEVELOPMENT OF NEW BENZOTHIAZOLA... Visualizza
557 Carresi C. Early up-regulation of hepatic m... Visualizza
558 Carresi C. Impaired glucose and lipid metab... Visualizza
559 Carresi C. HYPERCHOLESTEROLEMIA MODULATES M... Visualizza
3118 Carresi C. BERGAMOT POLYPHENOLS PROTECT AGA... Visualizza
560 Carresi CC. Sildenafil improves cardiac func... Visualizza
561 Carrubba A. Phytochemical Profile and Photot... Visualizza
4186 Carr“ M. T. Energy metabolism as a target fo... Visualizza
562 Carta F. CARBONIC ANHYDRASE IX AND COX-2 ... Visualizza
563 Cartocci V. CHANGES IN THE ENDOCANNABINOID S... Visualizza
564 Caruso D. Fatty acid synthesis is crucial ... Visualizza
565 Caruso D. INHIBITION OF 5-ALPHA REDUCTASE ... Visualizza
566 Carvalho AL. STARGAZIN REGULATES THE BIOCHEMI... Visualizza
567 Casamassima D. Evaluation of protective effect ... Visualizza
568 Casella M. Fluoroscopy-associated oxidative... Visualizza
569 Caselli G. Characterization of adipokines s... Visualizza
570 Cases DR. ANTI-ATHEROSCLEROTIC EFFECTS OF ... Visualizza
571 Casili G. Multiple mechanisms of dimethyl ... Visualizza
572 Casili G. Absence of TLR4 reduces neuroinf... Visualizza
3119 Casili G. Dimethyl fumarate attenuates neu... Visualizza
573 Cassano T. EFFECT OF PALMYTOILETHANOLAMIDE ... Visualizza
574 Cassano T. BEHAVIOURAL AND NEUROPATHOLOGICA... Visualizza
575 Cassano T. EFFECT OF ULTRAMICRONIZED-PALMYT... Visualizza
4164 Cassano T. "The ugly the bad and the good":... Visualizza
576 Cassano V. TOCILIZUMAB'S EFFECT ON EPILEPTO... Visualizza
3120 Castaldo P. INVOLVEMENT OF NCX IN GLUTAMATE-... Visualizza
3563 Castaldo P. PIVOTAL ROLE OF NCX1 IN GLUTAMAT... Visualizza
577 Castellani G. EFFECT OF ANTIBIOTIC-INDUCED DYS... Visualizza
3121 Castellani G. Effect of amphetamine on choroid... Visualizza
578 Castelli R. BLOCKADE OF EPHB-EPHRINB SIGNALL... Visualizza
3564 Castelli R. DUAL TARGETING OF EPH-EPHRIN SYS... Visualizza
579 Castellotti B. Compound heterozygosis in the kc... Visualizza
3122 Casula M. USE OF PROTON PUMP INHIBITORS AN... Visualizza
580 Cataldi A. CM554, A NEW POTENT AND SELECTIV... Visualizza
581 Catanzaro D. ROLE OF MITOCHONDRIA IN CISPLATI... Visualizza
3123 Catanzaro D. GLUCOSE-6-PHOSPHATE DEHYDROGENAS... Visualizza
3124 Catanzaro E. A NEW SYNTHETIC ISOTHIOCYANATE D... Visualizza
3565 Catanzaro E. NON THERMAL PLASMA AS INNOVATIVE... Visualizza
582 Catanzaro M. MODULATION OF OXIDATIVE AND INFL... Visualizza
583 Catapano A. Fatty acid synthesis is crucial ... Visualizza
584 Catapano A. Apolipoprotein E modulates adapt... Visualizza
585 Catapano AL. USE OF PROTON PUMP INHIBITORS AN... Visualizza
3566 Catapano AL. PCSK9 (PROPROTEIN CONVERTASE SUB... Visualizza
3567 Catarinicchia S. Megalin and Sodium-Hydrogen Exch... Visualizza
586 Catarzi D. ANTI-NOCICEPTIVE EFFECTS OF NOVE... Visualizza
587 Cattaneo L. Altered Mechanisms Underlying th... Visualizza
588 Cattaneo L. IN-VIVO EFFECTS OF KNOCKING-DOWN... Visualizza
589 Cattaneo MG. FATTY ACIDS RESTORE IN VITRO ANG... Visualizza
3125 Cattaneo MG. SEX-DEPENDENT EXPRESSION AND FUN... Visualizza
590 Cavagnoli R. Characterization of adipokines s... Visualizza
591 Cavalca V. Fluoroscopy-associated oxidative... Visualizza
3568 Cavalca V. POOR RESPONSIVENESS TO LOW-DOSE ... Visualizza
592 Cavaletti G. Understanding the pathogenesis o... Visualizza
3569 Cavaliere G. BUTYRATE REDUCES VALPROATE-INDUC... Visualizza
593 Cavallaro S. Involvement of bradykinin B2 rec... Visualizza
3570 Cavalleri L. KETAMINE INDUCED STRUCTURAL PLAS... Visualizza
594 Cavaluzzi MM. DEVELOPMENT OF NEW BENZOTHIAZOLA... Visualizza
595 Caviglioli G. Subcutaneous slow-release metfor... Visualizza
596 Ceccarelli G. OBSERVATIONAL, PROSPECTIVE CLINI... Visualizza
597 Cecchin E. Next generation sequencing for i... Visualizza
598 Cecchin E. COST-EVALUATION OF FLUOROPYRIMID... Visualizza
599 Cecchin E. GENETIC MARKERS IN NUCLEAR RECEP... Visualizza
600 Ceci A. Failures to further developing o... Visualizza
601 Cedazo-minguez A. Cross-Disease Analysis of Alzhei... Visualizza
602 Celano M. Anti-proliferative effects of Cy... Visualizza
603 Celano M. Evaluation of protective effect ... Visualizza
604 Celestino I. Antiviral and antioxidant activi... Visualizza
605 Cella SG. DRUGS PRESCRIPTION AS A MEASURE ... Visualizza
606 Cella SG. Hedonic eating in Prader-Willi s... Visualizza
607 Cellini M. THE ROLE OF SNPs ANALYSIS IN NEU... Visualizza
608 Cento AS. TOXICOLOGICAL IMPACT OF HIGH FRU... Visualizza
609 Cento AS. THE AGEs INHIBITOR PYRIDOXAMINE ... Visualizza
610 Cerantola S. Changes of small bowel inhibitor... Visualizza
611 Cerantola S. Involvement of catechol-O-methyl... Visualizza
612 Cerantola S. Enteric glia is involved in colo... Visualizza
3126 Cerantola S. Antibiotic-induced dysbiosis aff... Visualizza
613 Cerbai E. Angiotensin-II activates p-38 an... Visualizza
614 Cerbai E. Enhancement of cardiac different... Visualizza
1079 Cerbai E. Isoform-selective blockade of HC... Visualizza
3571 Cerbai E. EFFECT OF RACEMIC AND LEVO-METHA... Visualizza
3572 Cerbai E. REMODELING OF ATRIAL REPOLARIZAT... Visualizza
4192 Cerbai E. Ion channels and cardiac disease... Visualizza
615 Ceriani M. EFFECT OF CANNABIGEROL, A NON-PS... Visualizza
616 Cerlesi MC. PHARMACOLOGICAL CHARACTERIZATION... Visualizza
617 Cermenati G. Fatty acid synthesis is crucial ... Visualizza
618 Cerretani D. NO level and oxidative stress in... Visualizza
619 Cerri S. EFFECTS OF L-DOPA/BENSERAZIDE CO... Visualizza
620 Cerullo V. Role of miR-34a as biomarker and... Visualizza
621 Cervelli M. VULNERABILITY TO SEIZURES AND AS... Visualizza
622 Cervetto C. PHARMACOLOGICAL CHARACTERIZATION... Visualizza
623 Cervetto C. CHEMOTHERAPY-INDUCED NEUROPATHIC... Visualizza
3127 Cervetto C. VULNERABILITY TO SEIZURES AND AS... Visualizza
624 Charlier B. A novel methodology for the dosa... Visualizza
625 Charlier B. Health status and concomitant pr... Visualizza
3573 Chazot PL. Megalin and Sodium-Hydrogen Exch... Visualizza
626 Chegaev K. Effects of NO and H2S releasing ... Visualizza
627 Chegaev K. IN VITRO CARDIOVASCULAR TOXICITY... Visualizza
628 Chen J. Functional interaction between n... Visualizza
3574 Chen J. THE ANTI-INFLAMMATORY PROTEIN AN... Visualizza
629 Chessa S. IN VITRO AND IN VIVO MODELING OF... Visualizza
3575 Chiamulera C. KETAMINE INDUCED STRUCTURAL PLAS... Visualizza
3576 Chiamulera C. THE MULTIPLE EFFECTS OF THE KETA... Visualizza
3577 Chiamulera C. METAPLASTIC TREATMENTS WITH KETA... Visualizza
3578 Chiamulera C. POST-SYNAPTIC GLUTAMATE DYSFUNCT... Visualizza
3579 Chiappalone M. Intracellular chloride accumulat... Visualizza
630 Chiara C. Targeting nicotinamide phosphory... Visualizza
632 Chiariotti L. Behavioral and Metabolic Charact... Visualizza
633 Chiavaroli A. Peripheral RVD-hemopressin(_) ad... Visualizza
634 Chiavaroli A. Effects of Growth Hormone-Releas... Visualizza
3128 Chiavaroli A. HARPAGOPHYTUM PROCUMBENS AQUEOUS... Visualizza
3580 Chiavaroli A. Emotional Disorders Induced by H... Visualizza
635 Chiazza F. EFFECT OF VITAMIN D ON INSULIN S... Visualizza
3129 Chiazza F. THE AGEs INHIBITOR PYRIDOXAMINE ... Visualizza
3130 Chiazza F. TOXICOLOGICAL IMPACT OF HIGH FRU... Visualizza
4045 Chiazza F. THE ANTI-INFLAMMATORY PROTEIN AN... Visualizza
3581 Chiechio S. Chronic treatment with fluoxetin... Visualizza
636 Chillotti C. CONVERGENT ANALYSIS OF GENOME-WI... Visualizza
637 Chillotti C. SPRUE-LIKE ENTEROPATHY ASSOCIATE... Visualizza
638 Chinellato A. EVALUATION OF HEALTH DIRECT COST... Visualizza
639 Chinellato A. Real world data about biosimilar... Visualizza
640 Chinellato A. MANAGING CHRONIC MYELOID LEUKEMI... Visualizza
641 Chinellato A. NSAIDs utilization in a large co... Visualizza
642 Chinellato A. HEPATITIS C VIRUS (HCV) INFECTIO... Visualizza
643 Chini B. BIVALENT LIGANDS DISCLOSE GPCR D... Visualizza
3582 Chini B. KCC2 is a key target of oxytocin... Visualizza
644 Chini MG. DOWN REGULATION OF PRO-INFLAMMAT... Visualizza
3583 Chiocchetti A. EFFECTS OF THROMBIN CLEAVAGE OF ... Visualizza
3584 Chiodelli P. DUAL TARGETING OF EPH-EPHRIN SYS... Visualizza
3585 Chisari M. Dopamine D3 receptors control dy... Visualizza
645 Chou TH. Autoregulation of retinal gangli... Visualizza
646 Christofori G. PGE2 SIGNALING INDUCES EGFR NUCL... Visualizza
647 Ciabatti E. The ABCB1 pharmacogenetics of R-... Visualizza
648 Ciana P. Inhibition of SIRT1 Deacetylase ... Visualizza
649 Cibelli A. SKELETAL MUSCLE CLC-1 CHANNEL: F... Visualizza
3586 Cicala C. A ROLE FOR FIBROBLAST GROWTH FAC... Visualizza
650 Cicala G. ADVERSE DRUG REACTIONS ASSOCIATE... Visualizza
1245 Cicala G. Safety profile of antipsychotic ... Visualizza
651 Ciccarelli M. CARDIOTOXIC EFFECTS OF SHORT-TER... Visualizza
652 Ciccocioppo R. PPARγ Acti vati on reduces alco... Visualizza
653 Ciccocioppo R. ACTIVATION OF PPAR_ AS A NEW PHA... Visualizza
3587 Ciccocioppo R. N/OFQ and CRF systems dysregulat... Visualizza
3588 Ciccocioppo R. TARGETING THE NOCICEPTINE/ORPHAN... Visualizza
3131 Ciccone V. Tumor stemness and cancer drug-r... Visualizza
4138 Cicero A. F. Clinical research applied to nut... Visualizza
3589 Cidlowski JA. A NOVEL INTERACTION BETWEEN GLUC... Visualizza
654 Cifani C. ROLE OF THE AREA POSTREMA IN THE... Visualizza
655 Cifani C. OLFACTORY RECEPTOR 984 A NEW TAR... Visualizza
4154 Cifani C. Corticotropin-releasing hormone ... Visualizza
656 Cignarella A. Effects of digitoxin on cell mig... Visualizza
657 Cignarella A. G-protein coupled estrogen recep... Visualizza
658 Cimino F. In Vitro Protective Effects of C... Visualizza
659 Cimino F. Curcumin Potentiates Antitumor A... Visualizza
660 Cimino F. Curcumin Ameliorates the In Vitr... Visualizza
661 Cimino F. Phytochemical Profile and Photot... Visualizza
3590 Cimino F. Alpha-Lipoic Acid, But Not Dihyd... Visualizza
662 Cimino M. THE EFFECT OF ARA-C TREATMENT ON... Visualizza
663 Cimino M. FUNCTIONAL COMPARISON AMONG THRE... Visualizza
664 Cimino S. Survivin and NAIP in Human Benig... Visualizza
665 Cimmaruta D. ANALYSIS OF THE ADVERSE DRUG REA... Visualizza
666 Cimmaruta D. LONG TERM DRUG SAFETY IN CHILDRE... Visualizza
667 Cinci L. AN IN VITRO MODEL FOR SCREENING ... Visualizza
3132 Cinci L. Effects of NO and H2S releasing ... Visualizza
3591 Cinci L. Nutraceutical properties of Arth... Visualizza
3592 Cinti S. ANTI-CANCER PROPERTIES OF ERUCIN... Visualizza
668 Cioccoloni G. ANTIOXIDANT EFFECTS OF A HYDROXY... Visualizza
669 Cione E. Myotrophin and miR-375 as pharma... Visualizza
670 Ciotti MT. Involvement of bradykinin B2 rec... Visualizza
3593 Cipriani S. The bile acid receptor GPBAR1 re... Visualizza
3594 Ciranna L. Dopamine D3 receptors control dy... Visualizza
671 Cirillo S. E-CIGARETTES INDUCE TOXICOLOGICA... Visualizza
672 Cirillo S. Effects of electronic cigarette ... Visualizza
673 Cirillo S. The chemopreventive effects of i... Visualizza
3133 Cirillo S. Development of microparticles fo... Visualizza
674 Cirino G. ACETYL DEACYLASADISULFIDE, A NAT... Visualizza
675 Cirino G. Modulation of the inflammatory r... Visualizza
676 Cirino G. COX-2 EXPRESSION IN MALIGNANT ME... Visualizza
677 Cirino G. Kv7 channels are involved in hum... Visualizza
678 Cirino G. TLR4 IS INVOLVED IN S1P/S1P1 PAT... Visualizza
679 Cirino G. THE H2S-DONOR, 4-CPI, PROMOTES A... Visualizza
680 Cirino G. 3-Mercaptopyruvate relaxes aorta... Visualizza
3595 Cirino G. Hydrogen sulfide pathway as a ne... Visualizza
3596 Cirino G. SEX-DEPENDENT ROLE OF LEUKOTRIEN... Visualizza
3597 Cirino G. DIFFERENT EFFECT OF HYDROGEN SUL... Visualizza
3598 Cirino GC. KEY PATHWAYS AND EMERGING PLAYER... Visualizza
3134 Cirmi S. Growth inhibition, cell-cycle ar... Visualizza
3599 Cirmi S. Potential of a flavonoid-rich ex... Visualizza
3135 Cirronis M. TAGATOSE BENEFICIAL EFFECTS IN A... Visualizza
681 Citarella A. Increasing trend in admission ra... Visualizza
682 Citi V. MYOCARDIAL ANTI-AGEING EFFECTS O... Visualizza
683 Citi V. Kv7 channels are involved in hum... Visualizza
684 Citi V. 3-Mercaptopyruvate relaxes aorta... Visualizza
685 Citi V. THE H2S-DONOR, 4-CPI, PROMOTES A... Visualizza
3600 Citi V. ANTI-CANCER PROPERTIES OF ERUCIN... Visualizza
3994 Citi V. NARINGENIN PROTECTS MYOCARDIUM A... Visualizza
4046 Citi V. ANTICANCER EFFECTS OF NOVEL LDH-... Visualizza
686 Citraro R. PHARMACOLOGICAL EFFECT OF PERAMP... Visualizza
687 Citraro R. MONITORING SAFETY AND USE OF OLD... Visualizza
688 Citraro R. VILDAGLIPTIN IMPROVES ANIMAL BEH... Visualizza
689 Citraro R. TOCILIZUMAB'S EFFECT ON EPILEPTO... Visualizza
3136 Citraro R. EFFECTS OF HISTONE DEACETYLASE I... Visualizza
690 Ciuffreda LP. Effects of lung resident mesench... Visualizza
3137 Ciuffreda LP. Ranolazine attenuates adverse my... Visualizza
3601 Ciuffreda LP. Cardio-renal positive effects of... Visualizza
691 Clark A. THE ROLE OF THE mRNA BINDING PRO... Visualizza
692 Clemente N. SOLID LIPID NANOPARTICLES CARRYI... Visualizza
3602 Clemente N. EFFECTS OF THROMBIN CLEAVAGE OF ... Visualizza
693 Clementi E. On the possible relationship bet... Visualizza
694 Clementi E. MARKAR survey: influence of dire... Visualizza
4196 Clementi E. Pharmacovigilance and Pharmacoge... Visualizza
695 Cocchi M. An Omega-3 PUFA/Vitamin A enrich... Visualizza
696 Cocchi V. 6-(METHYLSULFINYL)HEXYLISOTHIOCY... Visualizza
697 Cocchi V. CASTANEA SATIVA MILL. BARK EXTRA... Visualizza
3138 Cocetta V. ROLE OF MITOCHONDRIA IN CISPLATI... Visualizza
698 Cocolin L. TOXICOLOGICAL IMPACT OF HIGH FRU... Visualizza
699 Coe D. Apolipoprotein E modulates adapt... Visualizza
700 Coggi D. CAROTID PLAQUE-THICKNESS AND COM... Visualizza
701 Coggi D. A PRIORI-DEFINED MEDITERRANEAN-L... Visualizza
3139 Cojutti P. CLINICAL PHARMACOLOGICAL ADVICE ... Visualizza
3140 Colalto C. NEED FOR EVIDENCE-BASED GUIDELIN... Visualizza
3141 Colarusso C. EFFECT OF ULTRAFINE PARTICLE MAT... Visualizza
3603 Colarusso CC. Human Peripheral blood mononucle... Visualizza
702 Colasanti M. HYDRA VULGARIS AS A MODEL TO STU... Visualizza
703 Collino M. EFFECT OF VITAMIN D ON INSULIN S... Visualizza
704 Collino M. THE AGEs INHIBITOR PYRIDOXAMINE ... Visualizza
705 Collino M. TOXICOLOGICAL IMPACT OF HIGH FRU... Visualizza
3604 Collino M. THE ANTI-INFLAMMATORY PROTEIN AN... Visualizza
706 Colliva C. LYMNAEA STAGNALIS AS A NEW MODEL... Visualizza
3142 Colliva C. THE ROLE OF SNPs ANALYSIS IN NEU... Visualizza
4047 Collo G. KETAMINE INDUCED STRUCTURAL PLAS... Visualizza
707 Collodel G. NO level and oxidative stress in... Visualizza
708 Collotta D. THE AGEs INHIBITOR PYRIDOXAMINE ... Visualizza
3605 Collotta D. THE ANTI-INFLAMMATORY PROTEIN AN... Visualizza
3606 Colombi I. Intracellular chloride accumulat... Visualizza
709 Colombo F. OBSERVATIONAL, PROSPECTIVE CLINI... Visualizza
710 Colombo G. INVESTIGATION OF A PUTATIVE NICO... Visualizza
3607 Colombo L. EVALUATION OF GASTRIC ANTI-INFLA... Visualizza
3608 Colombo V. NON THERMAL PLASMA AS INNOVATIVE... Visualizza
711 Colotta V. ANTI-NOCICEPTIVE EFFECTS OF NOVE... Visualizza
3143 Colucci P. AMPHETAMINE AND THE "BATH SALT" ... Visualizza
712 Colucci R. APIGENIN SUPPLEMENTATION PREVENT... Visualizza
713 Colucci R. EFFECTS OF L-DOPA/BENSERAZIDE CO... Visualizza
714 Colucci R. Bifidobacterium Longum and Lacto... Visualizza
715 Colucci R. Enteric glia is involved in colo... Visualizza
3609 Colucci R. COMPARATIVE PRE-CLINICAL STUDY O... Visualizza
716 Coluccia M. IRREVERSIBLE BK CHANNEL BLOCKING... Visualizza
717 Colzani M. UNRAVELING THE MECHANISM OF ACTI... Visualizza
3610 Comi C. EFFECTS OF THROMBIN CLEAVAGE OF ... Visualizza
718 Commodo M. EFFECT OF ULTRAFINE PARTICLE MAT... Visualizza
719 Conciarelli G. Tryptophan 2,3-dioxygenase inhib... Visualizza
720 Congiu D. CONVERGENT ANALYSIS OF GENOME-WI... Visualizza
721 Contarini G. Effect of amphetamine on choroid... Visualizza
722 Contarini G. Involvement of catechol-O-methyl... Visualizza
3144 Contarini G. CANNABINOID INVOLVMENT IN THE DE... Visualizza
723 Conte camerino D. DEVELOPMENT OF NEW BENZOTHIAZOLA... Visualizza
724 Conte Camerino D. Gender-dependent involvement of ... Visualizza
725 Conte Camerino D. SEARCHING FOR NOVEL DRUGS IN MYO... Visualizza
726 Conte D. BARTTER'S SYNDROME AND KIDNEY CL... Visualizza
727 Conte D. GROWTH HORMONE SECRETAGOGUES PRE... Visualizza
728 Conte E. COLD STRESS CHALLENGE IS ASSOCIA... Visualizza
729 Conte E. NEW BIOMARKERS IN ALS ETIOLOGY: ... Visualizza
730 Conte E. STATIN THERAPY: CLC-1 CHLORIDE C... Visualizza
731 Conte E. IN VIVO AND IN VITRO PRECLINICAL... Visualizza
732 Conte E. EFFECT OF A LONG TERM TREATMENT ... Visualizza
3145 Conte E. GROWTH HORMONE SECRETAGOGUES PRE... Visualizza
3146 Conte E. SKELETAL MUSCLE CLC-1 CHANNEL: F... Visualizza
4048 Contestabile A. Intracellular chloride accumulat... Visualizza
733 Conti F. IN-VIVO EFFECTS OF KNOCKING-DOWN... Visualizza
734 Conti P. Inhibition of SIRT1 Deacetylase ... Visualizza
735 Conti V. INFLUENCE OF GENDER ON SPA (SALU... Visualizza
736 Conti V. SPA THERAPY: SULPHUROUS MINERAL ... Visualizza
737 Conti V. ATYPICAL SYMPTOMS OF TRAMADOL WI... Visualizza
4222 Contin M. Update on treatment of Parkinson... Visualizza
738 Contursi A. DEVELOPMENT OF A NOVEL DIRECT BI... Visualizza
739 Contursi A. OVER-EXPRESSION OF MIR-574-5P IN... Visualizza
4049 Contursi A. MICRORNA-574-5P MODULATES MICROS... Visualizza
740 Convertino I. ADVERSE DRUG REACTIONS IN ONCOLO... Visualizza
741 Convertino I. INTENSIVE MONITORING PROGRAM OF ... Visualizza
3147 Convertino I. A CLINICIAN NETWORK FOR SHARING ... Visualizza
742 Cooper EC. FUNCTIONAL COMPARISON AMONG THRE... Visualizza
743 Coppi E. THE SELECTIVE ANTAGONISM OF ADEN... Visualizza
744 Coppi E. The antimigraine butterbur ingre... Visualizza
4050 Coppi E. Molecular basis of adenosine A3 ... Visualizza
745 Coppi EC. Aromatase inhibitor-evoked pain ... Visualizza
3611 Coppini R. EFFECT OF RACEMIC AND LEVO-METHA... Visualizza
4189 Coppini R. Late sodium current inhibitors t... Visualizza
746 Coppolino GT. GPR17-expressing oligodendrocyte... Visualizza
747 Coppolino GT. Multiple sclerosis and depressio... Visualizza
748 Corace G. Development of microparticles fo... Visualizza
749 Corbi G. INFLUENCE OF GENDER ON SPA (SALU... Visualizza
750 Corciulo C. ADENOSINE 2A RECEPTOR STIMULATIO... Visualizza
751 Cordaro M. ANTI-INFLAMMATORY AND NEUROPROTE... Visualizza
4051 Cordaro M. EFFECTS OF A CO-MICRONIZED COMPO... Visualizza
752 Cordero C. SEDENTARY-TIME: EFFECT ON PRO- A... Visualizza
753 Cordero C. TOXICOLOGICAL IMPACT OF HIGH FRU... Visualizza
754 Coretti L. Behavioral and Metabolic Charact... Visualizza
755 Corona T. INTENSIVE MONITORING PROGRAM OF ... Visualizza
756 Corona T. ADVERSE DRUG REACTIONS IN ONCOLO... Visualizza
757 Corr M. The protective effect of naringe... Visualizza
3148 Corrado M. PHARMACOLOGICAL CHARACTERIZATION... Visualizza
758 Corrao G. USE OF PROTON PUMP INHIBITORS AN... Visualizza
759 Corrao G. NSAIDs utilization in a large co... Visualizza
760 Corrao G. REAL-LIFE SAFETY AND EFFECTIVENE... Visualizza
761 Corrao S. Access to the market of medicine... Visualizza
762 Correale CC. TRANSIENT RECEPTOR POTENTIAL VAN... Visualizza
763 Corsaro A. PRION PROTEIN SIGNALLING CONTROL... Visualizza
764 Corsi M. Cross-Disease Analysis of Alzhei... Visualizza
765 Corsini A. Recombinant LCAT rescues defecti... Visualizza
766 Corsini A. LIPID CONTENT OF HUMAN TUMOR EXO... Visualizza
767 Corsini A. LIPIDOMICS AS A TOOL TO UNRAVEL ... Visualizza
768 Corsini A. UNRAVELING THE MECHANISM OF ACTI... Visualizza
3612 Corsini A. Geranylgeraniol prevents the sim... Visualizza
769 Corsini AC. LEAF EXTRACT OF MORUS ALBA, A CO... Visualizza
770 Cortelazzo S. The ABCB1 pharmacogenetics of R-... Visualizza
4223 Cortelli P. Update on treatment of Parkinson... Visualizza
3613 Cosentino N. Vitamin D levels and Tissue Fact... Visualizza
1758 cosio M. ALPHA-1 ANTITRYPSIN (AAT) POLYME... Visualizza
3614 Cossu A. Real-time detection of ethanol i... Visualizza
771 Cossu M. PROTECTIVE EFFECT OF GENISTEIN-L... Visualizza
61 costa A. DIFFERENTIAL CONTRIBUTION OF IH ... Visualizza
772 Costa A. An Omega-3 PUFA/Vitamin A enrich... Visualizza
3149 Costa A. THE FAT SENSING MOLECULE OLEOYLE... Visualizza
773 Costa B. EFFECT OF CANNABIGEROL, A NON-PS... Visualizza
774 Costa M. CONVERGENT ANALYSIS OF GENOME-WI... Visualizza
775 Costa V. Gamma-hydroxybutyrate intoxicati... Visualizza
776 Costabile G. Development of hyaluronan/mannit... Visualizza
777 Costantino D. TREND OF ADVERSE DRUG REACTION R... Visualizza
778 Costantino M. ATYPICAL SYMPTOMS OF TRAMADOL WI... Visualizza
3150 Costantino M. INFLUENCE OF GENDER ON SPA (SALU... Visualizza
3151 Costantino M. SPA THERAPY: SULPHUROUS MINERAL ... Visualizza
779 Costanzi G. MOLECULAR MONITORING OF CHRONIC ... Visualizza
780 Cotugno R. A multiple approach allowed unve... Visualizza
781 Couture F. GENETIC MARKERS IN NUCLEAR RECEP... Visualizza
782 Cozzi A. Alteration of visceral sensitivi... Visualizza
783 Cozzoli A. IN VIVO AND IN VITRO PRECLINICAL... Visualizza
784 Cozzoli A. EFFECT OF A LONG TERM TREATMENT ... Visualizza
785 Cravotto G. ANTIPROLIFERATIVE, ANTIOXIDANT A... Visualizza
786 Crema F. Involvement of catechol-O-methyl... Visualizza
787 Cremolini C. Colon cancer therapy beyond tumo... Visualizza
788 Crescioli G. Drug-utilization of new oral ant... Visualizza
789 Crescioli G. Pharmacoutilization of Antidiabe... Visualizza
3152 Crescioli G. Adverse drug reactions in paedia... Visualizza
790 Crevani M. Gamma-hydroxybutyrate intoxicati... Visualizza
791 Crevani M. Antidote treatment in Viper enve... Visualizza
4188 Crippa V. The role of protein quality cont... Visualizza
792 Crisafulli C. In search of biological substant... Visualizza
793 Cristani M. Curcumin Potentiates Antitumor A... Visualizza
794 Cristani M. In Vitro Protective Effects of C... Visualizza
3153 Cristani M. Phytochemical Profile and Photot... Visualizza
795 Cristiano C. THE FAT SENSING MOLECULE OLEOYLE... Visualizza
796 Cristiano C. BUTYRATE ATTENUATES MOTOR DEFICI... Visualizza
797 Cristiano C. DOWN REGULATION OF PRO-INFLAMMAT... Visualizza
798 Cristiano C. PALMITOYLETAHNOLAMIDE ATTENUATES... Visualizza
799 Cristiano C. PHARMACOLOGICAL EFFECT OF PERAMP... Visualizza
3154 Cristiano C. Hypothalamic Circuit Mediates Th... Visualizza
3155 Cristiano C. Behavioral and Metabolic Charact... Visualizza
3156 Cristina C. Targeting nicotinamide phosphory... Visualizza
800 Crocetti L. Development of an in vitro model... Visualizza
801 Cronstein BN. ADENOSINE 2A RECEPTOR STIMULATIO... Visualizza
802 Crooks JC. CpG type-A induction of an early... Visualizza
3157 Crucitta S. DETECTION OF AR-V7 IN PLASMA-DER... Visualizza
803 Crupi R. ANTI-INFLAMMATORY AND NEUROPROTE... Visualizza
804 Cuccurazzu B. SALMETEROL, A SELECTIVE AND LONG... Visualizza
805 Culicchi F. THE EFFECT OF ARA-C TREATMENT ON... Visualizza
806 Cuomo R. Increasing trend in admission ra... Visualizza
807 Cuomo V. FERULIC ACID AFFECTS MEMORY CONS... Visualizza
808 Curci A. IRREVERSIBLE BK CHANNEL BLOCKING... Visualizza
809 Curci A. DEVELOPMENT OF NOVEL LACTATE-NA2... Visualizza
810 Curci A. Gender-dependent involvement of ... Visualizza
811 Currò D. EFFECTS OF TETRAETHYLAMMONIUM ON... Visualizza
812 Cusato J. A NEW UHPLC-MS/MS METHOD FOR THE... Visualizza
813 Cutrignelli A. DEVELOPMENT OF NOVEL LACTATE-NA2... Visualizza
814 Cutrignelli A. IN VIVO AND IN VITRO PRECLINICAL... Visualizza
815 Cutrin JC. THE AGEs INHIBITOR PYRIDOXAMINE ... Visualizza
816 Cutrin JC. TOXICOLOGICAL IMPACT OF HIGH FRU... Visualizza
3615 Cutrin JC. THE ANTI-INFLAMMATORY PROTEIN AN... Visualizza
3158 Cutroneo P. ADVERSE DRUG REACTIONS ASSOCIATE... Visualizza
817 Cutroneo PM. ADVERSE DRUG REACTIONS IN EMERGE... Visualizza
3159 Cutroneo PM. Trends in Spontaneous Adverse Dr... Visualizza
818 Cuzzocrea S. Intestine as a Source of Inflamm... Visualizza
819 Cuzzocrea S. Dimethyl fumarate attenuates neu... Visualizza
820 Cuzzocrea S. Multiple mechanisms of dimethyl ... Visualizza
821 Cuzzocrea S. ANTI-INFLAMMATORY AND NEUROPROTE... Visualizza
822 Cuzzocrea S. Absence of TLR4 reduces neuroinf... Visualizza
3616 Cuzzocrea S. EFFECTS OF A CO-MICRONIZED COMPO... Visualizza
823 Cuzzocrea SC. Bergamot Juice extract treatment... Visualizza
824 Cuzzocrea SC. Inhibition of inflammasome activ... Visualizza
825 Cuzzocrea SC. PEA/PLD ASSOCIATION, REDUCE INFL... Visualizza
826 Cvijetic S. CONTRIBUTION OF ASTROCYTES TO NE... Visualizza
829 D'addario C. OLFACTORY RECEPTOR 984 A NEW TAR... Visualizza
4177 D'Addario C. Epigenetic regulation of CNR1 ge... Visualizza
2 D'Agostino B. NOCICEPTIN/ORPHANINFQ (N/OFQ) CO... Visualizza
402 d'agostino B. THE ROLE OF NOCICEPTIN/ORPHANIN ... Visualizza
403 d'agostino B. NOCICEPTIN REDUCES THE INFLAMMAT... Visualizza
404 d'agostino B. ALPHA-1 ANTITRYPSIN (AAT) POLYME... Visualizza
833 D'agostino B. TLR4 IS INVOLVED IN S1P/S1P1 PAT... Visualizza
834 D'agostino B. Effects of lung resident mesench... Visualizza
3617 D'agostino B. SEX-DEPENDENT ROLE OF LEUKOTRIEN... Visualizza
4139 D'Agostino B. Nociceptin/orphanin FQ (N/OFQ) c... Visualizza
835 D'agostino G. Hypothalamic Circuit Mediates Th... Visualizza
3160 D'agostino I. DEVELOPMENT OF A NOVEL DIRECT BI... Visualizza
3618 D'agostino I. REDUCED VARIABILITY TO ASPIRIN A... Visualizza
838 D'alessandro N. MDA-9/SYNTENIN AS A POTENTIAL DR... Visualizza
3162 D'aloia A. EFFECT OF CANNABIGEROL, A NON-PS... Visualizza
3620 D'amario D. Cardio-renal positive effects of... Visualizza
4191 D'Amario D. Microvascular dysfunction in acu... Visualizza
843 D'ambrosio M. AN IN VITRO MODEL FOR SCREENING ... Visualizza
844 D'ambrosio M. Effects of NO and H2S releasing ... Visualizza
3621 D'ambrosio M. Nutraceutical properties of Arth... Visualizza
845 D'amelio M. VULNERABILITY TO SEIZURES AND AS... Visualizza
5 D'Amico D. ADVERSE DRUG REACTIONS WITH BIOL... Visualizza
846 D'amico G. NEWER LONG-ACTING INJECTABLE ANT... Visualizza
847 D'amico M. PHARMACOLOGICAL MODULATION OF CA... Visualizza
848 D'amico M. MODULATION OF DIABETIC RETINOPAT... Visualizza
849 D'amico RD. PEA/PLD ASSOCIATION, REDUCE INFL... Visualizza
3163 D'amico RD. Bergamot Juice extract treatment... Visualizza
850 D'amore C. EFFECT OF ANTIBIOTIC-INDUCED DYS... Visualizza
851 D'amore C. ATYPICAL SYMPTOMS OF TRAMADOL WI... Visualizza
852 D'andrea M. GENETIC MARKERS IN NUCLEAR RECEP... Visualizza
859 D'angelo I. Development of hyaluronan/mannit... Visualizza
860 D'aniello A. D-ASPARTIC ACID AMELIORATES COGN... Visualizza
861 D'anna A. EFFECT OF ULTRAFINE PARTICLE MAT... Visualizza
862 D'anna R. PHYTO.VIG.GEST: "VIGILANCE ON US... Visualizza
864 D'antona G. EFFECT OF VITAMIN D ON INSULIN S... Visualizza
865 D'armineto M. TRPM8 and experimental colorecta... Visualizza
866 D'Atanasio N. In vitro and in vivo antibacteri... Visualizza
867 D'ausilio A. Access to the market of medicine... Visualizza
872 D'avolio A. A NEW UHPLC-MS/MS METHOD FOR THE... Visualizza
4218 D'Avolio A. The pharmacological difference o... Visualizza
964 D'elia N. The protective effect of naringe... Visualizza
970 D'emmanuele di villa bianca R. Development of hyaluronan/mannit... Visualizza
971 D'emmanuele di villa bianca R. 3-Mercaptopyruvate relaxes aorta... Visualizza
3634 D'emmanuele di villa bianca R. Hydrogen sulfide pathway as a ne... Visualizza
974 D'errico V. SEDENTARY-TIME: EFFECT ON PRO- A... Visualizza
828 Da cas R. SAFETY OF FOOD SUPPLEMENTS CONTA... Visualizza
3477 Da Pozzo E. NARINGENIN PROTECTS MYOCARDIUM A... Visualizza
830 Daga A. PRION PROTEIN SIGNALLING CONTROL... Visualizza
831 Daga A. Subcutaneous slow-release metfor... Visualizza
832 Daga A. bFGF/FGFR1 SIGNALING IS THE MAIN... Visualizza
3619 Dahl K. Dopamine D3 receptor-dependent c... Visualizza
4 Dal Piaz F. A novel methodology for the dosa... Visualizza
836 Dal Piaz F. Health status and concomitant pr... Visualizza
837 Dal Piaz F. A multiple approach allowed unve... Visualizza
840 Dall'acqua S. HPLC-MS Analysis of Glucosinolat... Visualizza
841 Dall'acqua S. Phytochemical Investigation and ... Visualizza
839 Dalla Porta F. THE ROLE OF SNPs ANALYSIS IN NEU... Visualizza
3161 Dalla Pozza A. CLINICAL VALIDATION OF THE REALQ... Visualizza
842 Damante G. Tacrolimus Therapeutic Drug Moni... Visualizza
23 Damiano M. The loss of Aristaless related h... Visualizza
853 Danese SD. TRANSIENT RECEPTOR POTENTIAL VAN... Visualizza
854 Danesi R. DETECTION OF AR-V7 IN PLASMA-DER... Visualizza
855 Danesi R. EARLY VARIATIONS OF KRAS MUTATIO... Visualizza
856 Danesi R. LIQUID BIOPSY: A REAL CLINICAL P... Visualizza
857 Danesi R. The ABCB1 pharmacogenetics of R-... Visualizza
858 Danesi R. Monitoring of Epidermal Growth F... Visualizza
863 Dante G. PHYTO.VIG.GEST: "VIGILANCE ON US... Visualizza
3164 Dattoli S.D. AN EXTRACT OF HYPERICUM PERFORAT... Visualizza
3165 Dattoli S.D. ANTIALLERGIC ACTIVITY OF A NOVEL... Visualizza
868 Dautaj E. S1PR1, S1PR3 and FTY720 in vascu... Visualizza
871 Davidson iv JT. PROTECTIVE ROLE OF CONVENTIONAL ... Visualizza
3622 Dav“ G. Shedding light on PCSK9 function... Visualizza
873 De angelis A. Ranolazine attenuates adverse my... Visualizza
874 De angelis A. FREQUENCY AND CHARACTERISTICS OF... Visualizza
875 De angelis A. Effects of lung resident mesench... Visualizza
3623 De angelis A. Cardio-renal positive effects of... Visualizza
4181 De Angelis A. Diastolic dysfunction in doxorub... Visualizza
876 De angioletti M. Effects of NO and H2S releasing ... Visualizza
877 De bellis M. NEW BIOMARKERS IN ALS ETIOLOGY: ... Visualizza
878 De bellis M. EFFECT OF A LONG TERM TREATMENT ... Visualizza
879 De bellis M. GROWTH HORMONE SECRETAGOGUES PRE... Visualizza
880 De bellis M. IN VIVO AND IN VITRO PRECLINICAL... Visualizza
881 De bock M. Into the unexplored pathophysiol... Visualizza
6 De Bonis E. A novel methodology for the dosa... Visualizza
882 De caro C. EFFECTS OF HISTONE DEACETYLASE I... Visualizza
883 De Caro C. BUTYRATE ATTENUATES MOTOR DEFICI... Visualizza
884 De caro C. DOWN REGULATION OF PRO-INFLAMMAT... Visualizza
885 De caro C. N-(1-CARBAMOYL-2-PHENYLETHYL) BU... Visualizza
3166 De Caro C. PHARMACOLOGICAL EFFECT OF PERAMP... Visualizza
886 De cicco P. COX-2 EXPRESSION IN MALIGNANT ME... Visualizza
887 De cicco P. ACETYL DEACYLASADISULFIDE, A NAT... Visualizza
3167 De cicco P. Modulation of the inflammatory r... Visualizza
3624 De cicco PD. KEY PATHWAYS AND EMERGING PLAYER... Visualizza
888 De cillis E. POTENTIAL MECHANISMS LINKING DEF... Visualizza
889 De col A. Hedonic eating in Prader-Willi s... Visualizza
890 De dominicis G. Kv7 channels are involved in hum... Visualizza
891 De falco G. EFFECT OF ULTRAFINE PARTICLE MAT... Visualizza
3625 De felice M. EFFECTS OF THE PPAR-ALPHA AGONIS... Visualizza
892 De feo V. DOWN REGULATION OF PRO-INFLAMMAT... Visualizza
893 De filippis B. CM554, A NEW POTENT AND SELECTIV... Visualizza
3168 De fina M. ADVERSE DRUG REACTIONS WITH BIOL... Visualizza
894 De francesco A. Intravitreal anti-VEGF injection... Visualizza
895 De francesco R. Proatherosclerotic effect of tri... Visualizza
896 De gregorio D. Palmitoylethanolamide Reduces Ne... Visualizza
897 De gregorio D. PALMITOYLETHANOLAMIDE, VIA PPAR-... Visualizza
3626 De gregorio D. DIMETHYL FUMARATE REDUCES TACTIL... Visualizza
898 De iudicibus S. Pharmacoepigenomic markers invol... Visualizza
899 De iudicibus S. THE ROLE OF THE mRNA BINDING PRO... Visualizza
900 De logu F. The antimigraine butterbur ingre... Visualizza
3169 De logu FD. Aromatase inhibitor-evoked pain ... Visualizza
901 De lorenzo A. ANTIOXIDANT EFFECTS OF A HYDROXY... Visualizza
902 De luca A. SKELETAL MUSCLE CLC-1 CHANNEL: F... Visualizza
903 De luca A. A LONG TERM TREATMENT WITH TAURI... Visualizza
904 De luca A. EFFECT OF A LONG TERM TREATMENT ... Visualizza
905 De luca A. IN VIVO AND IN VITRO PRECLINICAL... Visualizza
3627 De luca MA. Dopamine D3 receptors control dy... Visualizza
4111 De Marchi E. Role of P2X7 receptor (purinocep... Visualizza
906 De marco R. ANTIALLERGIC ACTIVITY OF A NOVEL... Visualizza
907 De martin S. Effect of amphetamine on choroid... Visualizza
908 De martin S. EFFECT OF ANTIBIOTIC-INDUCED DYS... Visualizza
909 De mattia E. Next generation sequencing for i... Visualizza
910 De mattia E. COST-EVALUATION OF FLUOROPYRIMID... Visualizza
3170 De mattia E. GENETIC MARKERS IN NUCLEAR RECEP... Visualizza
3628 De metrio M. Vitamin D levels and Tissue Fact... Visualizza
911 De Metrio S. UNRAVELING THE MECHANISM OF ACTI... Visualizza
912 De metrio S. LIPID CONTENT OF HUMAN TUMOR EXO... Visualizza
3171 De Metrio S. LIPIDOMICS AS A TOOL TO UNRAVEL ... Visualizza
913 De nadai G. Phytochemical Investigation and ... Visualizza
914 De nes M. A CLINICIAN NETWORK FOR SHARING ... Visualizza
915 De nicola G. The chemopreventive effects of i... Visualizza
916 De nicolò A. A NEW UHPLC-MS/MS METHOD FOR THE... Visualizza
917 De novellis V. Stimulation of CB2 receptor affe... Visualizza
918 De novellis V. Palmitoylethanolamide Reduces Ne... Visualizza
919 De novellis V. D-ASPARTIC ACID AMELIORATES COGN... Visualizza
920 De novellis V. PALMITOYLETHANOLAMIDE, VIA PPAR-... Visualizza
3629 De novellis V. DIMETHYL FUMARATE REDUCES TACTIL... Visualizza
921 De paoli A. Next generation sequencing for i... Visualizza
922 De paoli A. COST-EVALUATION OF FLUOROPYRIMID... Visualizza
923 De Pasquale D. AN EXTRACT OF HYPERICUM PERFORAT... Visualizza
924 De ponti F. Occurrence of Liver Injury with ... Visualizza
925 De ponti F. SAFETY OF FOOD SUPPLEMENTS CONTA... Visualizza
926 De ponti F. MYOPERICARDITIS AND VACCINES: GA... Visualizza
927 De ponti F. DRUG-INDUCED KOUNIS SYNDROME: IN... Visualizza
928 De Ponti F. Renal impairment in very low bir... Visualizza
3630 De ponti F. In vitro effects of mediators de... Visualizza
929 De salvia MA. INTERMITTENT ANTAGONISM OF BK2-R... Visualizza
3631 De salvia MA. ACTIVATION OF AMPK/SIRT-1 AXIS I... Visualizza
930 De sarro C. VILDAGLIPTIN IMPROVES ANIMAL BEH... Visualizza
931 De Sarro C. TOCILIZUMAB'S EFFECT ON EPILEPTO... Visualizza
932 De sarro C. MONITORING SAFETY AND USE OF OLD... Visualizza
933 De sarro G. ADVERSE DRUG REACTIONS BY BIOLOG... Visualizza
934 De sarro G. OVERTREATMENT IN PHARMACORESISTA... Visualizza
935 De sarro G. EFFECTS OF HISTONE DEACETYLASE I... Visualizza
936 De sarro G. Therapeutic benefits of methylxa... Visualizza
937 De sarro G. Myotrophin and miR-375 as pharma... Visualizza
938 De sarro G. Intravitreal anti-VEGF injection... Visualizza
939 De Sarro G. ADVERSE DRUG REACTIONS WITH BIOL... Visualizza
940 De sarro G. TREND OF ADVERSE DRUG REACTION R... Visualizza
3632 De sarro G. BUTYRATE REDUCES VALPROATE-INDUC... Visualizza
941 De Sarro GB. PHARMACOLOGICAL EFFECT OF PERAMP... Visualizza
942 De siena G. Central effects induced by syste... Visualizza
943 De Tommasi N. A multiple approach allowed unve... Visualizza
944 De vita S. DOWN REGULATION OF PRO-INFLAMMAT... Visualizza
945 Deagostino A. VANADIUM COMPOUNDS INHIBIT CELL ... Visualizza
946 Debetto P. Antibiotic-induced dysbiosis aff... Visualizza
947 Decimo I. SEX-DEPENDENT EXPRESSION AND FUN... Visualizza
948 Decimo I. TRANSPLANTATION OF MENINGEAL-DER... Visualizza
949 Decimo I. MENINGEAL NEURAL PRECURSORS CONT... Visualizza
950 Decorti G. Surfaced-enhanced Raman spectros... Visualizza
951 Decorti G. Pharmacoepigenomic markers invol... Visualizza
952 Decorti G. THE ROLE OF THE mRNA BINDING PRO... Visualizza
953 Degli Esposti L. Healthcare resources use in pati... Visualizza
954 Degli Esposti L. Burden of comorbidities in HCV p... Visualizza
955 Deidda A. PSYCHOTROPIC MEDICATIONS IN MOOD... Visualizza
3172 Deidda A. SPRUE-LIKE ENTEROPATHY ASSOCIATE... Visualizza
956 Del grosso E. Nicotinamide phosphoribosyltrans... Visualizza
3173 Del lungo M. FREQUENCY AND CHARACTERISTICS OF... Visualizza
957 Del porto P. Development of hyaluronan/mannit... Visualizza
958 Del re M. DETECTION OF AR-V7 IN PLASMA-DER... Visualizza
959 Del re M. LIQUID BIOPSY: A REAL CLINICAL P... Visualizza
960 Del Re M. EARLY VARIATIONS OF KRAS MUTATIO... Visualizza
961 Del re M. Monitoring of Epidermal Growth F... Visualizza
4207 Del Re M. Role of circulating tumor DNA in... Visualizza
962 Del rio D. Proatherosclerotic effect of tri... Visualizza
963 Del Zompo M. CONVERGENT ANALYSIS OF GENOME-WI... Visualizza
966 Dell'agli M. Cutaneous hypoxia: effect of oxy... Visualizza
3633 Dell'agli M. EVALUATION OF GASTRIC ANTI-INFLA... Visualizza
4149 Dell'Agli M. Nutraceuticals and gastro-intest... Visualizza
3175 Dell'omo G. Inhibition of SIRT1 Deacetylase ... Visualizza
3174 Della croce CM. Evaluation of protective effect ... Visualizza
965 Della torre S. FROM METABOLIC FITNESS TO METABO... Visualizza
967 Delle fratte C. COST-EVALUATION OF FLUOROPYRIMID... Visualizza
968 Delodi G. bFGF/FGFR1 SIGNALING IS THE MAIN... Visualizza
969 Delvecchio P. EFFECTS OF HEXARELIN IN A MODEL ... Visualizza
3176 Denaro M. IN VITRO EVALUATION OF ANTIOXIDA... Visualizza
972 Denora N. DEVELOPMENT OF NOVEL LACTATE-NA2... Visualizza
973 Denora N. IN VIVO AND IN VITRO PRECLINICAL... Visualizza
975 Derudas M. SPRUE-LIKE ENTEROPATHY ASSOCIATE... Visualizza
4119 Desaphy J. Bench to patient side developmen... Visualizza
976 Desaphy J.F. SEARCHING FOR NOVEL DRUGS IN MYO... Visualizza
977 Desaphy JF. DEVELOPMENT OF NEW BENZOTHIAZOLA... Visualizza
978 Dettori I. THE SELECTIVE ANTAGONISM OF ADEN... Visualizza
979 Dettori I. THE SELECTIVE HISTAMINE H4 RECEP... Visualizza
3177 Dettori I. THE SELECTIVE HISTAMINE H4 RECEP... Visualizza
980 Devoto P. INHIBITION OF 5-ALPHA REDUCTASE ... Visualizza
3635 Devoto P. EFFECTS OF THE PPAR-ALPHA AGONIS... Visualizza
981 Dewerchin M. MENINGEAL NEURAL PRECURSORS CONT... Visualizza
982 Di biase E. THE PROGESTIN DESOGESTREL AFFECT... Visualizza
3636 Di cairano E. PCSK9 (PROPROTEIN CONVERTASE SUB... Visualizza
983 Di cesare mannelli Alteration of visceral sensitivi... Visualizza
984 Di cesare mannelli Into the unexplored pathophysiol... Visualizza
985 Di cesare mannelli A PRECLINICAL SET UP OF A RAT MO... Visualizza
986 Di cesare mannelli Studying the mechanism of rat ad... Visualizza
987 Di Cesare Mannelli Development of an in vitro model... Visualizza
988 Di cesare mannelli CHEMOTHERAPY-INDUCED NEUROPATHIC... Visualizza
989 Di cesare mannelli VEGF INVOLVEMENT IN THE OXALIPLA... Visualizza
990 Di cesare mannelli ENVIRONMENTAL TRAINING AMELIORAT... Visualizza
991 Di cesare mannelli Prophylactic versus Therapeutic ... Visualizza
992 Di Chio M. SEX-DEPENDENT EXPRESSION AND FUN... Visualizza
3637 Di chio M. METAPLASTIC TREATMENTS WITH KETA... Visualizza
3638 Di chio M. POST-SYNAPTIC GLUTAMATE DYSFUNCT... Visualizza
993 Di cristo V. Pharmacokinetics of darunavir/co... Visualizza
994 Di Desidero T. Melanocortin receptor-4 as a nov... Visualizza
3178 Di Desidero T. Colon cancer therapy beyond tumo... Visualizza
3421 Di Desidero T. Metronomic vinorelbine is active... Visualizza
3639 Di febbo C. REDUCED VARIABILITY TO ASPIRIN A... Visualizza
995 Di filippo C. PHARMACOLOGICAL MODULATION OF CA... Visualizza
996 Di filippo C. MODULATION OF DIABETIC RETINOPAT... Visualizza
3640 Di francesco L. REDUCED VARIABILITY TO ASPIRIN A... Visualizza
997 Di gennaro P. Tryptophan 2,3-dioxygenase inhib... Visualizza
4052 Di Giacomo ë_-Caryophyllene oxide as a new... Visualizza
998 Di giacomo S. Effects of the metronomic treatm... Visualizza
999 Di Giacomo S. Antiviral and antioxidant activi... Visualizza
1000 Di Giorgio FP. In vitro and in vivo antibacteri... Visualizza
1001 Di giulio S. Analytically confirmed post-inje... Visualizza
1002 Di giulio S. Methotrexate therapeutic error i... Visualizza
1003 Di giulio S. Antidote treatment in Viper enve... Visualizza
3179 Di giulio S. Gamma-hydroxybutyrate intoxicati... Visualizza
1004 Di guida F. PALMITOYLETAHNOLAMIDE ATTENUATES... Visualizza
1005 Di guida F. N-(1-CARBAMOYL-2-PHENYLETHYL) BU... Visualizza
3641 Di guida F. BUTYRATE REDUCES VALPROATE-INDUC... Visualizza
1006 Di iorio BR. Intestine as a Source of Inflamm... Visualizza
1007 Di lascio S. THE PROGESTIN DESOGESTREL AFFECT... Visualizza
1008 Di lascio S. BIVALENT LIGANDS DISCLOSE GPCR D... Visualizza
3180 Di lascio S. NEWLY IDENTIFIED PHOX2B TARGET G... Visualizza
3642 Di lascio S. THE ACETYLCHOLINESTERASE DONEPEZ... Visualizza
1009 Di lieto M. LIQUID BIOPSY: A REAL CLINICAL P... Visualizza
1010 Di lorenzo A. S1PR1, S1PR3 and FTY720 in vascu... Visualizza
1011 Di lorenzo D. Reporting of adverse drug reacti... Visualizza
4053 Di Marco Dopamine D3 receptor-dependent c... Visualizza
7 Di Martino A. Kv7 channels are involved in hum... Visualizza
4229 Di Martino MT. Identification and validation of... Visualizza
28 Di Marzo V. The loss of Aristaless related h... Visualizza
1012 Di marzo V. Hedonic eating in Prader-Willi s... Visualizza
1013 Di marzo V. A COMPARISON BETWEEN A CANNABIS ... Visualizza
1014 Di marzo V. ENDOCANNABINOID SYSTEM AND MOUSE... Visualizza
1015 Di marzo V. CHRONIC CANNABIDIVARIN ADMINISTR... Visualizza
3181 Di Matteo A. In vitro and in vivo antibacteri... Visualizza
1016 Di matteo M. CM554, A NEW POTENT AND SELECTIV... Visualizza
1017 Di mauro G. SAFETY OF NEW DIRECT-ACTING ANTI... Visualizza
1018 Di minno A. A PRIORI-DEFINED MEDITERRANEAN-L... Visualizza
3182 Di minno A. Fluoroscopy-associated oxidative... Visualizza
3643 Di minno G. Hydrogen sulfide pathway as a ne... Visualizza
3644 Di minno MN. Hydrogen sulfide pathway as a ne... Visualizza
1019 Di nisio C. Peripheral RVD-hemopressin(_) ad... Visualizza
1020 Di nisio C. Effects of Growth Hormone-Releas... Visualizza
1021 Di paola L. Role of P2X7 receptor in early d... Visualizza
3645 Di paola R. EFFECTS OF A CO-MICRONIZED COMPO... Visualizza
1022 Di paola RD. Bergamot Juice extract treatment... Visualizza
1023 Di paola RD. Inhibition of inflammasome activ... Visualizza
1024 Di paola RD. PEA/PLD ASSOCIATION, REDUCE INFL... Visualizza
1025 Di paolo A. The ABCB1 pharmacogenetics of R-... Visualizza
3183 Di paolo V. SCREENING OF HUMAN SULFOTRANSFER... Visualizza
1026 Di perri G. A NEW UHPLC-MS/MS METHOD FOR THE... Visualizza
1027 Di renzo G. IDENTIFICATION OF TRANSCRIPTION ... Visualizza
1028 Di renzo L. ANTIOXIDANT EFFECTS OF A HYDROXY... Visualizza
1029 Di sabatino M. Development of microparticles fo... Visualizza
1030 Di Silvestre A. Pharmacoepigenomic markers invol... Visualizza
3184 Di silvestre A. THE ROLE OF THE mRNA BINDING PRO... Visualizza
1031 Di silvestre S. CM554, A NEW POTENT AND SELECTIV... Visualizza
1032 Di sotto A. Effects of the metronomic treatm... Visualizza
3185 Di Sotto A. Antiviral and antioxidant activi... Visualizza
3646 Di Sotto A. ë_-Caryophyllene oxide as a new... Visualizza
1033 Di tommaso MD. Aromatase inhibitor-evoked pain ... Visualizza
1034 Diacciati S. ADVERSE DRUG REACTIONS IN ONCOLO... Visualizza
1036 Diana E. VANADIUM COMPOUNDS INHIBIT CELL ... Visualizza
1037 Dianzani C. SOLID LIPID NANOPARTICLES CARRYI... Visualizza
3647 Dianzani C. EFFECTS OF THROMBIN CLEAVAGE OF ... Visualizza
3648 Dianzani U. EFFECTS OF THROMBIN CLEAVAGE OF ... Visualizza
1038 Diemberger I. DRUG-INDUCED KOUNIS SYNDROME: IN... Visualizza
1039 Diemeberger I. MYOPERICARDITIS AND VACCINES: GA... Visualizza
1040 Dietrich A. OLFACTORY RECEPTOR 984 A NEW TAR... Visualizza
1041 Difrancesco JC. Compound heterozygosis in the kc... Visualizza
1042 Dimiccoli V. DEVELOPMENT OF NOVEL LACTATE-NA2... Visualizza
1043 Dimou L. GPR17-expressing oligodendrocyte... Visualizza
3649 Dini L. EFFECT OF RACEMIC AND LEVO-METHA... Visualizza
3650 Dini L. REMODELING OF ATRIAL REPOLARIZAT... Visualizza
3186 Dini L. M. Isoform-selective blockade of HC... Visualizza
3651 Diolaiuti L. EFFECT OF RACEMIC AND LEVO-METHA... Visualizza
1044 Diomede F. Conditioned medium of human peri... Visualizza
1045 Dionisi M. Understanding the pathogenesis o... Visualizza
1046 Distasi C. Understanding the pathogenesis o... Visualizza
1047 Dobrowolny G. NEW BIOMARKERS IN ALS ETIOLOGY: ... Visualizza
1048 Dolci S. MENINGEAL NEURAL PRECURSORS CONT... Visualizza
3187 Dolci S. TRANSPLANTATION OF MENINGEAL-DER... Visualizza
1049 Doldo P. ADVERSE DRUG REACTIONS BY BIOLOG... Visualizza
3652 Domi A. TARGETING THE NOCICEPTINE/ORPHAN... Visualizza
1050 Dominici C. THE EPHRIN RECEPTOR KINASE INHIB... Visualizza
1051 Donghia R. EFFECT OF CARBACHOL AND VIP IN H... Visualizza
1052 Donnarumma E. 3-Mercaptopyruvate relaxes aorta... Visualizza
1053 Donnini S. PGE2 SIGNALING INDUCES EGFR NUCL... Visualizza
1054 Donnini S. Tumor stemness and cancer drug-r... Visualizza
1055 Donnini S. The Impact Of ALDH-2 Activity On... Visualizza
1056 Donnini S. GLUCOCORTICOID-INDUCED LEUCINE Z... Visualizza
1057 Donnini S. OVER-EXPRESSION OF MIR-574-5P IN... Visualizza
3653 Donnini S. GLUCOCORTICOID-INDUCED LEUCINE Z... Visualizza
3654 Donnini S. Interaction between mPGES-1 and ... Visualizza
4054 Donnini S. Hydroxytyrosol inhibits EGFR sig... Visualizza
4055 Dothel G. In vitro effects of mediators de... Visualizza
1058 Dovizio M. PLATELET-DEPENDENT ACTIVATION OF... Visualizza
1059 Dovizio M. LIPIDOMICS OF EICOSANOIDS GENERA... Visualizza
1060 Dovizio M. Targeting platelet purinergic si... Visualizza
1061 Dovizio M. OVER-EXPRESSION OF MIR-574-5P IN... Visualizza
1062 Dovizio M. DEVELOPMENT OF A NOVEL DIRECT BI... Visualizza
1063 Dovizio M. Generation of 12- hydroxyeicosat... Visualizza
3655 Dovizio M. REDUCED VARIABILITY TO ASPIRIN A... Visualizza
3656 Dovizio M. MICRORNA-574-5P MODULATES MICROS... Visualizza
4056 Dovizio M. Platelet-derived microparticles ... Visualizza
3657 Dragani A. POOR RESPONSIVENESS TO LOW-DOSE ... Visualizza
8 Drago F. Small molecules to treat diabeti... Visualizza
9 Drago F. Ensure patients access to invest... Visualizza
10 Drago F. Off-label drug use and safety of... Visualizza
11 Drago F. Off-label drug use at the Policl... Visualizza
1064 Drago F. Structure based approach for sea... Visualizza
1065 Drago F. Autoregulation of retinal gangli... Visualizza
1066 Drago F. Effects of Taurine in dry eye mo... Visualizza
1067 Drago F. Role of P2X7 receptor in early d... Visualizza
1068 Drago F. Off-label drug use at the Univer... Visualizza
1069 Drago F. Sulodexide prevents high glucose... Visualizza
1070 Drago F. Role of TGF-_1 in age-related ma... Visualizza
1071 Drago F. PALMITOYLETHANOLAMIDE LOADED IN ... Visualizza
3658 Drago F. VEGF EXACERBATES DAMAGE INDUCED ... Visualizza
3659 Drago F. Buspirone rescues MK-801-induced... Visualizza
3660 Drago F. Retinal bioavailability of curcu... Visualizza
3661 Drago F. Dopamine D3 receptor-dependent c... Visualizza
3662 Drago F. Dopamine D3 receptors control dy... Visualizza
1072 Dreussi E. GENETIC MARKERS IN NUCLEAR RECEP... Visualizza
3663 Drufuca L. THE ACETYLCHOLINESTERASE DONEPEZ... Visualizza
1073 Dugo P. Evaluation of protective effect ... Visualizza
1074 Durai V. PROTECTIVE ROLE OF CONVENTIONAL ... Visualizza
1075 Durante M. TAGATOSE BENEFICIAL EFFECTS IN A... Visualizza
1076 Durante M. HISTAMINE H3 RECEPTOR ANTAGONISM... Visualizza
1077 Durante M. CARBONIC ANHYDRASE IX AND COX-2 ... Visualizza
3188 Durante M. IN VITRO CARDIOVASCULAR TOXICITY... Visualizza
1078 Duranti E. APIGENIN SUPPLEMENTATION PREVENT... Visualizza
3664 Dyson P. RNA-SEQ ANALYSIS OF DIFFERENTIAL... Visualizza
1081 Eberini I. Inhibition of SIRT1 Deacetylase ... Visualizza
1082 Ecca F. COST-EVALUATION OF FLUOROPYRIMID... Visualizza
3189 Ecca F. Next generation sequencing for i... Visualizza
1084 Edwards CH. IN VITRO AND IN VIVO MODELING OF... Visualizza
1085 Eiandi CM. Sulodexide prevents high glucose... Visualizza
1087 Ellis PR. IN VITRO AND IN VIVO MODELING OF... Visualizza
1088 Ercolano G. Modulation of the inflammatory r... Visualizza
1089 Ercolano G. COX-2 EXPRESSION IN MALIGNANT ME... Visualizza
1090 Ercolano G. ACETYL DEACYLASADISULFIDE, A NAT... Visualizza
3665 Ercolano GE. KEY PATHWAYS AND EMERGING PLAYER... Visualizza
1092 Esposito E. Dimethyl fumarate attenuates neu... Visualizza
1093 Esposito E. Multiple mechanisms of dimethyl ... Visualizza
1094 Esposito E. ANTI-INFLAMMATORY AND NEUROPROTE... Visualizza
1095 Esposito E. Absence of TLR4 reduces neuroinf... Visualizza
3666 Esposito E. EFFECTS OF A CO-MICRONIZED COMPO... Visualizza
4159 Esposito E. Nuclear factor erythroid 2-relat... Visualizza
1096 Esposito G. Ranolazine attenuates adverse my... Visualizza
1097 Esposito G. TARGETING S100B-P53WT PROTEIN-PR... Visualizza
1098 Esposito G. Rifaximin induces a PXR-mediated... Visualizza
3190 Esposito G. Effects of lung resident mesench... Visualizza
3667 Esposito G. Cardio-renal positive effects of... Visualizza
3668 Esposito G. PALMITOYLETHANOLAMIDE IMPROVES H... Visualizza
2416 esposito R. THE ROLE OF NOCICEPTIN/ORPHANIN ... Visualizza
1099 Esteller M. DNA METHYLATION: GENE PROFILING ... Visualizza
1100 Evangelista A. The ABCB1 pharmacogenetics of R-... Visualizza
3669 Evangelista V. REDUCED VARIABILITY TO ASPIRIN A... Visualizza
12 Everard A. Chronic Oleoylethanolamide Treat... Visualizza
1102 Fabio F. Targeting nicotinamide phosphory... Visualizza
1103 Facchinetti F. PHYTO.VIG.GEST: "VIGILANCE ON US... Visualizza
1104 Facchinetti R. EFFECT OF PALMYTOILETHANOLAMIDE ... Visualizza
3191 Facchinetti R. EFFECT OF ULTRAMICRONIZED-PALMYT... Visualizza
4163 Fadda P. The endocannabinoid system: poss... Visualizza
3274 faggi L. SYNERGISTIC ASSOCIATION OF VALPR... Visualizza
1105 Failli P. VEGF INVOLVEMENT IN THE OXALIPLA... Visualizza
1106 Failli P. Studying the mechanism of rat ad... Visualizza
1107 Falcicchia C. Sestrin 3 as a regulator of pro-... Visualizza
1108 Falcone A. DETECTION OF AR-V7 IN PLASMA-DER... Visualizza
1109 Falcone A. EARLY VARIATIONS OF KRAS MUTATIO... Visualizza
1110 Falcone A. Colon cancer therapy beyond tumo... Visualizza
1111 Fallarino F. Aryl hydrocarbon receptor: a nov... Visualizza
1112 Fallarino F. PROTECTIVE ROLE OF CONVENTIONAL ... Visualizza
3670 Fallarino F. The proteasome inhibitor bortezo... Visualizza
3671 Fallarino F. REINSTALLING IMMUNE REGULATORY T... Visualizza
3672 Fallarino F. IDO1 activity in selected immune... Visualizza
4057 Fallarino F. INTERLEUKIN 4-INDUCED GENE-1 AS ... Visualizza
1113 Fallarino FF. CpG type-A induction of an early... Visualizza
4213 Falsini B. Neurodegeneration in retina and ... Visualizza
3192 Fancello S. PROTECTIVE EFFECT OF GENISTEIN-L... Visualizza
1114 Fanni S. INHIBITION OF 5-ALPHA REDUCTASE ... Visualizza
3673 Fanni S. EFFECTS OF THE PPAR-ALPHA AGONIS... Visualizza
1115 Fantacuzzi ML. CM554, A NEW POTENT AND SELECTIV... Visualizza
1116 Fantin M. The protective effect of naringe... Visualizza
1117 Fantozzi R. EFFECT OF VITAMIN D ON INSULIN S... Visualizza
1118 Fantozzi R. THE AGEs INHIBITOR PYRIDOXAMINE ... Visualizza
1119 Fantozzi R. TOXICOLOGICAL IMPACT OF HIGH FRU... Visualizza
3674 Fantozzi R. THE ANTI-INFLAMMATORY PROTEIN AN... Visualizza
1120 Farina C. A PRECLINICAL SET UP OF A RAT MO... Visualizza
3675 Farina D. Real-time detection of ethanol i... Visualizza
3193 Farinato A. DEVELOPMENT OF NEW BENZOTHIAZOLA... Visualizza
1121 Fattore C. OVERTREATMENT IN PHARMACORESISTA... Visualizza
4058 Fattore L. THE MULTIPLE EFFECTS OF THE KETA... Visualizza
2448 fattorusso R. NOCICEPTIN REDUCES THE INFLAMMAT... Visualizza
3676 Fava C. REDUCED VARIABILITY TO ASPIRIN A... Visualizza
1122 Favata F. A NEW UHPLC-MS/MS METHOD FOR THE... Visualizza
1123 Favoni RE. bFGF/FGFR1 SIGNALING IS THE MAIN... Visualizza
1124 Fedele E. PRESYNAPTIC GLP-1 RECEPTORS ENHA... Visualizza
1125 Fedele E. GEBR-32A, A NEW PROMISING PDE4D ... Visualizza
3194 Fedele E. cGMP MODULATES LONG-TERM POTENTI... Visualizza
1127 Fehrentz J-. GROWTH HORMONE SECRETAGOGUES PRE... Visualizza
1128 Fehrentz JA. EFFECTS OF HEXARELIN IN A MODEL ... Visualizza
1129 Feligioni M. ENVIRONMENTAL TRAINING AMELIORAT... Visualizza
1130 Felisi M. Failures to further developing o... Visualizza
3677 Femia AP. INHIBITION OF SPONTANEOUS COLON ... Visualizza
3678 Femia AP. Potential of a flavonoid-rich ex... Visualizza
3679 Ferketich AK. Results from an e-learning cours... Visualizza
1131 Ferland-mccollough D. LIPIDOMICS AS A TOOL TO UNRAVEL ... Visualizza
1132 Ferlazzo N. Growth inhibition, cell-cycle ar... Visualizza
3680 Ferlazzo N. Potential of a flavonoid-rich ex... Visualizza
3195 Ferrajolo C. LONG TERM DRUG SAFETY IN CHILDRE... Visualizza
3196 Ferrajolo C. GENDER SPECIFIC DRUG USE IN PEDI... Visualizza
1133 Ferrante C. HARPAGOPHYTUM PROCUMBENS AQUEOUS... Visualizza
1134 Ferrante C. Effects of Growth Hormone-Releas... Visualizza
3197 Ferrante C. Peripheral RVD-hemopressin(_) ad... Visualizza
3681 Ferrante C. Emotional Disorders Induced by H... Visualizza
3198 Ferrara B. SOLID LIPID NANOPARTICLES CARRYI... Visualizza
3199 Ferrara B. ANALYSIS OF TOPOLOGICAL FEATURES... Visualizza
4059 Ferrara B. EFFECTS OF THROMBIN CLEAVAGE OF ... Visualizza
1135 Ferrari D. In Vitro Protective Effects of C... Visualizza
3200 Ferrari F. EFFECTS OF CLONIDINE ON HIPPOCAM... Visualizza
3201 Ferrari F. PHARMACOLOGICAL CHARACTERIZATION... Visualizza
3682 Ferrari F. NOP RECEPTOR AND FUNCTIONAL SELE... Visualizza
1136 Ferrari M. THE ROLE OF SNPs ANALYSIS IN NEU... Visualizza
1137 Ferrari S. Phytochemical Investigation and ... Visualizza
4172 Ferraro E. Cachexia and heart failure: meta... Visualizza
3683 Ferraro L. Gestational cannabinoid exposure... Visualizza
4187 Ferraro L. N. Evaluation of the possible thera... Visualizza
1138 Ferreira LM. IMMUNOSURVEILLANCE OF TUMORS: IG... Visualizza
1139 Ferreira LM. THERAPEUTIC EFFECT OF SYSTEMIC I... Visualizza
1140 Ferrero S. The ABCB1 pharmacogenetics of R-... Visualizza
1141 Ferri N. G-protein coupled estrogen recep... Visualizza
3684 Ferri N. Shedding light on PCSK9 function... Visualizza
3685 Ferri N. High density lipoproteins inhibi... Visualizza
3686 Ferri N. Geranylgeraniol prevents the sim... Visualizza
3202 Ferri NF. LEAF EXTRACT OF MORUS ALBA, A CO... Visualizza
1142 Ferro S. LIPID CONTENT OF HUMAN TUMOR EXO... Visualizza
1143 Ferrocino I. TOXICOLOGICAL IMPACT OF HIGH FRU... Visualizza
1144 Fertonani affini L. DRUG-INDUCED KOUNIS SYNDROME: IN... Visualizza
1145 Festuccia C. U0126 MEK/ERK INHIBITOR INCREASE... Visualizza
1146 Festuccia C. THE EPHRIN RECEPTOR KINASE INHIB... Visualizza
3687 Festuccia C. DUAL TARGETING OF EPH-EPHRIN SYS... Visualizza
3203 Fiaschi AI. NO level and oxidative stress in... Visualizza
1147 Fidilio A. Role of TGF-_1 in age-related ma... Visualizza
3204 Fidilio A. Effects of Taurine in dry eye mo... Visualizza
3688 Fidilio A. Retinal bioavailability of curcu... Visualizza
1148 Fiengo L. A multiple approach allowed unve... Visualizza
13 Filippelli A. A novel methodology for the dosa... Visualizza
1149 Filippelli A. A multiple approach allowed unve... Visualizza
1150 Filippelli A. Health status and concomitant pr... Visualizza
1151 Filippelli A. INFLUENCE OF GENDER ON SPA (SALU... Visualizza
1152 Filippelli A. SPA THERAPY: SULPHUROUS MINERAL ... Visualizza
1153 Filippelli A. ATYPICAL SYMPTOMS OF TRAMADOL WI... Visualizza
1154 Filippelli W. INFLUENCE OF GENDER ON SPA (SALU... Visualizza
1155 Filippelli W. SPA THERAPY: SULPHUROUS MINERAL ... Visualizza
1156 Filippi L. Enhancement of cardiac different... Visualizza
1157 Filippone A. Multiple mechanisms of dimethyl ... Visualizza
1158 Filippone A. Dimethyl fumarate attenuates neu... Visualizza
3205 Filippone A. Absence of TLR4 reduces neuroinf... Visualizza
1159 Filocamo A. Evaluation of protective effect ... Visualizza
1160 Fimognari C. Creatine preserves the myogenic ... Visualizza
1161 Fimognari C. A NEW SYNTHETIC ISOTHIOCYANATE D... Visualizza
3689 Fimognari C. NON THERMAL PLASMA AS INNOVATIVE... Visualizza
1162 Finelli A. Health status and concomitant pr... Visualizza
1163 Finesso N. Cutaneous hypoxia: effect of oxy... Visualizza
1164 Fini M. THE ROLE OF SIRT3 PATHWAY IN NEU... Visualizza
1165 Finizio S. A COMPARISON BETWEEN A CANNABIS ... Visualizza
1166 Finocchio E. A prospective observational stud... Visualizza
1167 Fioravanti A. Colon cancer therapy beyond tumo... Visualizza
3206 Fiore D. RIMONABANT KILLS COLON CANCER ST... Visualizza
1170 Fiorentino M. The importance of Integrated Car... Visualizza
1171 Fiorentino S. ANALYSIS OF THE ADVERSE DRUG REA... Visualizza
1172 Fiorini G. DRUGS PRESCRIPTION AS A MEASURE ... Visualizza
3690 Fiorucci S. The bile acid receptor GPBAR1 re... Visualizza
1173 Fisichella V. Role of TGF-_1 in age-related ma... Visualizza
1174 Flacco ME. Increasing trend in admission ra... Visualizza
1175 Flamini S. GLUCOCORTICOID-INDUCED LEUCINE Z... Visualizza
3207 Flamini S. THE EFFECT OF ARA-C TREATMENT ON... Visualizza
3691 Flamini S. GLUCOCORTICOID-INDUCED LEUCINE Z... Visualizza
1176 Flammini L. BENEFICIAL EFFECTS OF PHARMACOLO... Visualizza
1177 Florio C. GENETIC IDENTIFICATION OF Na+/K+... Visualizza
1178 Florio L. TREND OF ADVERSE DRUG REACTION R... Visualizza
1179 Florio T. bFGF/FGFR1 SIGNALING IS THE MAIN... Visualizza
1180 Florio T. Subcutaneous slow-release metfor... Visualizza
3208 Florio T. PRION PROTEIN SIGNALLING CONTROL... Visualizza
1181 Foc E. Pharmacokinetics of darunavir/co... Visualizza
1182 Fogli S. Role of miR-34a as biomarker and... Visualizza
1183 Fogli S. Potential relationship between t... Visualizza
1184 Fonzino A. SKELETAL MUSCLE CLC-1 CHANNEL: F... Visualizza
1185 Fonzino A. COLD STRESS CHALLENGE IS ASSOCIA... Visualizza
1186 Fonzino A. Gender-dependent involvement of ... Visualizza
1187 Fonzino A. EFFECT OF A LONG TERM TREATMENT ... Visualizza
1188 Fonzino A. GROWTH HORMONE SECRETAGOGUES PRE... Visualizza
3209 Fonzino A. NEW BIOMARKERS IN ALS ETIOLOGY: ... Visualizza
1189 Forcesi E. Occurrence of Liver Injury with ... Visualizza
1190 Forcesi E. MYOPERICARDITIS AND VACCINES: GA... Visualizza
1191 Forcesi E. DRUG-INDUCED KOUNIS SYNDROME: IN... Visualizza
1192 Forgiarini A. The protective effect of naringe... Visualizza
1193 Formica D. Access to the market of medicine... Visualizza
3210 Formica D. EVALUATION OF HEALTH DIRECT COST... Visualizza
1194 Formisano L. IDENTIFICATION OF TRANSCRIPTION ... Visualizza
4127 Formisano L. Epigenetic Regulation of NCXs (s... Visualizza
1195 Fornai M. Bifidobacterium Longum and Lacto... Visualizza
1196 Fornai M. APIGENIN SUPPLEMENTATION PREVENT... Visualizza
1197 Fornai M. Alteration of visceral sensitivi... Visualizza
1198 Fornai M. EFFECTS OF L-DOPA/BENSERAZIDE CO... Visualizza
3211 Fornai M. Enteric glia is involved in colo... Visualizza
3692 Fornai M. COMPARATIVE PRE-CLINICAL STUDY O... Visualizza
1199 Fornaro L. EARLY VARIATIONS OF KRAS MUTATIO... Visualizza
1200 Fornasari D. THE PROGESTIN DESOGESTREL AFFECT... Visualizza
1201 Fornasari D. NEWLY IDENTIFIED PHOX2B TARGET G... Visualizza
3693 Fornasari D. THE ACETYLCHOLINESTERASE DONEPEZ... Visualizza
4168 Fornasari D. Opioid medications: indispensabl... Visualizza
1202 Fornasaro S. Surfaced-enhanced Raman spectros... Visualizza
1203 Fornasero S. ANTIPROLIFERATIVE, ANTIOXIDANT A... Visualizza
1204 Forni M. Effects of ethanolic extracts of... Visualizza
3694 Forni M. In vitro effects of mediators de... Visualizza
3695 Fotia Y. TARGETING THE NOCICEPTINE/ORPHAN... Visualizza
3212 Fotio Y. PPARγ Acti vati on reduces alco... Visualizza
1205 Fragni M. In vitro identification of molec... Visualizza
3213 Fragni M. IN VITRO ASSESSMENT OF CABAZITAX... Visualizza
1206 Frammartino T. GLUCOCORTICOID-INDUCED LEUCINE Z... Visualizza
1207 Francescato S. HPLC-MS Analysis of Glucosinolat... Visualizza
1208 Francescato S. Phytochemical Investigation and ... Visualizza
1209 Franceschini G. Recombinant LCAT rescues defecti... Visualizza
3696 Franceschini G. High density lipoproteins inhibi... Visualizza
1212 Franchi S. THERAPEUTIC EFFECT OF SYSTEMIC I... Visualizza
1213 Franchin G. MANAGING CHRONIC MYELOID LEUKEMI... Visualizza
1214 Franchin G. HEPATITIS C VIRUS (HCV) INFECTIO... Visualizza
1215 Francia G. Bocci Metronomic vinorelbine is active... Visualizza
3697 Francisci D. The bile acid receptor GPBAR1 re... Visualizza
1216 Franco M. DEVELOPMENT OF NOVEL LACTATE-NA2... Visualizza
3214 Franco V. OVERTREATMENT IN PHARMACORESISTA... Visualizza
1217 Frassoldati A. LIQUID BIOPSY: A REAL CLINICAL P... Visualizza
1218 Fratantonio D. Curcumin Potentiates Antitumor A... Visualizza
3698 Fratantonio D. Alpha-Lipoic Acid, But Not Dihyd... Visualizza
3699 Fratta W. THE MULTIPLE EFFECTS OF THE KETA... Visualizza
1219 Frau R. INHIBITION OF 5-ALPHA REDUCTASE ... Visualizza
3700 Frau R. EFFECTS OF THE PPAR-ALPHA AGONIS... Visualizza
4140 Frau R. The Neurosteroidogenic Enzyme 5_... Visualizza
1220 Freri E. Compound heterozygosis in the kc... Visualizza
1221 Frezza C. GLUCOSE-6-PHOSPHATE DEHYDROGENAS... Visualizza
1223 Frigerio B. CAROTID PLAQUE-THICKNESS AND COM... Visualizza
1224 Frigerio B. A PRIORI-DEFINED MEDITERRANEAN-L... Visualizza
1222 Friòn herrera Y. ACTIVITY OF ALOE ARBORESCENS LEA... Visualizza
3215 Friòn-herrera Y. Antiproliferative effect of Cuba... Visualizza
3216 Froldi G. ACTIVITY OF ALOE ARBORESCENS LEA... Visualizza
1225 Frosini M. IN VITRO CARDIOVASCULAR TOXICITY... Visualizza
1226 Fruttero R. UNRAVELING THE MECHANISM OF ACTI... Visualizza
1227 Fucile C. Measurement of deferasirox plasm... Visualizza
1228 Fucile C. Subcutaneous slow-release metfor... Visualizza
1229 Fugazzotto F. AN EXTRACT OF HYPERICUM PERFORAT... Visualizza
3701 Fulceri F. COMPARATIVE PRE-CLINICAL STUDY O... Visualizza
1230 Fullone R. LIPIDOMICS OF EICOSANOIDS GENERA... Visualizza
1231 Fullone R. Generation of 12- hydroxyeicosat... Visualizza
3702 Fullone R. Platelet-derived microparticles ... Visualizza
1232 Fumagalli F. Acute behavioral and molecular e... Visualizza
1233 Fumagalli F. REPEATED EXPOSURE TO COCAINE DUR... Visualizza
3217 Fumagalli F. ACTIVITY-BASED ANOREXIA ALTERS N... Visualizza
3703 Fumagalli F. POST-SYNAPTIC GLUTAMATE DYSFUNCT... Visualizza
1234 Fumagalli GF. TRANSPLANTATION OF MENINGEAL-DER... Visualizza
1235 Fumagalli M. Cutaneous hypoxia: effect of oxy... Visualizza
1236 Fumagalli M. GPR17-expressing oligodendrocyte... Visualizza
1237 Fumagalli M. Multiple sclerosis and depressio... Visualizza
3704 Fumagalli M. EVALUATION OF GASTRIC ANTI-INFLA... Visualizza
4112 Fumagalli M. Investigating microglia and olig... Visualizza
1238 Furlan R. GPR17-expressing oligodendrocyte... Visualizza
1239 Fusari V. PPARγ Acti vati on reduces alco... Visualizza
1240 Fusco I. Involvement of the Prokineticin ... Visualizza
3218 Fusco I. THE SELECTIVE ANTAGONISM OF ADEN... Visualizza
3705 Fusco I. Molecular basis of adenosine A3 ... Visualizza
3219 Fusco L. CHARACTERIZATION OF THE MECHANIS... Visualizza
3706 Fusco R. EFFECTS OF A CO-MICRONIZED COMPO... Visualizza
1241 Fusco RF. Bergamot Juice extract treatment... Visualizza
1242 Fusco RF. PEA/PLD ASSOCIATION, REDUCE INFL... Visualizza
3220 Fusco RF. Inhibition of inflammasome activ... Visualizza
1243 Fusi CF. Aromatase inhibitor-evoked pain ... Visualizza
1244 Fusi F. IN VITRO CARDIOVASCULAR TOXICITY... Visualizza
3221 Gabaglio M. CHRONIC CANNABIDIVARIN ADMINISTR... Visualizza
1249 Gabbia D. Antiproliferative effect of Cuba... Visualizza
1250 Gabbia D. ACTIVITY OF ALOE ARBORESCENS LEA... Visualizza
3708 Gabrielli E. GLUCOCORTICOID-INDUCED LEUCINE Z... Visualizza
1251 Gaetani S. EFFECTS OF SUBDIAPHRAGMATIC DEAF... Visualizza
1252 Gaetani S. Chronic Oleoylethanolamide Treat... Visualizza
1253 Gaetani S. ROLE OF THE AREA POSTREMA IN THE... Visualizza
1255 Gagliardi A. GLUCOCORTICOID-INDUCED LEUCINE Z... Visualizza
3709 Gagliardi A. GLUCOCORTICOID-INDUCED LEUCINE Z... Visualizza
4231 Galeano T. Identification and validation of... Visualizza
1256 Galfo F. HIGH VARIABILITY IN TACROLIMUS B... Visualizza
1257 Galfo F. CURCUMIN POTENTIATES THE ANTI-IN... Visualizza
3710 Galfo F. FLAVONOIDS CONTAINED IN FLAVOCOX... Visualizza
1258 Galimberti CA. OVERTREATMENT IN PHARMACORESISTA... Visualizza
1259 Galimberti S. The ABCB1 pharmacogenetics of R-... Visualizza
1260 Galiulo M. A CLINICIAN NETWORK FOR SHARING ... Visualizza
1261 Galiulo M. INTENSIVE MONITORING PROGRAM OF ... Visualizza
3222 Galiulo M. ADVERSE DRUG REACTIONS IN ONCOLO... Visualizza
1262 Gallelli CA. EFFECTS OF SUBDIAPHRAGMATIC DEAF... Visualizza
1263 Gallelli CA. Chronic Oleoylethanolamide Treat... Visualizza
3223 Gallelli CA. ROLE OF THE AREA POSTREMA IN THE... Visualizza
3224 Gallelli L. Myotrophin and miR-375 as pharma... Visualizza
3225 Gallelli L. Therapeutic benefits of methylxa... Visualizza
1264 Galleri G. PROTECTIVE EFFECT OF GENISTEIN-L... Visualizza
1265 Galletti P. EFFECTS OF RGD LIGANDS ON INTEGR... Visualizza
1266 Galletti S. Renal impairment in very low bir... Visualizza
1267 Galli D. IN VITRO ASSESSMENT OF CABAZITAX... Visualizza
1268 Galli L. DETECTION OF AR-V7 IN PLASMA-DER... Visualizza
1269 Gallia E. Altered Mechanisms Underlying th... Visualizza
1270 Gallia E. IN-VIVO EFFECTS OF KNOCKING-DOWN... Visualizza
3226 Gallia E. THE DOWN REGULATION OF MGLUR5 AT... Visualizza
1271 Gallicchio M. ANTIPROLIFERATIVE, ANTIOXIDANT A... Visualizza
3227 Gallicchio M. VANADIUM COMPOUNDS INHIBIT CELL ... Visualizza
3228 Gallicchio M. INDOMETHACIN INHIBITS PROLIFERAT... Visualizza
1272 Gallo A. ROSACEA DURING FINGOLIMOD THERAP... Visualizza
1273 Galloni C. FREQUENCY AND CHARACTERISTICS OF... Visualizza
1274 Gallorini M. CM554, A NEW POTENT AND SELECTIV... Visualizza
1275 Galuppini F. Involvement of catechol-O-methyl... Visualizza
1276 Gani A. MOLECULAR MONITORING OF CHRONIC ... Visualizza
1277 Garau D. SPRUE-LIKE ENTEROPATHY ASSOCIATE... Visualizza
1278 Garavaglia S. Nicotinamide phosphoribosyltrans... Visualizza
1279 Garbi M. Analytically confirmed post-inje... Visualizza
1280 Garbi M. Gamma-hydroxybutyrate intoxicati... Visualizza
1281 Garcia-serna R. In search of biological substant... Visualizza
4123 Gardoni F. Targeting GluN2A-containing N-Me... Visualizza
1282 Gargaro M. Aryl hydrocarbon receptor: a nov... Visualizza
3229 Gargaro M. PROTECTIVE ROLE OF CONVENTIONAL ... Visualizza
3711 Gargaro M. INTERLEUKIN 4-INDUCED GENE-1 AS ... Visualizza
3712 Gargaro M. IDO1 activity in selected immune... Visualizza
1283 Gargaro MG. CpG type-A induction of an early... Visualizza
1284 Gargini M. THE H2S-DONOR, 4-CPI, PROMOTES A... Visualizza
3482 Gargini M.C. NARINGENIN PROTECTS MYOCARDIUM A... Visualizza
1285 Gargini MC. MYOCARDIAL ANTI-AGEING EFFECTS O... Visualizza
3230 Gargiulo A. S1PR1, S1PR3 and FTY720 in vascu... Visualizza
1286 Garibaldi G. Cutaneous hypoxia: effect of oxy... Visualizza
1287 Garlaschelli K. Apolipoprotein E modulates adapt... Visualizza
1288 Garofalo P. Characterization of adipokines s... Visualizza
1289 Gasco A. UNRAVELING THE MECHANISM OF ACTI... Visualizza
1290 Gasperoni L. Reporting of adverse drug reacti... Visualizza
1291 Gasperoni L. DRUGS - INDUCED DISSEMINATED INT... Visualizza
1292 Gaude E. GLUCOSE-6-PHOSPHATE DEHYDROGENAS... Visualizza
4193 Gaviani P. Liposomal cytarabine in leptomen... Visualizza
1293 Gaviano L. THE SELECTIVE HISTAMINE H4 RECEP... Visualizza
1294 Gaviano L. THE SELECTIVE ANTAGONISM OF ADEN... Visualizza
3231 Gaviano L. THE SELECTIVE HISTAMINE H4 RECEP... Visualizza
1295 Gavini E. PROTECTIVE EFFECT OF GENISTEIN-L... Visualizza
1296 Gazzano E. IN VITRO CARDIOVASCULAR TOXICITY... Visualizza
1297 Gazzerro P. RIMONABANT KILLS COLON CANCER ST... Visualizza
1298 Gellera C. Compound heterozygosis in the kc... Visualizza
1299 Genazzani A.A. Understanding the pathogenesis o... Visualizza
1300 Genazzani AA. Nicotinamide phosphoribosyltrans... Visualizza
1301 Genazzani AA. INVESTIGATION OF A PUTATIVE NICO... Visualizza
1302 Genazzani AA. The pharmacogenetics of the resp... Visualizza
1303 Genazzani AA. Real world data about biosimilar... Visualizza
1304 Gennazzani A. EVALUATION OF HEALTH DIRECT COST... Visualizza
3232 Genova E. Surfaced-enhanced Raman spectros... Visualizza
4142 Gentile A. Exercise attenuates myelin loss ... Visualizza
1305 Gentile D. Bifidobacterium Longum and Lacto... Visualizza
1306 Gentile D. Enteric glia is involved in colo... Visualizza
1307 Gentile D. EFFECTS OF L-DOPA/BENSERAZIDE CO... Visualizza
3233 Gentile D. APIGENIN SUPPLEMENTATION PREVENT... Visualizza
3713 Gentile D. COMPARATIVE PRE-CLINICAL STUDY O... Visualizza
1308 Gentili M. On the possible relationship bet... Visualizza
3234 Gentili M. MARKAR survey: influence of dire... Visualizza
3235 Gentili M. Stimulation of CB2 receptor affe... Visualizza
3714 Gentili M. GLUCOCORTICOID-INDUCED LEUCINE Z... Visualizza
1309 Gentilucci L. ANTIALLERGIC ACTIVITY OF A NOVEL... Visualizza
1310 Georgescu T. Hypothalamic Circuit Mediates Th... Visualizza
1311 Geppetti P. The antimigraine butterbur ingre... Visualizza
1312 Geppetti PG. Aromatase inhibitor-evoked pain ... Visualizza
4060 Gerace E. METAPLASTIC TREATMENTS WITH KETA... Visualizza
1313 Geraci F. Effects of Taurine in dry eye mo... Visualizza
1314 Geraci F. Role of TGF-_1 in age-related ma... Visualizza
3236 Geraci F. PALMITOYLETHANOLAMIDE LOADED IN ... Visualizza
3715 Geraci F. Buspirone rescues MK-801-induced... Visualizza
3716 Geraci F. Retinal bioavailability of curcu... Visualizza
3717 Gerdol M. RNA-SEQ ANALYSIS OF DIFFERENTIAL... Visualizza
1315 Gerlini G. Tryptophan 2,3-dioxygenase inhib... Visualizza
1316 Gessi S. PULSED ELECTROMAGNETIC FIELDS TR... Visualizza
1317 Gessi S. ANTI-NOCICEPTIVE EFFECTS OF NOVE... Visualizza
1318 Gessi S. A2B adenosine receptors stimulat... Visualizza
1319 Gesualdo C. MODULATION OF DIABETIC RETINOPAT... Visualizza
1320 Ghalardini C. THE FAT SENSING MOLECULE OLEOYLE... Visualizza
1321 Ghelardini C. VEGF INVOLVEMENT IN THE OXALIPLA... Visualizza
1322 Ghelardini C. CHEMOTHERAPY-INDUCED NEUROPATHIC... Visualizza
1323 Ghelardini C. A PRECLINICAL SET UP OF A RAT MO... Visualizza
1324 Ghelardini C. Studying the mechanism of rat ad... Visualizza
1325 Ghelardini C. Development of an in vitro model... Visualizza
1326 Ghelardini C. Alteration of visceral sensitivi... Visualizza
1327 Ghelardini C. Into the unexplored pathophysiol... Visualizza
1328 Ghelardini C. ENVIRONMENTAL TRAINING AMELIORAT... Visualizza
1329 Ghelardini C. Prophylactic versus Therapeutic ... Visualizza
3718 Gherardi M. NON THERMAL PLASMA AS INNOVATIVE... Visualizza
1330 Ghibaudi E. VANADIUM COMPOUNDS INHIBIT CELL ... Visualizza
3719 Giachetti A. Interaction between mPGES-1 and ... Visualizza
1331 Giacomini D. EFFECTS OF RGD LIGANDS ON INTEGR... Visualizza
1332 Giambelli R. Characterization of adipokines s... Visualizza
1333 Giampietro L. CM554, A NEW POTENT AND SELECTIV... Visualizza
1334 Giancotta C. BERGAMOT POLYPHENOLS PROTECT AGA... Visualizza
1335 Giancotta C. Early up-regulation of hepatic m... Visualizza
1336 Giancotta C. HYPERCHOLESTEROLEMIA MODULATES M... Visualizza
1337 Giancotta GC. Sildenafil improves cardiac func... Visualizza
1338 Giancotti LA. THE ROLE OF SIRT3 PATHWAY IN NEU... Visualizza
430 Giannasi C. ASC-DERIVED CONDITIONED MEDIUM (... Visualizza
3237 Giannasi C. Bisphosphonates modulate bone bi... Visualizza
1339 Giannotti G. Acute behavioral and molecular e... Visualizza
1340 Giannotti G. REPEATED EXPOSURE TO COCAINE DUR... Visualizza
3720 Giannotti G. POST-SYNAPTIC GLUTAMATE DYSFUNCT... Visualizza
1341 Giannuzzi F. Failures to further developing o... Visualizza
3238 Giannuzzi V. Failures to further developing o... Visualizza
4204 Giannuzzi V. The European Regulation for the ... Visualizza
1342 Giardina C. ADVERSE DRUG REACTIONS IN EMERGE... Visualizza
1343 Giaroni C. Antibiotic-induced dysbiosis aff... Visualizza
1344 Giaroni C. Involvement of catechol-O-methyl... Visualizza
1345 Gigli S. Rifaximin induces a PXR-mediated... Visualizza
3239 Gigli S. TARGETING S100B-P53WT PROTEIN-PR... Visualizza
3479 Gigli S. PALMITOYLETHANOLAMIDE IMPROVES H... Visualizza
3721 Gigliotti CL. EFFECTS OF THROMBIN CLEAVAGE OF ... Visualizza
1346 Ginestra G. IN VITRO EVALUATION OF ANTIOXIDA... Visualizza
1347 Gini R. Utilization of biological drugs ... Visualizza
1348 Gini R. EVALUATION OF HEALTH DIRECT COST... Visualizza
1349 Gini R. Real world data about biosimilar... Visualizza
1350 Gini R. NSAIDs utilization in a large co... Visualizza
1351 Ginobbi P. HOSPICE PALLIATIVE CARE MEDICATI... Visualizza
1353 Giordano C. Palmitoylethanolamide Reduces Ne... Visualizza
1354 Giorgi G. NO level and oxidative stress in... Visualizza
3241 Giorgi G. Evaluation of salivary catalase ... Visualizza
1355 Giorgia G. Targeting nicotinamide phosphory... Visualizza
1356 Giorgianni F. Intravitreal anti-VEGF injection... Visualizza
1357 Giorgianni F. EVALUATION OF HEALTH DIRECT COST... Visualizza
1358 Giorgianni F. Real world data about biosimilar... Visualizza
1359 Giorgianni F. GENDER SPECIFIC DRUG USE IN PEDI... Visualizza
3242 Giorgianni F. WHAT IS THE EFFECT OF RISK MINIM... Visualizza
1360 Giorgio C. PHARMACOLOGICAL CHARACTERIZATION... Visualizza
4061 Giorgio C. DUAL TARGETING OF EPH-EPHRIN SYS... Visualizza
3722 Giorgio E. High density lipoproteins inhibi... Visualizza
1361 Giorgio V. The Impact Of ALDH-2 Activity On... Visualizza
1362 Giovannelli L. Adverse drug reactions in paedia... Visualizza
3723 Giovannelli L. INHIBITION OF SPONTANEOUS COLON ... Visualizza
1363 Giovannini MG. THE SELECTIVE ANTAGONISM OF ADEN... Visualizza
1364 Giovannoni MP. Development of an in vitro model... Visualizza
1365 Girardi A. SAFETY OF FOOD SUPPLEMENTS CONTA... Visualizza
3243 Girardi A. Renal impairment in very low bir... Visualizza
1366 Giron MC. Changes of small bowel inhibitor... Visualizza
1367 Giron MC. EFFECT OF ANTIBIOTIC-INDUCED DYS... Visualizza
1368 Giron MC. Enteric glia is involved in colo... Visualizza
1369 Giron MC. The protective effect of naringe... Visualizza
1370 Giron MC. Involvement of catechol-O-methyl... Visualizza
1371 Giron MC. Antibiotic-induced dysbiosis aff... Visualizza
1372 Giugliano M. MENINGEAL NEURAL PRECURSORS CONT... Visualizza
1373 Giuliani D. STUDY ON PROTECTIVE ACTION OF HY... Visualizza
1374 Giuliani D. Melanocortin receptor-4 as a nov... Visualizza
3724 Giuliani D. PROTECTIVE EFFECT OF NDP-_-MSH O... Visualizza
3725 Giuliani D. LACK OF THE NLRP3 INFLAMMASOME I... Visualizza
4136 Giuliani P. Influence of P2X7 receptors (pur... Visualizza
1375 Giulivi C. Changes of small bowel inhibitor... Visualizza
1376 Giurdanella G. Role of P2X7 receptor in early d... Visualizza
3244 Giurdanella G. Sulodexide prevents high glucose... Visualizza
3726 Giurdanella G. VEGF EXACERBATES DAMAGE INDUCED ... Visualizza
3727 Giurdanella G. Dopamine D3 receptor-dependent c... Visualizza
3245 Giuseppe Spaziano GS. NOCICEPTIN/ORPHANINFQ (N/OFQ) CO... Visualizza
3246 Giuseppe spaziano GS. NOCICEPTIN REDUCES THE INFLAMMAT... Visualizza
3247 Giusepponi ME. OLFACTORY RECEPTOR 984 A NEW TAR... Visualizza
1380 Giusti P. MANAGING CHRONIC MYELOID LEUKEMI... Visualizza
1381 Giusti P. HEPATITIS C VIRUS (HCV) INFECTIO... Visualizza
1382 Giusti P. CLINICAL VALIDATION OF THE REALQ... Visualizza
1383 Giusti P. MOLECULAR MONITORING OF CHRONIC ... Visualizza
1384 Giustino A. IN VIVO AND IN VITRO PRECLINICAL... Visualizza
3728 Giva LB. Sphingosine 1-Phosphate And Athe... Visualizza
1385 Gliozzi GM. Sildenafil improves cardiac func... Visualizza
1386 Gliozzi M. BERGAMOT POLYPHENOLS PROTECT AGA... Visualizza
1387 Gliozzi M. THE ROLE OF SIRT3 PATHWAY IN NEU... Visualizza
1388 Gliozzi M. Early up-regulation of hepatic m... Visualizza
1389 Gliozzi M. HYPERCHOLESTEROLEMIA MODULATES M... Visualizza
3248 Gliozzi M. Impaired glucose and lipid metab... Visualizza
1390 Gomaraschi M. Recombinant LCAT rescues defecti... Visualizza
3729 Gomaraschi M. High density lipoproteins inhibi... Visualizza
1391 Gonella L. VIGINETWORK: A COMMUNITY PHARMAC... Visualizza
1392 Gontero E. A NEW UHPLC-MS/MS METHOD FOR THE... Visualizza
3249 Gonzalez Ruiz P. MOLECULAR MONITORING OF CHRONIC ... Visualizza
1393 Gori A. miRNA-218 TARGETS LIPIN-1 AND GL... Visualizza
3250 Gori A. Pharmacokinetics of darunavir/co... Visualizza
1394 Gorini A. EFFECTS OF CLONIDINE ON HIPPOCAM... Visualizza
4217 Govoni S. Targeting pathologic amyloid wit... Visualizza
14 Gozzo L. Ensure patients access to invest... Visualizza
3251 Gozzo L. Off-label drug use and safety of... Visualizza
3252 Gozzo L. Off-label drug use at the Policl... Visualizza
3253 Gozzo L. Off-label drug use at the Univer... Visualizza
1395 Gran BG. CpG type-A induction of an early... Visualizza
1396 Granata A. UNRAVELING THE MECHANISM OF ACTI... Visualizza
1397 Granata A. LIPIDOMICS AS A TOOL TO UNRAVEL ... Visualizza
1398 Granata A. LIPID CONTENT OF HUMAN TUMOR EXO... Visualizza
3730 Granchi C. ANTICANCER EFFECTS OF NOVEL LDH-... Visualizza
1399 Grande R. Targeting platelet purinergic si... Visualizza
1400 Grande R. PLATELET-DEPENDENT ACTIVATION OF... Visualizza
1401 Grande R. Generation of 12- hydroxyeicosat... Visualizza
3254 Grande R. LIPIDOMICS OF EICOSANOIDS GENERA... Visualizza
3731 Grande R. Platelet-derived microparticles ... Visualizza
1402 Grandi A. BLOCKADE OF EPHB-EPHRINB SIGNALL... Visualizza
1403 Grandi A. BENEFICIAL EFFECTS OF PHARMACOLO... Visualizza
1404 Grandi S. DRUGS - INDUCED DISSEMINATED INT... Visualizza
1405 Grandi S. CARDIOVASCULAR SAFETY OF MACROLI... Visualizza
3255 Grandi S. Reporting of adverse drug reacti... Visualizza
3732 Grange C. Megalin and Sodium-Hydrogen Exch... Visualizza
1406 Grassby T. IN VITRO AND IN VIVO MODELING OF... Visualizza
4062 Grassi MC. Results from an e-learning cours... Visualizza
1407 Gravina GL. U0126 MEK/ERK INHIBITOR INCREASE... Visualizza
1408 Gravina GL. THE EPHRIN RECEPTOR KINASE INHIB... Visualizza
3733 Gravina GL. DUAL TARGETING OF EPH-EPHRIN SYS... Visualizza
1409 Graziani V. CM554, A NEW POTENT AND SELECTIV... Visualizza
3256 Graziano A. ROSMARINUS OFFICINALIS EXTRACT P... Visualizza
1411 Graziosi A. THE 6-(METHYLSULFINYL)HEXYL ISOT... Visualizza
1412 Greco D. Vitamin D replacement in pre-men... Visualizza
1413 Greco G. A NEW SYNTHETIC ISOTHIOCYANATE D... Visualizza
3734 Greco G. NON THERMAL PLASMA AS INNOVATIVE... Visualizza
1414 Gregori M. Measurement of deferasirox plasm... Visualizza
1415 Grieco P. MODULATION OF DIABETIC RETINOPAT... Visualizza
1416 Grigore L. Apolipoprotein E modulates adapt... Visualizza
1417 Grilli M. CONTRIBUTION OF ASTROCYTES TO NE... Visualizza
1418 Grilli M. SALMETEROL, A SELECTIVE AND LONG... Visualizza
1419 Grilli M. Prophylactic versus Therapeutic ... Visualizza
3257 Grilli M. Functional interaction between n... Visualizza
32 Grimaldi A. LEVELS OF SOLUBLE CD73 IN MELANO... Visualizza
1420 Gritti L. NEWLY IDENTIFIED PHOX2B TARGET G... Visualizza
3735 Grohmann G. REINSTALLING IMMUNE REGULATORY T... Visualizza
3736 Grohmann U. IMMUNOREGULATORY SYNERGISM BETWE... Visualizza
3737 Grohmann U. The proteasome inhibitor bortezo... Visualizza
3258 Grolla AA. Nicotinamide phosphoribosyltrans... Visualizza
1421 Groppuzzo M. Tacrolimus Therapeutic Drug Moni... Visualizza
1422 Grotti A. Characterization of adipokines s... Visualizza
1423 Grugni G. Hedonic eating in Prader-Willi s... Visualizza
1424 Grundy MM. IN VITRO AND IN VIVO MODELING OF... Visualizza
1425 Gualtieri P. ANTIOXIDANT EFFECTS OF A HYDROXY... Visualizza
1426 Guarini S. STUDY ON PROTECTIVE ACTION OF HY... Visualizza
1427 Guarini S. Melanocortin receptor-4 as a nov... Visualizza
3738 Guarini S. PROTECTIVE EFFECT OF NDP-_-MSH O... Visualizza
3739 Guarini S. LACK OF THE NLRP3 INFLAMMASOME I... Visualizza
1428 Guerini R. OVERTREATMENT IN PHARMACORESISTA... Visualizza
1429 Guerra A. THE ROLE OF SNPs ANALYSIS IN NEU... Visualizza
1430 Guerrini R. PHARMACOLOGICAL CHARACTERIZATION... Visualizza
3740 Guerrini R. NOP RECEPTOR AND FUNCTIONAL SELE... Visualizza
3741 Gugliandolo E. EFFECTS OF A CO-MICRONIZED COMPO... Visualizza
1431 Gugliandolo EG. Inhibition of inflammasome activ... Visualizza
1432 Gugliandolo EG. Bergamot Juice extract treatment... Visualizza
3259 Gugliandolo EG. PEA/PLD ASSOCIATION, REDUCE INFL... Visualizza
1433 Guglielmo L. Curcumin Ameliorates the In Vitr... Visualizza
1434 Guida F. Palmitoylethanolamide Reduces Ne... Visualizza
1435 Guida F. Pathological gambling new therap... Visualizza
1436 Guida F. Stimulation of CB2 receptor affe... Visualizza
1437 Guida F. PALMITOYLETHANOLAMIDE, VIA PPAR-... Visualizza
3742 Guida F. DIMETHYL FUMARATE REDUCES TACTIL... Visualizza
1438 Guida N. IDENTIFICATION OF TRANSCRIPTION ... Visualizza
1441 Guillem-llobat P. Targeting platelet purinergic si... Visualizza
1440 Guillemette C. GENETIC MARKERS IN NUCLEAR RECEP... Visualizza
1442 Gulisano M. Into the unexplored pathophysiol... Visualizza
1443 Gulisano W. cGMP MODULATES LONG-TERM POTENTI... Visualizza
1444 Gumeni S. The protective effect of naringe... Visualizza
3260 Gurgone D. 3-Mercaptopyruvate relaxes aorta... Visualizza
3743 Gurgone D. Hydrogen sulfide pathway as a ne... Visualizza
1445 Gurlek A. Vitamin D replacement in pre-men... Visualizza
1446 Gurses KM. Vitamin D replacement in pre-men... Visualizza
1448 Guzzo G. GLUCOSE-6-PHOSPHATE DEHYDROGENAS... Visualizza
1449 Haxhi J. SEDENTARY-TIME: EFFECT ON PRO- A... Visualizza
1450 Heilbronner U. CONVERGENT ANALYSIS OF GENOME-WI... Visualizza
1451 Heisler LK. Hypothalamic Circuit Mediates Th... Visualizza
1452 Hinz C. LIPIDOMICS OF EICOSANOIDS GENERA... Visualizza
1453 Hinz C. Generation of 12- hydroxyeicosat... Visualizza
1454 Hla T. S1PR1, S1PR3 and FTY720 in vascu... Visualizza
1455 Hope BT. ROLE OF DORSOMEDIAL STRIATUM NEU... Visualizza
1456 Hossain F. CROSSTALK BETWEEN ADENOSINE AND ... Visualizza
1457 Hou L. CONVERGENT ANALYSIS OF GENOME-WI... Visualizza
1458 Howell LA. BIVALENT LIGANDS DISCLOSE GPCR D... Visualizza
1459 Hoxha M. CYP27A1 GENETIC POLYMORPHISM IN ... Visualizza
1460 Hrelia P. 6-(METHYLSULFINYL)HEXYLISOTHIOCY... Visualizza
1461 Hrelia P. NEUROPROTECTIVE EFFECTS OF THE N... Visualizza
1462 Hrelia P. MIR-139-5P AND MIR-455-5P AS POT... Visualizza
1463 Hrelia P. THE 6-(METHYLSULFINYL)HEXYL ISOT... Visualizza
1464 Hrelia P. DNA METHYLATION: GENE PROFILING ... Visualizza
1465 Hrelia P. CASTANEA SATIVA MILL. BARK EXTRA... Visualizza
1466 Hrelia P. A NEW SYNTHETIC ISOTHIOCYANATE D... Visualizza
3744 Hrelia P. NON THERMAL PLASMA AS INNOVATIVE... Visualizza
4200 Hrelia P. Exposome, genetic traits and fun... Visualizza
1467 Hrelia S. CASTANEA SATIVA MILL. BARK EXTRA... Visualizza
4199 Hrelia S. Biochemical mechanisms of nutrac... Visualizza
3745 Hu H. Chronic treatment with fluoxetin... Visualizza
1468 Huang X. PROTECTIVE ROLE OF CONVENTIONAL ... Visualizza
1469 Huber V. LIPID CONTENT OF HUMAN TUMOR EXO... Visualizza
1489 I-grade investigators. NSAIDs utilization in a large co... Visualizza
1470 Iaccarino G. CARDIOTOXIC EFFECTS OF SHORT-TER... Visualizza
3261 Iacobelli C. LIQUID BIOPSY: A REAL CLINICAL P... Visualizza
3746 Ialenti A. A ROLE FOR FIBROBLAST GROWTH FAC... Visualizza
1471 Ianaro A. ACETYL DEACYLASADISULFIDE, A NAT... Visualizza
1472 Ianaro A. Modulation of the inflammatory r... Visualizza
1473 Ianaro A. COX-2 EXPRESSION IN MALIGNANT ME... Visualizza
4063 Ianaro AI. KEY PATHWAYS AND EMERGING PLAYER... Visualizza
1474 Iannaccone T. SPA THERAPY: SULPHUROUS MINERAL ... Visualizza
1475 Iannaccone T. INFLUENCE OF GENDER ON SPA (SALU... Visualizza
1476 Iannaccone T. ATYPICAL SYMPTOMS OF TRAMADOL WI... Visualizza
4236 Iannone M. Identification and validation of... Visualizza
1477 Iannopollo M. LIQUID BIOPSY: A REAL CLINICAL P... Visualizza
1478 Iannotta M. Palmitoylethanolamide Reduces Ne... Visualizza
1479 Iannotta M. PALMITOYLETHANOLAMIDE, VIA PPAR-... Visualizza
3262 Iannotta M. D-ASPARTIC ACID AMELIORATES COGN... Visualizza
1480 Iannotti F. TRPM8 and experimental colorecta... Visualizza
3263 Iannotti F. The loss of Aristaless related h... Visualizza
1481 Iannotti FA. ENDOCANNABINOID SYSTEM AND MOUSE... Visualizza
1482 Iannuzzi F. ENVIRONMENTAL TRAINING AMELIORAT... Visualizza
1483 Idborg H. OVER-EXPRESSION OF MIR-574-5P IN... Visualizza
1484 Ientile V. LONG TERM DRUG SAFETY IN CHILDRE... Visualizza
1485 Ientile V. Real world data about biosimilar... Visualizza
1486 Ientile V. GENDER SPECIFIC DRUG USE IN PEDI... Visualizza
1487 Ieraci A. Environmental Chronic Stress Ind... Visualizza
1488 Ignazzi A. EFFECT OF CARBACHOL AND VIP IN H... Visualizza
1490 Ilari S. HYDRA VULGARIS AS A MODEL TO STU... Visualizza
3264 Ilari S. THE ROLE OF SIRT3 PATHWAY IN NEU... Visualizza
1491 Imbrici P. SEARCHING FOR NOVEL DRUGS IN MYO... Visualizza
3265 Imbrici P. BARTTER'S SYNDROME AND KIDNEY CL... Visualizza
1492 Imitazione P. EFFECT OF ULTRAFINE PARTICLE MAT... Visualizza
1493 Impellizzeri D. ANTI-INFLAMMATORY AND NEUROPROTE... Visualizza
3747 Impellizzeri D. EFFECTS OF A CO-MICRONIZED COMPO... Visualizza
1494 Imperi F. Development of hyaluronan/mannit... Visualizza
1495 Incerti M. PHARMACOLOGICAL CHARACTERIZATION... Visualizza
1496 Indraccolo S. Anti-angiogenic effect of therap... Visualizza
3748 Inferrera A. EFFECTS OF A CO-MICRONIZED COMPO... Visualizza
1497 Ingrasciotta Y. EVALUATION OF HEALTH DIRECT COST... Visualizza
3266 Ingrasciotta Y. Real world data about biosimilar... Visualizza
1498 Iori R. The chemopreventive effects of i... Visualizza
1499 Iorio A. Retrospective study on ItaliaN A... Visualizza
1500 Iorio A. REAL-LIFE SAFETY AND EFFECTIVENE... Visualizza
3749 Iorio A. IDO1 activity in selected immune... Visualizza
3267 Ipavec V. EFFECTS OF TETRAETHYLAMMONIUM ON... Visualizza
1501 Ippolito C. APIGENIN SUPPLEMENTATION PREVENT... Visualizza
1502 Ippolito C. EFFECTS OF L-DOPA/BENSERAZIDE CO... Visualizza
1503 Ippolito C. Enteric glia is involved in colo... Visualizza
1504 Irace C. DOWN REGULATION OF PRO-INFLAMMAT... Visualizza
1505 Irrera N. Activation of the EPOR-b common ... Visualizza
1506 Irrera N. Cadmium and its role in brain dy... Visualizza
1507 Irrera N. WHITE-TO-BROWN ADIPOSE TRANSDIFF... Visualizza
1508 Irrera N. Survivin and NAIP in Human Benig... Visualizza
1509 Irrera N. HIGH VARIABILITY IN TACROLIMUS B... Visualizza
3268 Irrera N. ADENOSINE 2A RECEPTOR STIMULATIO... Visualizza
3269 Irrera N. CURCUMIN POTENTIATES THE ANTI-IN... Visualizza
3750 Irrera N. FLAVONOIDS CONTAINED IN FLAVOCOX... Visualizza
4064 Irrera N. LACK OF THE NLRP3 INFLAMMASOME I... Visualizza
1510 Iudici M. Health status and concomitant pr... Visualizza
4233 Iuliano E. Identification and validation of... Visualizza
1511 Izzo AA. TRANSIENT RECEPTOR POTENTIAL VAN... Visualizza
1512 Izzo AA. TRPM8 and experimental colorecta... Visualizza
1513 Izzo AA. ENDOCANNABINOID SYSTEM AND MOUSE... Visualizza
1514 Izzo AA. A COMPARISON BETWEEN A CANNABIS ... Visualizza
1515 Izzo RI. LEAF EXTRACT OF MORUS ALBA, A CO... Visualizza
1516 Izzo V. Health status and concomitant pr... Visualizza
1517 Jakobsson PJ. OVER-EXPRESSION OF MIR-574-5P IN... Visualizza
3751 Jakobsson PJ. MICRORNA-574-5P MODULATES MICROS... Visualizza
1518 Johnson MR. Sestrin 3 as a regulator of pro-... Visualizza
1519 Jonker D. GENETIC MARKERS IN NUCLEAR RECEP... Visualizza
1520 Kagechika H. Myotrophin and miR-375 as pharma... Visualizza
1521 Kannan R. MODELING ROS1 TRANSLOCATION IN L... Visualizza
1522 Karathanasis S. Recombinant LCAT rescues defecti... Visualizza
3752 Keller C. EFFECTS OF THROMBIN CLEAVAGE OF ... Visualizza
1523 Kern M. OLFACTORY RECEPTOR 984 A NEW TAR... Visualizza
3753 Khatib M. INHIBITION OF SPONTANEOUS COLON ... Visualizza
1524 Kirchmayer U. NSAIDs utilization in a large co... Visualizza
4214 Kirchmayer U. The role of data sources in Real... Visualizza
1525 Kleinau G. BIVALENT LIGANDS DISCLOSE GPCR D... Visualizza
1526 Kloting N. OLFACTORY RECEPTOR 984 A NEW TAR... Visualizza
1527 Knezevic T. A CLINICIAN NETWORK FOR SHARING ... Visualizza
1528 Kocyigit D. Vitamin D replacement in pre-men... Visualizza
1529 Koczwara JB. ROLE OF THE AREA POSTREMA IN THE... Visualizza
1530 Koczwara JB. Chronic Oleoylethanolamide Treat... Visualizza
3270 Koczwara JB. EFFECTS OF SUBDIAPHRAGMATIC DEAF... Visualizza
3754 Kolachalam S. Clozapine as the most efficaciou... Visualizza
1531 Korotkova M. OVER-EXPRESSION OF MIR-574-5P IN... Visualizza
3755 Korotkova M. MICRORNA-574-5P MODULATES MICROS... Visualizza
3756 Korpi ER. Dopamine D3 receptor-dependent c... Visualizza
1532 Kreek MJ. EFFECTS OF A NOVEL SELECTIVE SHO... Visualizza
1551 L'Andolina M. ADVERSE DRUG REACTIONS WITH BIOL... Visualizza
1534 La neve A. OVERTREATMENT IN PHARMACORESISTA... Visualizza
1535 La Rana G. BUTYRATE ATTENUATES MOTOR DEFICI... Visualizza
1536 La Rana G. PHARMACOLOGICAL EFFECT OF PERAMP... Visualizza
1538 Labasque M. Sestrin 3 as a regulator of pro-... Visualizza
1539 Labbozzetta M. MDA-9/SYNTENIN AS A POTENTIAL DR... Visualizza
1540 Labriet A. GENETIC MARKERS IN NUCLEAR RECEP... Visualizza
1541 Ladetto M. The ABCB1 pharmacogenetics of R-... Visualizza
1542 Lama A. N-(1-CARBAMOYL-2-PHENYLETHYL) BU... Visualizza
1543 Lama A. Behavioral and Metabolic Charact... Visualizza
1544 Lama A. PALMITOYLETAHNOLAMIDE ATTENUATES... Visualizza
3757 Lama A. BUTYRATE REDUCES VALPROATE-INDUC... Visualizza
1545 Lambiase C. Analytically confirmed post-inje... Visualizza
1546 Lana D. THE SELECTIVE ANTAGONISM OF ADEN... Visualizza
1547 Lanati E. REAL-LIFE SAFETY AND EFFECTIVENE... Visualizza
3271 Lanati EP. Retrospective study on ItaliaN A... Visualizza
1548 Lancioni M. BEHAVIOURAL AND NEUROPATHOLOGICA... Visualizza
1549 Landi A. Failures to further developing o... Visualizza
1550 Landini I. SELECTION AND CHARACTERIZATION O... Visualizza
1552 Landonio S. MARKAR survey: influence of dire... Visualizza
1553 Landucci E. Central effects induced by syste... Visualizza
1554 Langasco R. PROTECTIVE EFFECT OF GENISTEIN-L... Visualizza
1555 Lange C. MENINGEAL NEURAL PRECURSORS CONT... Visualizza
1556 Langhans W. EFFECTS OF SUBDIAPHRAGMATIC DEAF... Visualizza
1557 Lanni C. MODULATION OF OXIDATIVE AND INFL... Visualizza
1558 Lanuti P. Generation of 12- hydroxyeicosat... Visualizza
3758 Lanuti P. Platelet-derived microparticles ... Visualizza
1559 Lanza M. Dimethyl fumarate attenuates neu... Visualizza
1560 Lanza M. Absence of TLR4 reduces neuroinf... Visualizza
3272 Lanza M. Multiple mechanisms of dimethyl ... Visualizza
1561 Lanzi C. TAGATOSE BENEFICIAL EFFECTS IN A... Visualizza
1562 Lanzi C. CARBONIC ANHYDRASE IX AND COX-2 ... Visualizza
3273 Lanzi C. HISTAMINE H3 RECEPTOR ANTAGONISM... Visualizza
107 lanzillotta A. SYNERGISTIC ASSOCIATION OF VALPR... Visualizza
1563 Lapi F. NSAIDs utilization in a large co... Visualizza
1564 Lapucci A. SELECTION AND CHARACTERIZATION O... Visualizza
1565 Laquintana A. DEVELOPMENT OF NOVEL LACTATE-NA2... Visualizza
1566 Larato A. ANALYSIS OF THE ADVERSE DRUG REA... Visualizza
1567 Larato A. SAFETY OF NEW DIRECT-ACTING ANTI... Visualizza
1568 Larato A. ESTIMATING INCIDENCE RATES OF AD... Visualizza
1569 Lariccia V. INVOLVEMENT OF NCX IN GLUTAMATE-... Visualizza
3759 Lariccia V. PIVOTAL ROLE OF NCX1 IN GLUTAMAT... Visualizza
1570 Larussa T. ADVERSE DRUG REACTIONS BY BIOLOG... Visualizza
1571 Lattanzi R. Involvement of the Prokineticin ... Visualizza
1572 Lattanzi R. ROLE OF PROKINETICIN SYSTEM IN A... Visualizza
1573 Laudati G. IDENTIFICATION OF TRANSCRIPTION ... Visualizza
1574 Laufk6tter O. SCREENING OF HUMAN SULFOTRANSFER... Visualizza
1575 Laurenti E. VANADIUM COMPOUNDS INHIBIT CELL ... Visualizza
1576 Lauria M. Cross-Disease Analysis of Alzhei... Visualizza
33 Laurino A. Isoform-selective blockade of HC... Visualizza
1577 Laurino A. Enhancement of cardiac different... Visualizza
1578 Laurino A. TAGATOSE BENEFICIAL EFFECTS IN A... Visualizza
3275 Laurino A. Central effects induced by syste... Visualizza
3276 Laurino A. Angiotensin-II activates p-38 an... Visualizza
3760 Laurita R. NON THERMAL PLASMA AS INNOVATIVE... Visualizza
1579 Lauritano A. Hedonic eating in Prader-Willi s... Visualizza
1580 Lauritano A. A COMPARISON BETWEEN A CANNABIS ... Visualizza
3277 Lauritano A. FUNCTIONAL COMPARISON AMONG THRE... Visualizza
1581 Lauro F. THE ROLE OF SIRT3 PATHWAY IN NEU... Visualizza
1582 Lavecchia AM. BEHAVIOURAL AND NEUROPATHOLOGICA... Visualizza
15 Lazzara A. Ensure patients access to invest... Visualizza
16 Lazzara A. Off-label drug use and safety of... Visualizza
17 Lazzara A. Off-label drug use at the Policl... Visualizza
1583 Lazzara A. Off-label drug use at the Univer... Visualizza
1584 Lazzara F. Effects of Taurine in dry eye mo... Visualizza
1585 Lazzara F. Sulodexide prevents high glucose... Visualizza
3278 Lazzara F. Role of TGF-_1 in age-related ma... Visualizza
3761 Lazzara F. VEGF EXACERBATES DAMAGE INDUCED ... Visualizza
3762 Lazzara F. Retinal bioavailability of curcu... Visualizza
1586 Lazzara S. Phytochemical Profile and Photot... Visualizza
1587 Lazzarato L. UNRAVELING THE MECHANISM OF ACTI... Visualizza
3763 Lazzeri L. ANTI-CANCER PROPERTIES OF ERUCIN... Visualizza
3764 Le grand B. REMODELING OF ATRIAL REPOLARIZAT... Visualizza
1588 Lecca D. GPR17-expressing oligodendrocyte... Visualizza
1589 Lecca D. Multiple sclerosis and depressio... Visualizza
1590 Lechi A. A prospective observational stud... Visualizza
1591 Leggio GM. Role of TGF-_1 in age-related ma... Visualizza
1592 Leggio GM. Role of P2X7 receptor in early d... Visualizza
1593 Leggio GM. Sulodexide prevents high glucose... Visualizza
3765 Leggio GM. Dopamine D3 receptor-dependent c... Visualizza
3766 Leggio GM. Buspirone rescues MK-801-induced... Visualizza
4066 Leggio GM. Dopamine D3 receptors control dy... Visualizza
1594 Lembo F. Behavioral and Metabolic Charact... Visualizza
1595 Lenti MC. PHYTO.VIG.GEST: "VIGILANCE ON US... Visualizza
1596 Lentini G. DEVELOPMENT OF NEW BENZOTHIAZOLA... Visualizza
3279 Lenzi M. 6-(METHYLSULFINYL)HEXYLISOTHIOCY... Visualizza
3280 Lenzi M. CASTANEA SATIVA MILL. BARK EXTRA... Visualizza
1597 Leo A. TOCILIZUMAB'S EFFECT ON EPILEPTO... Visualizza
1598 Leo A. EFFECTS OF HISTONE DEACETYLASE I... Visualizza
1599 Leo A. TREND OF ADVERSE DRUG REACTION R... Visualizza
1600 Leo A. PHARMACOLOGICAL EFFECT OF PERAMP... Visualizza
3281 Leo A. VILDAGLIPTIN IMPROVES ANIMAL BEH... Visualizza
1601 Leo V. INTERMITTENT ANTAGONISM OF BK2-R... Visualizza
1602 Leonardi L. Renal impairment in very low bir... Visualizza
1603 Leone R. A prospective observational stud... Visualizza
1604 Leone R. VIGINETWORK: A COMMUNITY PHARMAC... Visualizza
4134 Leone R. Frontiers in signal detection: f... Visualizza
1605 Leone S. Peripheral RVD-hemopressin(_) ad... Visualizza
1606 Leone S. HARPAGOPHYTUM PROCUMBENS AQUEOUS... Visualizza
1607 Leone S. Effects of Growth Hormone-Releas... Visualizza
4067 Leone S. Emotional Disorders Induced by H... Visualizza
1608 Leoni L. Development of hyaluronan/mannit... Visualizza
3767 Leonzino M. KCC2 is a key target of oxytocin... Visualizza
1609 Lepore SM. Anti-proliferative effects of Cy... Visualizza
1610 Lepore SM. Evaluation of protective effect ... Visualizza
1611 Leporini C. PHARMACOLOGICAL EFFECT OF PERAMP... Visualizza
3282 Leporini C. TREND OF ADVERSE DRUG REACTION R... Visualizza
3283 Leporini C. MONITORING SAFETY AND USE OF OLD... Visualizza
1612 Leporini L. HARPAGOPHYTUM PROCUMBENS AQUEOUS... Visualizza
1613 Letizia A. EFFECT OF PALMYTOILETHANOLAMIDE ... Visualizza
1614 Letizia A. EFFECT OF ULTRAMICRONIZED-PALMYT... Visualizza
1615 Levandis G. EFFECTS OF L-DOPA/BENSERAZIDE CO... Visualizza
3768 Levantesi G. REDUCED VARIABILITY TO ASPIRIN A... Visualizza
1537 Lèvesque E. GENETIC MARKERS IN NUCLEAR RECEP... Visualizza
1616 Leybaert L. Into the unexplored pathophysiol... Visualizza
3284 Li puma S. The antimigraine butterbur ingre... Visualizza
1617 Li puma SL. Aromatase inhibitor-evoked pain ... Visualizza
1619 Liantonio A. NEW BIOMARKERS IN ALS ETIOLOGY: ... Visualizza
1620 Liantonio A. BARTTER'S SYNDROME AND KIDNEY CL... Visualizza
1621 Liantonio A. GROWTH HORMONE SECRETAGOGUES PRE... Visualizza
1622 Liberto E. SEDENTARY-TIME: EFFECT ON PRO- A... Visualizza
1623 Liberto E. TOXICOLOGICAL IMPACT OF HIGH FRU... Visualizza
1624 Liedtke W. The antimigraine butterbur ingre... Visualizza
3769 Liepe J. EFFECTS OF THROMBIN CLEAVAGE OF ... Visualizza
1625 Lim D. Understanding the pathogenesis o... Visualizza
3770 Limanaqi F. COMPARATIVE PRE-CLINICAL STUDY O... Visualizza
96 liparulo A. THE ROLE OF NOCICEPTIN/ORPHANIN ... Visualizza
97 liparulo A. NOCICEPTIN REDUCES THE INFLAMMAT... Visualizza
1626 Liparulo A. Effects of lung resident mesench... Visualizza
1627 Lippiello P. DOWN REGULATION OF PRO-INFLAMMAT... Visualizza
3285 Lisi L. Interactions between antiretrovi... Visualizza
1628 Liu C. S1PR1, S1PR3 and FTY720 in vascu... Visualizza
1629 Liu N. Myotrophin and miR-375 as pharma... Visualizza
1630 Llorens-bobadilla E. MENINGEAL NEURAL PRECURSORS CONT... Visualizza
1631 Lo giudice I. ADVERSE DRUG REACTIONS IN EMERGE... Visualizza
1632 Lo Monaco M. SEARCHING FOR NOVEL DRUGS IN MYO... Visualizza
1633 Lo schirico M. The ABCB1 pharmacogenetics of R-... Visualizza
1634 Locatelli CA. Methotrexate therapeutic error i... Visualizza
1635 Locatelli CA. Antidote treatment in Viper enve... Visualizza
1636 Locatelli CA. Analytically confirmed post-inje... Visualizza
1637 Locatelli CA. Gamma-hydroxybutyrate intoxicati... Visualizza
1638 Locatelli M. HARPAGOPHYTUM PROCUMBENS AQUEOUS... Visualizza
1639 Locatelli V. miRNA-218 TARGETS LIPIN-1 AND GL... Visualizza
1640 Locatelli V. EFFECTS OF HEXARELIN IN A MODEL ... Visualizza
1641 Locati M. ESTROGEN PROMOTES MACROPHAGE PRO... Visualizza
3771 Locati M. THE ACETYLCHOLINESTERASE DONEPEZ... Visualizza
1642 Lodola A. PHARMACOLOGICAL CHARACTERIZATION... Visualizza
3772 Lodola A. DUAL TARGETING OF EPH-EPHRIN SYS... Visualizza
1643 Lodovici M. Effects of electronic cigarette ... Visualizza
3773 Lodovici M. Nutraceutical properties of Arth... Visualizza
1644 Lodrini G. Methotrexate therapeutic error i... Visualizza
1645 Lodrini G. Analytically confirmed post-inje... Visualizza
3286 Lolli F. FROM METABOLIC FITNESS TO METABO... Visualizza
1646 Lolli M. INDOMETHACIN INHIBITS PROLIFERAT... Visualizza
869 lomas D. ALPHA-1 ANTITRYPSIN (AAT) POLYME... Visualizza
4147 Lombardi M. Proteomic analysis of ectosomes ... Visualizza
1647 Lombardi N. Adverse drug reactions in paedia... Visualizza
1648 Lombardi N. Risk of bone fractures among use... Visualizza
1649 Lombardi N. Drug-utilization of new oral ant... Visualizza
1650 Lombardi N. Pharmacoutilization of Antidiabe... Visualizza
1651 Lombardi N. FREQUENCY AND CHARACTERISTICS OF... Visualizza
1652 Lombardi S. Identification of a novel, funct... Visualizza
1653 Lombardo GE. Anti-proliferative effects of Cy... Visualizza
1654 Lombardo GE. Growth inhibition, cell-cycle ar... Visualizza
3287 Lombardo GE. Evaluation of protective effect ... Visualizza
1655 Lonati D. Antidote treatment in Viper enve... Visualizza
1656 Lonati D. Methotrexate therapeutic error i... Visualizza
18 Longo L. Off-label drug use and safety of... Visualizza
19 Longo L. Off-label drug use at the Policl... Visualizza
1657 Longo L. LONG-LASTING EFFECTS OF STRESS I... Visualizza
1658 Longo L. Trends in Spontaneous Adverse Dr... Visualizza
1659 Longo L. Off-label drug use at the Univer... Visualizza
3288 Longo L. Ensure patients access to invest... Visualizza
1660 Longo V. Evaluation of protective effect ... Visualizza
1661 Lopedota A. DEVELOPMENT OF NOVEL LACTATE-NA2... Visualizza
2162 lopez P. IN VITRO ASSESSMENT OF CABAZITAX... Visualizza
1662 Lora R. VIGINETWORK: A COMMUNITY PHARMAC... Visualizza
1663 Lorè F. Evaluation of salivary catalase ... Visualizza
1664 Lorusso D. EFFECT OF CARBACHOL AND VIP IN H... Visualizza
1665 Loupakis F. Colon cancer therapy beyond tumo... Visualizza
1666 Lovisari F. Sestrin 3 as a regulator of pro-... Visualizza
1667 Lucafò M. THE ROLE OF THE mRNA BINDING PRO... Visualizza
3289 Lucafo' M. Pharmacoepigenomic markers invol... Visualizza
1668 Lucarini E. A PRECLINICAL SET UP OF A RAT MO... Visualizza
1669 Lucarini E. Studying the mechanism of rat ad... Visualizza
1670 Lucarini E. Development of an in vitro model... Visualizza
1671 Lucarini E. VEGF INVOLVEMENT IN THE OXALIPLA... Visualizza
1672 Lucarini E. Into the unexplored pathophysiol... Visualizza
3290 Lucarini E. Alteration of visceral sensitivi... Visualizza
1673 Lucarini L. HISTAMINE H3 RECEPTOR ANTAGONISM... Visualizza
1674 Lucarini L. TAGATOSE BENEFICIAL EFFECTS IN A... Visualizza
1675 Lucarini L. THE SELECTIVE HISTAMINE H4 RECEP... Visualizza
1676 Lucarini L. THE SELECTIVE HISTAMINE H4 RECEP... Visualizza
3291 Lucarini L. CARBONIC ANHYDRASE IX AND COX-2 ... Visualizza
1677 Lucchetti E. Hedonic eating in Prader-Willi s... Visualizza
1678 Lucenteforte E. Drug-utilization of new oral ant... Visualizza
1679 Lucenteforte E. Pharmacoutilization of Antidiabe... Visualizza
1680 Lucenteforte E. Adverse drug reactions in paedia... Visualizza
1681 Lucenteforte E. NSAIDs utilization in a large co... Visualizza
3292 Lucenteforte E. Risk of bone fractures among use... Visualizza
1682 Luceri C. AN IN VITRO MODEL FOR SCREENING ... Visualizza
1683 Luceri C. Effects of NO and H2S releasing ... Visualizza
3774 Luceri C. INHIBITION OF SPONTANEOUS COLON ... Visualizza
3775 Luceri C. Potential of a flavonoid-rich ex... Visualizza
4068 Luceri C. Nutraceutical properties of Arth... Visualizza
1684 Lucia M. TREND OF ADVERSE DRUG REACTION R... Visualizza
1686 Lunerti V. ACTIVATION OF PPAR_ AS A NEW PHA... Visualizza
1687 Luongo L. Palmitoylethanolamide Reduces Ne... Visualizza
1688 Luongo L. PALMITOYLETHANOLAMIDE, VIA PPAR-... Visualizza
1689 Luongo L. D-ASPARTIC ACID AMELIORATES COGN... Visualizza
4069 Luongo L. DIMETHYL FUMARATE REDUCES TACTIL... Visualizza
1690 Lupo G. Sulodexide prevents high glucose... Visualizza
1691 Lupo ML. LEAF EXTRACT OF MORUS ALBA, A CO... Visualizza
1692 Luppi B. Development of microparticles fo... Visualizza
1693 Lutz T. ROLE OF THE AREA POSTREMA IN THE... Visualizza
1694 Luzza F. ADVERSE DRUG REACTIONS BY BIOLOG... Visualizza
1695 M. Melchiorre Isoform-selective blockade of HC... Visualizza
1696 M. Trombini Safety profile of antipsychotic ... Visualizza
1697 M.Capone LEVELS OF SOLUBLE CD73 IN MELANO... Visualizza
3294 Mabou Tagne A. Tithonia diversifolia (Hemsl.) A... Visualizza
1698 Macallini C. CM554, A NEW POTENT AND SELECTIV... Visualizza
3776 Maccherini M. REMODELING OF ATRIAL REPOLARIZAT... Visualizza
3777 Macchi C. High density lipoproteins inhibi... Visualizza
1699 Macedonio G. Peripheral RVD-hemopressin(_) ad... Visualizza
1700 Macr, ML. INVOLVEMENT OF NCX IN GLUTAMATE-... Visualizza
1701 Madeddu P. LIPIDOMICS AS A TOOL TO UNRAVEL ... Visualizza
1246 Madonna G. LEVELS OF SOLUBLE CD73 IN MELANO... Visualizza
1702 Maestrelli P. HEPATITIS C VIRUS GENOTYPE 3H: T... Visualizza
4201 Maffei F. Sport and Dietary supplements: e... Visualizza
3295 Maftei D. Involvement of the Prokineticin ... Visualizza
1703 Magarò G. In vitro and in vivo antibacteri... Visualizza
1704 Maggi A. ESTROGEN PROMOTES MACROPHAGE PRO... Visualizza
1705 Maggi A. STUDY OF MICROGLIA PROLIFERATION... Visualizza
1706 Maggi A. FROM METABOLIC FITNESS TO METABO... Visualizza
1707 Maggi A. Inhibition of SIRT1 Deacetylase ... Visualizza
1708 Maggio R. U0126 MEK/ERK INHIBITOR INCREASE... Visualizza
1709 Maggio R. THE EPHRIN RECEPTOR KINASE INHIB... Visualizza
3296 Maggisano V. Anti-proliferative effects of Cy... Visualizza
1710 Magi S. INVOLVEMENT OF NCX IN GLUTAMATE-... Visualizza
4070 Magi S. PIVOTAL ROLE OF NCX1 IN GLUTAMAT... Visualizza
1711 Magni C. MARKAR survey: influence of dire... Visualizza
3778 Magni P. High density lipoproteins inhibi... Visualizza
1712 Magro L. A prospective observational stud... Visualizza
3297 Magro L. VIGINETWORK: A COMMUNITY PHARMAC... Visualizza
1713 Maida F. MONITORING SAFETY AND USE OF OLD... Visualizza
1714 Maino B. Involvement of bradykinin B2 rec... Visualizza
1715 Maioli S. Cross-Disease Analysis of Alzhei... Visualizza
3779 Maiolino M. PIVOTAL ROLE OF NCX1 IN GLUTAMAT... Visualizza
3298 Maione F. DOWN REGULATION OF PRO-INFLAMMAT... Visualizza
1716 Maione S. Pathological gambling new therap... Visualizza
1717 Maione S. Stimulation of CB2 receptor affe... Visualizza
1718 Maione S. Palmitoylethanolamide Reduces Ne... Visualizza
1719 Maione S. D-ASPARTIC ACID AMELIORATES COGN... Visualizza
1720 Maione S. PALMITOYLETHANOLAMIDE, VIA PPAR-... Visualizza
3780 Maione S. DIMETHYL FUMARATE REDUCES TACTIL... Visualizza
1721 Maisto R. PHARMACOLOGICAL MODULATION OF CA... Visualizza
3299 Maisto R. MODULATION OF DIABETIC RETINOPAT... Visualizza
1722 Maiuolo J. Anti-proliferative effects of Cy... Visualizza
1723 Maiuolo J. Impaired glucose and lipid metab... Visualizza
1724 Maiuolo J. Early up-regulation of hepatic m... Visualizza
1725 Maiuolo J. HYPERCHOLESTEROLEMIA MODULATES M... Visualizza
1726 Maiuolo MJ. Sildenafil improves cardiac func... Visualizza
1727 Malafoglia V. THE ROLE OF SIRT3 PATHWAY IN NEU... Visualizza
3300 Malafoglia V. HYDRA VULGARIS AS A MODEL TO STU... Visualizza
3781 Malaguti L. ANTI-CANCER PROPERTIES OF ERUCIN... Visualizza
1728 Malaguti M. CASTANEA SATIVA MILL. BARK EXTRA... Visualizza
4106 Maldonado R. The endocannabinoid system as th... Visualizza
1729 Malfacini D. PHARMACOLOGICAL CHARACTERIZATION... Visualizza
3782 Malfacini D. NOP RECEPTOR AND FUNCTIONAL SELE... Visualizza
1254 malgieri G. NOCICEPTIN REDUCES THE INFLAMMAT... Visualizza
827 Mallardo D. LEVELS OF SOLUBLE CD73 IN MELANO... Visualizza
1730 Maloy K. Modulation of the inflammatory r... Visualizza
1731 Mammola CL. Effects of the metronomic treatm... Visualizza
3783 Manag˜ F. Dopamine D3 receptors control dy... Visualizza
3784 Manarini S. REDUCED VARIABILITY TO ASPIRIN A... Visualizza
1732 Mancinelli R. Effects of the metronomic treatm... Visualizza
1733 Mancini A. Kv7 channels are involved in hum... Visualizza
1734 Mancini G.F. AMPHETAMINE AND THE "BATH SALT" ... Visualizza
3785 Mancini T. Sphingosine 1-Phosphate And Athe... Visualizza
1735 Mancusi D. Pharmacokinetics of darunavir/co... Visualizza
1736 Mancuso C. FERULIC ACID AFFECTS MEMORY CONS... Visualizza
4124 Mancuso C. A preclinical study on the nootr... Visualizza
1737 Mandalari G. IN VITRO AND IN VIVO MODELING OF... Visualizza
1738 Mandrioli R. Effects of ethanolic extracts of... Visualizza
1739 Manduca A. CHANGES IN THE ENDOCANNABINOID S... Visualizza
4109 Manduca A. Nutritional omega-3 deficiency s... Visualizza
1740 Manega CM. Fluoroscopy-associated oxidative... Visualizza
1741 Manfredi M. INVESTIGATION OF A PUTATIVE NICO... Visualizza
1742 Mangano G. MONITORING SAFETY AND USE OF OLD... Visualizza
1743 Mangialardi G. LIPIDOMICS AS A TOOL TO UNRAVEL ... Visualizza
1744 Mangiatordi G.F. SEARCHING FOR NOVEL DRUGS IN MYO... Visualizza
1745 Mangiatordi GF. BARTTER'S SYNDROME AND KIDNEY CL... Visualizza
3301 Mango D. ACID-SENSING ION CHANNEL 1A IS R... Visualizza
1247 Mannaioni G. Isoform-selective blockade of HC... Visualizza
1439 mannaioni G. DIFFERENTIAL CONTRIBUTION OF IH ... Visualizza
1746 Mannaioni G. Central effects induced by syste... Visualizza
1747 Manni G. PROTECTIVE ROLE OF CONVENTIONAL ... Visualizza
3302 Manni GM. CpG type-A induction of an early... Visualizza
1748 Manning M. BIVALENT LIGANDS DISCLOSE GPCR D... Visualizza
1749 Mannino F. Activation of the EPOR-b common ... Visualizza
1750 Mannino F. HIGH VARIABILITY IN TACROLIMUS B... Visualizza
3303 Mannino F. WHITE-TO-BROWN ADIPOSE TRANSDIFF... Visualizza
3786 Mannino F. LACK OF THE NLRP3 INFLAMMASOME I... Visualizza
3787 Mannino F. FLAVONOIDS CONTAINED IN FLAVOCOX... Visualizza
1751 Mannucci C. NABILONE AND THC/CBD FOR THE TRE... Visualizza
3304 Mannucci C. PHYTO.VIG.GEST: "VIGILANCE ON US... Visualizza
3305 Manocchio L. STARGAZIN REGULATES THE BIOCHEMI... Visualizza
20 Mansueto S. Ensure patients access to invest... Visualizza
21 Mansueto S. Off-label drug use and safety of... Visualizza
22 Mansueto S. Off-label drug use at the Policl... Visualizza
1752 Mansueto S. Trends in Spontaneous Adverse Dr... Visualizza
1753 Mansueto S. Off-label drug use at the Univer... Visualizza
1754 Mantarro S. INTENSIVE MONITORING PROGRAM OF ... Visualizza
1755 Mantegazza R. SEARCHING FOR NOVEL DRUGS IN MYO... Visualizza
1756 Mantuano P. IN VIVO AND IN VITRO PRECLINICAL... Visualizza
1757 Mantuano P. A LONG TERM TREATMENT WITH TAURI... Visualizza
3306 Mantuano P. EFFECT OF A LONG TERM TREATMENT ... Visualizza
1761 Manzo V. SPA THERAPY: SULPHUROUS MINERAL ... Visualizza
1762 Manzo V. INFLUENCE OF GENDER ON SPA (SALU... Visualizza
3308 Manzo V. ATYPICAL SYMPTOMS OF TRAMADOL WI... Visualizza
1763 Manzoli L. Increasing trend in admission ra... Visualizza
1764 Maqoud F. Gender-dependent involvement of ... Visualizza
1765 Maqoud F. IN VITRO AND EX-VIVO EFFECTS OF ... Visualizza
3309 Maqoud F. IRREVERSIBLE BK CHANNEL BLOCKING... Visualizza
3310 Maqoud F. DEVELOPMENT OF NOVEL LACTATE-NA2... Visualizza
1767 Marabello D. VANADIUM COMPOUNDS INHIBIT CELL ... Visualizza
1768 Marabese I. PALMITOYLETHANOLAMIDE, VIA PPAR-... Visualizza
3311 Marampon F. THE EPHRIN RECEPTOR KINASE INHIB... Visualizza
3312 Marampon F. U0126 MEK/ERK INHIBITOR INCREASE... Visualizza
1769 Marangon D. Multiple sclerosis and depressio... Visualizza
3313 Marangon D. GPR17-expressing oligodendrocyte... Visualizza
1770 Marcelli A. Retrospective study on ItaliaN A... Visualizza
1771 Marchesi N. MODULATION OF OXIDATIVE AND INFL... Visualizza
3314 Marchi C. Vitamin D replacement in pre-men... Visualizza
1772 Marchi M. Functional interaction between n... Visualizza
1773 Marchi M. Prophylactic versus Therapeutic ... Visualizza
1774 Marchianò SM. LEAF EXTRACT OF MORUS ALBA, A CO... Visualizza
3788 Marchian˜ S. Shedding light on PCSK9 function... Visualizza
3789 Marchian˜ S. The bile acid receptor GPBAR1 re... Visualizza
4071 Marchian˜ S. Geranylgeraniol prevents the sim... Visualizza
1775 Marchione P. ADVERSE DRUG REACTIONS ASSOCIATE... Visualizza
1776 Marchisio M. Generation of 12- hydroxyeicosat... Visualizza
3790 Marchisio M. Platelet-derived microparticles ... Visualizza
1777 Marcianò I. Real world data about biosimilar... Visualizza
3315 Marcianò I. Intravitreal anti-VEGF injection... Visualizza
1778 Marcoli M. VULNERABILITY TO SEIZURES AND AS... Visualizza
1779 Marcoli M. CHEMOTHERAPY-INDUCED NEUROPATHIC... Visualizza
1780 Marconi E. Adverse drug reactions in paedia... Visualizza
1781 Marconi E. Pharmacoutilization of Antidiabe... Visualizza
3316 Marconi E. Drug-utilization of new oral ant... Visualizza
1782 Marelli-berg F. Apolipoprotein E modulates adapt... Visualizza
3791 Marenzi GC. Vitamin D levels and Tissue Fact... Visualizza
1783 Maresca M. A PRECLINICAL SET UP OF A RAT MO... Visualizza
1784 Maresca M. Development of an in vitro model... Visualizza
1785 Maresca M. Alteration of visceral sensitivi... Visualizza
1786 Maresca M. Studying the mechanism of rat ad... Visualizza
3317 Maresca M. Into the unexplored pathophysiol... Visualizza
1787 Maretta A. Impaired glucose and lipid metab... Visualizza
1788 Maretta A. Early up-regulation of hepatic m... Visualizza
1789 Maretta A. HYPERCHOLESTEROLEMIA MODULATES M... Visualizza
1790 Maretta MA. Sildenafil improves cardiac func... Visualizza
1794 Marin E. ACTIVITY OF ALOE ARBORESCENS LEA... Visualizza
1798 Marini H. Cadmium and its role in brain dy... Visualizza
1799 Marini H. Survivin and NAIP in Human Benig... Visualizza
1800 Marini V. Subcutaneous slow-release metfor... Visualizza
1801 Marini V. Measurement of deferasirox plasm... Visualizza
1802 Marino A. A CLINICIAN NETWORK FOR SHARING ... Visualizza
1803 Marino A. INTENSIVE MONITORING PROGRAM OF ... Visualizza
1804 Marino A. ADVERSE DRUG REACTIONS IN ONCOLO... Visualizza
1805 Marino Franca and Tithonia diversifolia (Hemsl.) A... Visualizza
1806 Marino R. The importance of Integrated Car... Visualizza
3792 Marino R. Insulin analogue glargine 300 U/... Visualizza
1807 Mariottini P. VULNERABILITY TO SEIZURES AND AS... Visualizza
3793 Maroli A. THE ACETYLCHOLINESTERASE DONEPEZ... Visualizza
1808 Marone I. The antimigraine butterbur ingre... Visualizza
1809 Marone IM. Aromatase inhibitor-evoked pain ... Visualizza
1810 Marongiu M.B. INFLUENCE OF GENDER ON SPA (SALU... Visualizza
1811 Marongiu M.B. SPA THERAPY: SULPHUROUS MINERAL ... Visualizza
1812 Marrosu F. INHIBITION OF 5-ALPHA REDUCTASE ... Visualizza
1813 Marshall J. THE ROLE OF THE mRNA BINDING PRO... Visualizza
1814 Marsilio I. Antibiotic-induced dysbiosis aff... Visualizza
1815 Marsilio I. Involvement of catechol-O-methyl... Visualizza
3318 Marsilio I. Changes of small bowel inhibitor... Visualizza
1816 Mart-n C. CHARACTERIZATION OF THE MECHANIS... Visualizza
1817 Marte A. Altered Mechanisms Underlying th... Visualizza
1818 Martelli A. Kv7 channels are involved in hum... Visualizza
1819 Martelli A. MYOCARDIAL ANTI-AGEING EFFECTS O... Visualizza
1820 Martelli A. Measurement of deferasirox plasm... Visualizza
1821 Martelli A. THE H2S-DONOR, 4-CPI, PROMOTES A... Visualizza
3475 Martelli A. NARINGENIN PROTECTS MYOCARDIUM A... Visualizza
3794 Martelli A. ANTICANCER EFFECTS OF NOVEL LDH-... Visualizza
4072 Martelli A. ANTI-CANCER PROPERTIES OF ERUCIN... Visualizza
1822 Martelossi S. Pharmacoepigenomic markers invol... Visualizza
1823 Martelossi S. THE ROLE OF THE mRNA BINDING PRO... Visualizza
1824 Marti M. Acute behavioral and molecular e... Visualizza
3795 Martin L. THE ANTI-INFLAMMATORY PROTEIN AN... Visualizza
1830 Martin-villalba A. MENINGEAL NEURAL PRECURSORS CONT... Visualizza
1825 Martinez J. EFFECTS OF HEXARELIN IN A MODEL ... Visualizza
1826 Martinez J. GROWTH HORMONE SECRETAGOGUES PRE... Visualizza
3476 Martini C. NARINGENIN PROTECTS MYOCARDIUM A... Visualizza
1827 Martinotti S. Peripheral RVD-hemopressin(_) ad... Visualizza
1828 Martinotti S. HARPAGOPHYTUM PROCUMBENS AQUEOUS... Visualizza
3796 Martinotti S. Emotional Disorders Induced by H... Visualizza
1829 Martinuzzi A. The protective effect of naringe... Visualizza
1831 Marzocco S. NIVALENOL AND DEOXYNIVALENOL IND... Visualizza
1832 Marzocco S. Intestine as a Source of Inflamm... Visualizza
1833 Marzola E. PHARMACOLOGICAL CHARACTERIZATION... Visualizza
3707 Mar“n G. JJ. ë_-Caryophyllene oxide as a new... Visualizza
3319 Mascolo L. IDENTIFICATION OF TRANSCRIPTION ... Visualizza
1834 Mascolo N. DOWN REGULATION OF PRO-INFLAMMAT... Visualizza
1835 Maselli D. LIPIDOMICS AS A TOOL TO UNRAVEL ... Visualizza
3320 Maselli M.A. EFFECT OF CARBACHOL AND VIP IN H... Visualizza
1836 Maselli R. Therapeutic benefits of methylxa... Visualizza
1837 Maserati R. Pharmacokinetics of darunavir/co... Visualizza
62 masi A. DIFFERENTIAL CONTRIBUTION OF IH ... Visualizza
1838 Masi A. Central effects induced by syste... Visualizza
1839 Masini E. THE SELECTIVE HISTAMINE H4 RECEP... Visualizza
1840 Masini E. HISTAMINE H3 RECEPTOR ANTAGONISM... Visualizza
1841 Masini E. CARBONIC ANHYDRASE IX AND COX-2 ... Visualizza
1842 Masini E. TAGATOSE BENEFICIAL EFFECTS IN A... Visualizza
1843 Masini E. TOXICOLOGICAL IMPACT OF HIGH FRU... Visualizza
1844 Masini E. THE SELECTIVE HISTAMINE H4 RECEP... Visualizza
1845 Mason S. CLINICAL VALIDATION OF THE REALQ... Visualizza
1846 Mason S. MOLECULAR MONITORING OF CHRONIC ... Visualizza
1847 Massai L. SELECTION AND CHARACTERIZATION O... Visualizza
1848 Mastrocola R. EFFECT OF VITAMIN D ON INSULIN S... Visualizza
1849 Mastrocola R. THE AGEs INHIBITOR PYRIDOXAMINE ... Visualizza
1850 Mastrocola R. TOXICOLOGICAL IMPACT OF HIGH FRU... Visualizza
3797 Mastrocola R. THE ANTI-INFLAMMATORY PROTEIN AN... Visualizza
3798 Mastrogiacomo R. Dopamine D3 receptors control dy... Visualizza
1851 Materazzi S. The antimigraine butterbur ingre... Visualizza
1852 Matii L. Potential relationship between t... Visualizza
3799 Matino D. INTERLEUKIN 4-INDUCED GENE-1 AS ... Visualizza
3800 Matino D. IDO1 activity in selected immune... Visualizza
1853 Matino DM. CpG type-A induction of an early... Visualizza
1854 Mattace raso G. Behavioral and Metabolic Charact... Visualizza
1855 Mattace raso G. BUTYRATE ATTENUATES MOTOR DEFICI... Visualizza
1856 Mattace raso G. N-(1-CARBAMOYL-2-PHENYLETHYL) BU... Visualizza
3321 Mattace raso G. PALMITOYLETAHNOLAMIDE ATTENUATES... Visualizza
3801 Mattace raso G. BUTYRATE REDUCES VALPROATE-INDUC... Visualizza
1792 matteis M. NOCICEPTIN REDUCES THE INFLAMMAT... Visualizza
1857 Mattera iacono V. TLR4 IS INVOLVED IN S1P/S1P1 PAT... Visualizza
3322 Mattioli F. Subcutaneous slow-release metfor... Visualizza
3323 Mattioli F. Measurement of deferasirox plasm... Visualizza
3802 Mattivi F. EVALUATION OF GASTRIC ANTI-INFLA... Visualizza
1858 Maugeri A. Growth inhibition, cell-cycle ar... Visualizza
3803 Maugeri A. Potential of a flavonoid-rich ex... Visualizza
1859 Maura G. CHEMOTHERAPY-INDUCED NEUROPATHIC... Visualizza
1860 Maura G. VULNERABILITY TO SEIZURES AND AS... Visualizza
3804 Maurel OM. Buspirone rescues MK-801-induced... Visualizza
1861 Maximova N. Measurement of deferasirox plasm... Visualizza
1862 Mazzanti G. Effects of the metronomic treatm... Visualizza
1863 Mazzanti G. SAFETY OF FOOD SUPPLEMENTS CONTA... Visualizza
1864 Mazzanti G. Antiviral and antioxidant activi... Visualizza
3805 Mazzanti G. ë_-Caryophyllene oxide as a new... Visualizza
3806 Mazzanti M. KCC2 is a key target of oxytocin... Visualizza
3807 Mazzarella A. In vitro effects of mediators de... Visualizza
1865 Mazzei T. ADVERSE DRUG REACTIONS IN ONCOLO... Visualizza
1866 Mazzini G. AN ALTERNATIVE METHOD FOR EVALUA... Visualizza
1867 Mazzitelli M. PALMITOYLETHANOLAMIDE, VIA PPAR-... Visualizza
3808 Mazzitelli M. DIMETHYL FUMARATE REDUCES TACTIL... Visualizza
1868 Mccormick PJ. BIVALENT LIGANDS DISCLOSE GPCR D... Visualizza
1869 Mcdowell HP. THE EPHRIN RECEPTOR KINASE INHIB... Visualizza
1870 Mcmahon FJ. CONVERGENT ANALYSIS OF GENOME-WI... Visualizza
1871 Meconi A. BEHAVIOURAL AND NEUROPATHOLOGICA... Visualizza
1872 Meda C. FROM METABOLIC FITNESS TO METABO... Visualizza
1873 Medema JP. RIMONABANT KILLS COLON CANCER ST... Visualizza
1874 Megiorni F. THE EPHRIN RECEPTOR KINASE INHIB... Visualizza
3324 Mei R. MYOPERICARDITIS AND VACCINES: GA... Visualizza
1875 Melancia F. AUTISTIC-LIKE BEHAVIORAL ABNORMA... Visualizza
3325 Melancia F. CHANGES IN THE ENDOCANNABINOID S... Visualizza
1876 Melani A. THE SELECTIVE HISTAMINE H4 RECEP... Visualizza
1877 Melani A. THE SELECTIVE HISTAMINE H4 RECEP... Visualizza
1878 Mele A. DEVELOPMENT OF NOVEL LACTATE-NA2... Visualizza
1879 Mele A. GROWTH HORMONE SECRETAGOGUES PRE... Visualizza
1880 Mele A. NEW BIOMARKERS IN ALS ETIOLOGY: ... Visualizza
3326 Mele A. A LONG TERM TREATMENT WITH TAURI... Visualizza
3327 Mele A. Gender-dependent involvement of ... Visualizza
1881 Mele L. Proatherosclerotic effect of tri... Visualizza
24 Meli R. BUTYRATE ATTENUATES MOTOR DEFICI... Visualizza
1882 Meli R. Behavioral and Metabolic Charact... Visualizza
1883 Meli R. PALMITOYLETAHNOLAMIDE ATTENUATES... Visualizza
1884 Meli R. N-(1-CARBAMOYL-2-PHENYLETHYL) BU... Visualizza
3809 Meli R. BUTYRATE REDUCES VALPROATE-INDUC... Visualizza
1885 Melis M. DRUGS - INDUCED DISSEMINATED INT... Visualizza
1886 Melis M. CARDIOVASCULAR SAFETY OF MACROLI... Visualizza
3810 Melis M. EFFECTS OF THE PPAR-ALPHA AGONIS... Visualizza
1887 Mellai M. SOLID LIPID NANOPARTICLES CARRYI... Visualizza
1888 Melone M. IN-VIVO EFFECTS OF KNOCKING-DOWN... Visualizza
1889 Memo M. IN VITRO ASSESSMENT OF CABAZITAX... Visualizza
1890 Memo M. In vitro identification of molec... Visualizza
1891 Menchiari A. Evaluation of salivary catalase ... Visualizza
1892 Menchini M. Evaluation of protective effect ... Visualizza
3811 Meneguzzi A. REDUCED VARIABILITY TO ASPIRIN A... Visualizza
1893 Menghini L. HARPAGOPHYTUM PROCUMBENS AQUEOUS... Visualizza
1894 Menniti-ippolito F. SAFETY OF FOOD SUPPLEMENTS CONTA... Visualizza
1895 Merciaro I. Conditioned medium of human peri... Visualizza
1896 Merelli M. CLINICAL PHARMACOLOGICAL ADVICE ... Visualizza
1897 Mereu M. Effect of amphetamine on choroid... Visualizza
1898 Mereu M. CANNABINOID INVOLVMENT IN THE DE... Visualizza
1899 Mereu M. Involvement of catechol-O-methyl... Visualizza
3812 Mereu M. Dopamine D3 receptors control dy... Visualizza
1900 Merighi S. PULSED ELECTROMAGNETIC FIELDS TR... Visualizza
1901 Merighi S. ANTI-NOCICEPTIVE EFFECTS OF NOVE... Visualizza
3328 Merighi S. A2B adenosine receptors stimulat... Visualizza
1902 Merlino F. MODULATION OF DIABETIC RETINOPAT... Visualizza
3813 Merlo pich E. KETAMINE INDUCED STRUCTURAL PLAS... Visualizza
1903 Merlo S. THE CONTRIBUTION OF MICROGLIA TO... Visualizza
3814 Merlo S. Chronic treatment with fluoxetin... Visualizza
1904 Messa G. ACTIVITY-BASED ANOREXIA ALTERS N... Visualizza
3329 Messa G. REPEATED EXPOSURE TO COCAINE DUR... Visualizza
1905 Messori L. SELECTION AND CHARACTERIZATION O... Visualizza
1906 Mestres J. In search of biological substant... Visualizza
3330 Mhillaj E. FERULIC ACID AFFECTS MEMORY CONS... Visualizza
1907 Miano M. The loss of Aristaless related h... Visualizza
1908 Micali A. Survivin and NAIP in Human Benig... Visualizza
1909 Miceli F. FUNCTIONAL COMPARISON AMONG THRE... Visualizza
1910 Miceli N. Evaluation of protective effect ... Visualizza
1912 Micheli L. Alteration of visceral sensitivi... Visualizza
1913 Micheli L. Studying the mechanism of rat ad... Visualizza
1914 Micheli L. Into the unexplored pathophysiol... Visualizza
1915 Micheli L. VEGF INVOLVEMENT IN THE OXALIPLA... Visualizza
1916 Micheli L. Development of an in vitro model... Visualizza
1917 Micheli L. CHEMOTHERAPY-INDUCED NEUROPATHIC... Visualizza
1918 Micheli L. NO level and oxidative stress in... Visualizza
1919 Micheli L. Evaluation of salivary catalase ... Visualizza
3331 Micheli L. A PRECLINICAL SET UP OF A RAT MO... Visualizza
1920 Michl C. The chemopreventive effects of i... Visualizza
4153 Micioni Di Bonaventura M. V. Genetic and epigenetic regulatio... Visualizza
1921 Micioni di bonaventura MV. OLFACTORY RECEPTOR 984 A NEW TAR... Visualizza
1922 Micioni di bonaventura MV. ROLE OF THE AREA POSTREMA IN THE... Visualizza
1923 Miele L. CROSSTALK BETWEEN ADENOSINE AND ... Visualizza
1924 Migheli R. PROTECTIVE EFFECT OF GENISTEIN-L... Visualizza
3815 Migheli R. Real-time detection of ethanol i... Visualizza
1248 Migliardi G. Safety profile of antipsychotic ... Visualizza
1925 Migliardi G. ADVERSE DRUG REACTIONS ASSOCIATE... Visualizza
1926 Migliaro V. Hypoxia regulates ANXA1 expressi... Visualizza
1927 Miglio G. ANALYSIS OF TOPOLOGICAL FEATURES... Visualizza
3816 Migliorati G. GLUCOCORTICOID-INDUCED LEUCINE Z... Visualizza
1928 Milanese C. In vitro and in vivo antibacteri... Visualizza
1929 Milanese M. Altered Mechanisms Underlying th... Visualizza
1930 Milanese M. IN-VIVO EFFECTS OF KNOCKING-DOWN... Visualizza
1931 Milanese M. THE DOWN REGULATION OF MGLUR5 AT... Visualizza
1932 Milanese M. Prophylactic versus Therapeutic ... Visualizza
4197 Milanese M. Targeting Group I metabotropic g... Visualizza
1933 Milano W. HYPERPROLACTINEMIA INDUCED BY AN... Visualizza
1934 Milano W. DO CANNABINOIDS CONFER NEUROPROT... Visualizza
1935 Milano W. THE PSYCHOBIOLOGY OF ENDOCANNABI... Visualizza
1936 Milano W. BENEFICAL EFFECTS OF POLYPHENOLS... Visualizza
1937 Milano W. PROTECTIVE EFFECT OF HDAC INHIBI... Visualizza
1938 Milano W. CANNABINOIDS INVOLVEMENT IN NEUR... Visualizza
1939 Milelli A. A NEW SYNTHETIC ISOTHIOCYANATE D... Visualizza
1940 Milla M. Alteration of visceral sensitivi... Visualizza
3817 Millan MJ. KETAMINE INDUCED STRUCTURAL PLAS... Visualizza
1941 Minetto M. EFFECT OF VITAMIN D ON INSULIN S... Visualizza
4137 Minghetti P. Nutrients: when are they markete... Visualizza
3818 Mingozzi F. Intracellular chloride accumulat... Visualizza
3819 Mingrone G. Platelet-derived microparticles ... Visualizza
1942 Mini E. Next generation sequencing for i... Visualizza
1943 Mini E. COST-EVALUATION OF FLUOROPYRIMID... Visualizza
1944 Mini E. SELECTION AND CHARACTERIZATION O... Visualizza
1945 Mini E. ADVERSE DRUG REACTIONS IN ONCOLO... Visualizza
1946 Miniaci MC. DOWN REGULATION OF PRO-INFLAMMAT... Visualizza
1947 Minore C. Trends in Spontaneous Adverse Dr... Visualizza
4182 Minotti G. Beyond anthracyclines: new drugs... Visualizza
1948 Minutoli L. Cadmium and its role in brain dy... Visualizza
1949 Minutoli L. Activation of the EPOR-b common ... Visualizza
1950 Minutoli L. WHITE-TO-BROWN ADIPOSE TRANSDIFF... Visualizza
1951 Minutoli L. CURCUMIN POTENTIATES THE ANTI-IN... Visualizza
1952 Minutoli L. HIGH VARIABILITY IN TACROLIMUS B... Visualizza
3332 Minutoli L. Survivin and NAIP in Human Benig... Visualizza
3820 Minutoli L. LACK OF THE NLRP3 INFLAMMASOME I... Visualizza
3821 Minutoli L. FLAVONOIDS CONTAINED IN FLAVOCOX... Visualizza
3822 Minutolo F. ANTICANCER EFFECTS OF NOVEL LDH-... Visualizza
3823 Minuz P. REDUCED VARIABILITY TO ASPIRIN A... Visualizza
1086 miranda E. ALPHA-1 ANTITRYPSIN (AAT) POLYME... Visualizza
1953 Miranda R. ANTIOXIDANT EFFECTS OF A HYDROXY... Visualizza
1954 Miro A. Development of hyaluronan/mannit... Visualizza
1955 Miroddi M. PHYTO.VIG.GEST: "VIGILANCE ON US... Visualizza
1956 Miscioscia F. Interactions between antiretrovi... Visualizza
3824 Mishto M. EFFECTS OF THROMBIN CLEAVAGE OF ... Visualizza
1957 Mitidieri E. 3-Mercaptopyruvate relaxes aorta... Visualizza
1958 Mitidieri E. Development of hyaluronan/mannit... Visualizza
4073 Mitidieri E. Hydrogen sulfide pathway as a ne... Visualizza
1959 Mitro N. Fatty acid synthesis is crucial ... Visualizza
1960 Mitro N. Fatty acid synthesis is crucial ... Visualizza
3333 Mocciaro E. ADVERSE DRUG REACTIONS IN EMERGE... Visualizza
1961 Modugno M. Functional interaction between n... Visualizza
1962 Molinaro P. IDENTIFICATION OF TRANSCRIPTION ... Visualizza
1963 Molino A. EFFECT OF ULTRAFINE PARTICLE MAT... Visualizza
3825 Molino AM. Human Peripheral blood mononucle... Visualizza
1964 Mollace MV. Sildenafil improves cardiac func... Visualizza
1965 Mollace R. Early up-regulation of hepatic m... Visualizza
1966 Mollace V. Anti-proliferative effects of Cy... Visualizza
1967 Mollace V. Impaired glucose and lipid metab... Visualizza
1968 Mollace V. BERGAMOT POLYPHENOLS PROTECT AGA... Visualizza
1969 Mollace V. THE ROLE OF SIRT3 PATHWAY IN NEU... Visualizza
1970 Mollace V. Early up-regulation of hepatic m... Visualizza
1971 Mollace V. HYPERCHOLESTEROLEMIA MODULATES M... Visualizza
1972 Mollica A. Peripheral RVD-hemopressin(_) ad... Visualizza
3826 Mollica A. Emotional Disorders Induced by H... Visualizza
1973 Mollica MP. N-(1-CARBAMOYL-2-PHENYLETHYL) BU... Visualizza
3827 Mollica MP. BUTYRATE REDUCES VALPROATE-INDUC... Visualizza
1974 Molonia MS. Curcumin Potentiates Antitumor A... Visualizza
1975 Molonia MS. In Vitro Protective Effects of C... Visualizza
3334 Molonia MS. Curcumin Ameliorates the In Vitr... Visualizza
3828 Molonia MS. Alpha-Lipoic Acid, But Not Dihyd... Visualizza
1976 Molteni L. EFFECTS OF HEXARELIN IN A MODEL ... Visualizza
3335 Molteni L. miRNA-218 TARGETS LIPIN-1 AND GL... Visualizza
1977 Molteni R. Multiple sclerosis and depressio... Visualizza
1978 Moltoni L. NO level and oxidative stress in... Visualizza
3829 Mondanelli G. REINSTALLING IMMUNE REGULATORY T... Visualizza
3830 Mondanelli G. The proteasome inhibitor bortezo... Visualizza
4074 Mondanelli G. IMMUNOREGULATORY SYNERGISM BETWE... Visualizza
1979 Mondello C. NABILONE AND THC/CBD FOR THE TRE... Visualizza
1980 Mondello E. NABILONE AND THC/CBD FOR THE TRE... Visualizza
3831 Mondillo S. REMODELING OF ATRIAL REPOLARIZAT... Visualizza
1981 Montagnani M. INTERMITTENT ANTAGONISM OF BK2-R... Visualizza
1982 Montagnani M. POTENTIAL MECHANISMS LINKING DEF... Visualizza
1983 Montagnani M. CM554, A NEW POTENT AND SELECTIV... Visualizza
3832 Montagnani M. ACTIVATION OF AMPK/SIRT-1 AXIS I... Visualizza
1984 Montanaro G. Tacrolimus Therapeutic Drug Moni... Visualizza
1985 Montanucci P. Prevention of diabetes in NOD mi... Visualizza
3833 Monte MJ ë_-Caryophyllene oxide as a new... Visualizza
1986 Montopoli M. The protective effect of naringe... Visualizza
1987 Montopoli M. GLUCOSE-6-PHOSPHATE DEHYDROGENAS... Visualizza
1988 Montopoli M. ROLE OF MITOCHONDRIA IN CISPLATI... Visualizza
4215 Montuschi P. Breathomics for assessing pharma... Visualizza
1989 Morabito C. THE ROLE OF SIRT3 PATHWAY IN NEU... Visualizza
1990 Moran S. DNA METHYLATION: GENE PROFILING ... Visualizza
1991 Morbidelli L. TARGETING THE CANCER RESISTOME T... Visualizza
1992 Morbidelli L. PGE2 SIGNALING INDUCES EGFR NUCL... Visualizza
1993 Morbidelli L. Tumor stemness and cancer drug-r... Visualizza
1994 Morbioli L. SCREENING OF HUMAN SULFOTRANSFER... Visualizza
1995 Morello S. CROSSTALK BETWEEN ADENOSINE AND ... Visualizza
3414 Morello S. LEVELS OF SOLUBLE CD73 IN MELANO... Visualizza
4108 Morena M. Impact of different stress inten... Visualizza
1996 Mores N. HOSPICE PALLIATIVE CARE MEDICATI... Visualizza
1997 Moretti E. NO level and oxidative stress in... Visualizza
1998 Moretti U. LONG TERM DRUG SAFETY IN CHILDRE... Visualizza
1999 Moretti U. VIGINETWORK: A COMMUNITY PHARMAC... Visualizza
4132 Morgese M. G. Soluble beta amyloid as bridge b... Visualizza
2000 Morgese MG. A LONG TERM TREATMENT WITH TAURI... Visualizza
2001 Morgia G. Survivin and NAIP in Human Benig... Visualizza
2002 Morice AM. Aromatase inhibitor-evoked pain ... Visualizza
2003 Morici N. Recombinant LCAT rescues defecti... Visualizza
2004 Moro PA. SAFETY OF FOOD SUPPLEMENTS CONTA... Visualizza
2005 Moro S. SCREENING OF HUMAN SULFOTRANSFER... Visualizza
2006 Morreale I. Trends in Spontaneous Adverse Dr... Visualizza
2007 Morroni F. THE 6-(METHYLSULFINYL)HEXYL ISOT... Visualizza
2008 Morroni F. NEUROPROTECTIVE EFFECTS OF THE N... Visualizza
2009 Morroni F. Cross-Disease Analysis of Alzhei... Visualizza
2010 Morucci G. Into the unexplored pathophysiol... Visualizza
2011 Mosca I. STARGAZIN REGULATES THE BIOCHEMI... Visualizza
3336 Mosca I. Compound heterozygosis in the kc... Visualizza
2012 Moscato S. Potential relationship between t... Visualizza
2013 Moschetti G. THERAPEUTIC EFFECT OF SYSTEMIC I... Visualizza
3337 Moschetti G. ROLE OF PROKINETICIN SYSTEM IN A... Visualizza
1793 mota M. SYNERGISTIC ASSOCIATION OF VALPR... Visualizza
2014 Motola D. DRUGS - INDUCED DISSEMINATED INT... Visualizza
2015 Motola D. Reporting of adverse drug reacti... Visualizza
2016 Motola D. CARDIOVASCULAR SAFETY OF MACROLI... Visualizza
2017 Mottarlini F. Acute behavioral and molecular e... Visualizza
2018 Mottarlini F. REPEATED EXPOSURE TO COCAINE DUR... Visualizza
3834 Mottarlini F. POST-SYNAPTIC GLUTAMATE DYSFUNCT... Visualizza
2019 Mozzanica F. USE OF PROTON PUMP INHIBITORS AN... Visualizza
34 Mugelli A. Isoform-selective blockade of HC... Visualizza
2020 Mugelli A. Angiotensin-II activates p-38 an... Visualizza
2021 Mugelli A. Risk of bone fractures among use... Visualizza
2022 Mugelli A. Adverse drug reactions in paedia... Visualizza
2023 Mugelli A. FREQUENCY AND CHARACTERISTICS OF... Visualizza
2024 Mugelli A. Drug-utilization of new oral ant... Visualizza
2025 Mugelli A. Enhancement of cardiac different... Visualizza
2026 Mugelli A. Pharmacoutilization of Antidiabe... Visualizza
2027 Mugelli A. NSAIDs utilization in a large co... Visualizza
3483 Mugelli A. EFFECT OF RACEMIC AND LEVO-METHA... Visualizza
3835 Mugelli A. REMODELING OF ATRIAL REPOLARIZAT... Visualizza
3836 Mulinacci N. INHIBITION OF SPONTANEOUS COLON ... Visualizza
3837 Muntoni AL. EFFECTS OF THE PPAR-ALPHA AGONIS... Visualizza
2028 Muntoni E. SOLID LIPID NANOPARTICLES CARRYI... Visualizza
2029 Murphy KM. PROTECTIVE ROLE OF CONVENTIONAL ... Visualizza
3838 Murphy KM. INTERLEUKIN 4-INDUCED GENE-1 AS ... Visualizza
2030 Murphy TL. PROTECTIVE ROLE OF CONVENTIONAL ... Visualizza
2031 Musaro' A. NEW BIOMARKERS IN ALS ETIOLOGY: ... Visualizza
2032 Musazzi L. Altered Mechanisms Underlying th... Visualizza
2033 Musazzi L. MODELLING ANHEDONIA TO STUDY MEC... Visualizza
4128 Musazzi L. Acute stress rapidly increases e... Visualizza
2034 Muscar C. Curcumin Potentiates Antitumor A... Visualizza
3338 Muscar C. In Vitro Protective Effects of C... Visualizza
3839 MuscarˆÊ C. Alpha-Lipoic Acid, But Not Dihyd... Visualizza
3420 Muscatello B. Metronomic vinorelbine is active... Visualizza
2035 Muscatello M. NEWER LONG-ACTING INJECTABLE ANT... Visualizza
2036 Muscoli C. HYDRA VULGARIS AS A MODEL TO STU... Visualizza
2037 Muscoli C. Impaired glucose and lipid metab... Visualizza
2038 Muscoli C. BERGAMOT POLYPHENOLS PROTECT AGA... Visualizza
2039 Muscoli C. THE ROLE OF SIRT3 PATHWAY IN NEU... Visualizza
2040 Muscoli C. Early up-regulation of hepatic m... Visualizza
2041 Muscoli C. HYPERCHOLESTEROLEMIA MODULATES M... Visualizza
2042 Muscoli MC. Sildenafil improves cardiac func... Visualizza
2043 Musolino C. Curcumin Ameliorates the In Vitr... Visualizza
3339 Musolino MV. Sildenafil improves cardiac func... Visualizza
2044 Musolino V. BERGAMOT POLYPHENOLS PROTECT AGA... Visualizza
2045 Musolino V. Early up-regulation of hepatic m... Visualizza
2046 Musolino V. Impaired glucose and lipid metab... Visualizza
2047 Musolino V. HYPERCHOLESTEROLEMIA MODULATES M... Visualizza
2048 Musumeci O. STATIN THERAPY: CLC-1 CHLORIDE C... Visualizza
2049 Muttenthaler M. BIVALENT LIGANDS DISCLOSE GPCR D... Visualizza
3840 Mutti A. THE MULTIPLE EFFECTS OF THE KETA... Visualizza
2050 Nacci C. INTERMITTENT ANTAGONISM OF BK2-R... Visualizza
3340 Nacci C. POTENTIAL MECHANISMS LINKING DEF... Visualizza
3841 Nacci C. ACTIVATION OF AMPK/SIRT-1 AXIS I... Visualizza
2051 Nagahara N. 3-Mercaptopyruvate relaxes aorta... Visualizza
3341 Nannelli G. The Impact Of ALDH-2 Activity On... Visualizza
2052 Nannini M. MIR-139-5P AND MIR-455-5P AS POT... Visualizza
3342 Napoli B. The protective effect of naringe... Visualizza
2054 Napoli C. SELECTION AND CHARACTERIZATION O... Visualizza
2053 Napoli E. Changes of small bowel inhibitor... Visualizza
2055 Napoli E. Phytochemical Profile and Photot... Visualizza
2056 Nappi P. FUNCTIONAL COMPARISON AMONG THRE... Visualizza
2057 Nappo A. Reporting of adverse drug reacti... Visualizza
3842 Naskar S. Intracellular chloride accumulat... Visualizza
2058 Nassini R. The antimigraine butterbur ingre... Visualizza
2059 Nassini RN. Aromatase inhibitor-evoked pain ... Visualizza
3843 Natale G. COMPARATIVE PRE-CLINICAL STUDY O... Visualizza
2060 Navarra M. Growth inhibition, cell-cycle ar... Visualizza
2061 Navarra M. PHYTO.VIG.GEST: "VIGILANCE ON US... Visualizza
4075 Navarra M. Potential of a flavonoid-rich ex... Visualizza
2062 Navarra P. Interactions between antiretrovi... Visualizza
2063 Naviglio S. Pharmacoepigenomic markers invol... Visualizza
2064 Nencioni L. Antiviral and antioxidant activi... Visualizza
2065 Nesci V. VILDAGLIPTIN IMPROVES ANIMAL BEH... Visualizza
2066 Nesci V. TOCILIZUMAB'S EFFECT ON EPILEPTO... Visualizza
2067 Nguyen TP. Cross-Disease Analysis of Alzhei... Visualizza
2068 Niada S. Bisphosphonates modulate bone bi... Visualizza
3415 Niada S. ASC-DERIVED CONDITIONED MEDIUM (... Visualizza
2069 Nicchia GP. SKELETAL MUSCLE CLC-1 CHANNEL: F... Visualizza
3844 Niccolai A. Nutraceutical properties of Arth... Visualizza
2070 Nicoletti F. PHARMACOLOGICAL CHARACTERIZATION... Visualizza
2071 Nicoletti M. Antiviral and antioxidant activi... Visualizza
2072 Nicolotti O. BARTTER'S SYNDROME AND KIDNEY CL... Visualizza
2073 Nicolotti O. SEARCHING FOR NOVEL DRUGS IN MYO... Visualizza
2074 Nicotri S. Failures to further developing o... Visualizza
2075 Nieri P. Potential relationship between t... Visualizza
2076 Nieri P. Role of miR-34a as biomarker and... Visualizza
2077 Nieri P. APIGENIN SUPPLEMENTATION PREVENT... Visualizza
2078 Niero F. MARKAR survey: influence of dire... Visualizza
2079 Nigro D. TOXICOLOGICAL IMPACT OF HIGH FRU... Visualizza
2080 Nigro D. EFFECT OF VITAMIN D ON INSULIN S... Visualizza
2081 Nigro D. THE AGEs INHIBITOR PYRIDOXAMINE ... Visualizza
3845 Nigro D. THE ANTI-INFLAMMATORY PROTEIN AN... Visualizza
3343 Nigro EA. IMMUNOSURVEILLANCE OF TUMORS: IG... Visualizza
2082 Nisticò R. ACID-SENSING ION CHANNEL 1A IS R... Visualizza
2083 Nisticò R. Involvement of bradykinin B2 rec... Visualizza
2084 Nistico R. Involvement of the Prokineticin ... Visualizza
2085 Nitrato izzo A. N-(1-CARBAMOYL-2-PHENYLETHYL) BU... Visualizza
2086 Nitrato izzo A. PALMITOYLETAHNOLAMIDE ATTENUATES... Visualizza
3846 Nitrato izzo A. BUTYRATE REDUCES VALPROATE-INDUC... Visualizza
2087 Nizzari M. PRION PROTEIN SIGNALLING CONTROL... Visualizza
2088 Nobili S. Next generation sequencing for i... Visualizza
2089 Nobili S. COST-EVALUATION OF FLUOROPYRIMID... Visualizza
2090 Nobili S. ADVERSE DRUG REACTIONS IN ONCOLO... Visualizza
3344 Nobili S. SELECTION AND CHARACTERIZATION O... Visualizza
2091 Nocentini G. Prevention of diabetes in NOD mi... Visualizza
3847 Nofer JR. Sphingosine 1-Phosphate And Athe... Visualizza
2092 Norata D. Fatty acid synthesis is crucial ... Visualizza
2093 Norata D. Apolipoprotein E modulates adapt... Visualizza
2094 Norata GD. ACTIVITY-BASED ANOREXIA ALTERS N... Visualizza
3848 Norata GD. PCSK9 (PROPROTEIN CONVERTASE SUB... Visualizza
3345 Notarbartolo M. MDA-9/SYNTENIN AS A POTENTIAL DR... Visualizza
2095 Nucera NS. Sildenafil improves cardiac func... Visualizza
2096 Nucera S. HYPERCHOLESTEROLEMIA MODULATES M... Visualizza
3346 Nucera S. Early up-regulation of hepatic m... Visualizza
2097 Nucifora D. NEWER LONG-ACTING INJECTABLE ANT... Visualizza
2098 Nunnari P. The importance of Integrated Car... Visualizza
3347 Nunnari P. OBSERVATIONAL, PROSPECTIVE CLINI... Visualizza
3849 Nunnari P. Insulin analogue glargine 300 U/... Visualizza
2099 Nunnari PN. SAFETY AND EFFICACY OF GLP-1 REC... Visualizza
2100 Nunziata A. IMPORTANCE OF ADHERENCE TO TREAT... Visualizza
3348 Nunziata A. Pathological gambling new therap... Visualizza
2102 O'Donnell V. LIPIDOMICS OF EICOSANOIDS GENERA... Visualizza
2103 O'donnell V. Generation of 12- hydroxyeicosat... Visualizza
2101 Occhiuto F. AN EXTRACT OF HYPERICUM PERFORAT... Visualizza
2104 Oguz SH. Vitamin D replacement in pre-men... Visualizza
2105 Oliva F. Recombinant LCAT rescues defecti... Visualizza
2106 Olivero G. Functional interaction between n... Visualizza
2107 Olivero G. ENVIRONMENTAL TRAINING AMELIORAT... Visualizza
2108 Olivero G. Prophylactic versus Therapeutic ... Visualizza
3349 Olivero G. PHARMACOLOGICAL CHARACTERIZATION... Visualizza
2109 Ombrato R. In vitro and in vivo antibacteri... Visualizza
2110 Onder G. NSAIDs utilization in a large co... Visualizza
2111 Onofri F. Altered Mechanisms Underlying th... Visualizza
2112 Onore ME. FUNCTIONAL COMPARISON AMONG THRE... Visualizza
2113 Oppedisano F. BERGAMOT POLYPHENOLS PROTECT AGA... Visualizza
2114 Oppedisano F. Early up-regulation of hepatic m... Visualizza
2115 Oppedisano F. HYPERCHOLESTEROLEMIA MODULATES M... Visualizza
2116 Oppedisano OF. Sildenafil improves cardiac func... Visualizza
2117 Opri S. VIGINETWORK: A COMMUNITY PHARMAC... Visualizza
3850 Orabona C. IMMUNOREGULATORY SYNERGISM BETWE... Visualizza
3851 Orabona C. The proteasome inhibitor bortezo... Visualizza
4076 Orabona C. REINSTALLING IMMUNE REGULATORY T... Visualizza
2119 Orlandi P. Colon cancer therapy beyond tumo... Visualizza
2120 Orlandi P. Melanocortin receptor-4 as a nov... Visualizza
3422 Orlandi P. Metronomic vinorelbine is active... Visualizza
2121 Orlando G. Peripheral RVD-hemopressin(_) ad... Visualizza
2122 Orlando G. Effects of Growth Hormone-Releas... Visualizza
2123 Orlando G. HARPAGOPHYTUM PROCUMBENS AQUEOUS... Visualizza
3852 Orlando G. Emotional Disorders Induced by H... Visualizza
2124 Orlando P. ENDOCANNABINOID SYSTEM AND MOUSE... Visualizza
2125 Orso G. Antibiotic-induced dysbiosis aff... Visualizza
2126 Orso G. Changes of small bowel inhibitor... Visualizza
2127 Orso G. GLUCOSE-6-PHOSPHATE DEHYDROGENAS... Visualizza
2128 Orso G. Involvement of catechol-O-methyl... Visualizza
2129 Orso G. Enteric glia is involved in colo... Visualizza
2130 Orso G. The protective effect of naringe... Visualizza
2131 Ossato A. Acute behavioral and molecular e... Visualizza
3350 Ossoli A. Recombinant LCAT rescues defecti... Visualizza
2132 Ostacolo C. PALMITOYLETHANOLAMIDE LOADED IN ... Visualizza
2133 Oteri A. Trends in Spontaneous Adverse Dr... Visualizza
2134 Ottani A. STUDY ON PROTECTIVE ACTION OF HY... Visualizza
2135 Ottani A. Melanocortin receptor-4 as a nov... Visualizza
3853 Ottani A. PROTECTIVE EFFECT OF NDP-_-MSH O... Visualizza
2136 P. Ascierto. LEVELS OF SOLUBLE CD73 IN MELANO... Visualizza
2137 P.M. Cutroneo Safety profile of antipsychotic ... Visualizza
3351 Paccagnella N. EFFECT OF ANTIBIOTIC-INDUCED DYS... Visualizza
2139 Pace S. SEX BIAS IN LIPID MEDIATOR BIOSY... Visualizza
2140 Pacini A. Into the unexplored pathophysiol... Visualizza
2141 Pacor S. TARGETING THE CANCER RESISTOME T... Visualizza
2142 Padolecchia C. Functional interaction between n... Visualizza
3854 Padovani L. METAPLASTIC TREATMENTS WITH KETA... Visualizza
2143 Pagano E. ENDOCANNABINOID SYSTEM AND MOUSE... Visualizza
3352 Pagano E. A COMPARISON BETWEEN A CANNABIS ... Visualizza
3353 Pagano E. TRPM8 and experimental colorecta... Visualizza
3855 Pagnotta E. ANTI-CANCER PROPERTIES OF ERUCIN... Visualizza
2144 Paladin D. HEPATITIS C VIRUS GENOTYPE 3H: T... Visualizza
2145 Paladin D. EFFECT OF ANTIBIOTIC-INDUCED DYS... Visualizza
2146 Paladin D. CLINICAL VALIDATION OF THE REALQ... Visualizza
2147 Paladin D. MOLECULAR MONITORING OF CHRONIC ... Visualizza
3354 Paladini MS. Multiple sclerosis and depressio... Visualizza
2148 Palazzo E. PALMITOYLETHANOLAMIDE, VIA PPAR-... Visualizza
3856 Pallavicini A. RNA-SEQ ANALYSIS OF DIFFERENTIAL... Visualizza
2149 Palleria C. ADVERSE DRUG REACTIONS WITH BIOL... Visualizza
2150 Palleria C. TREND OF ADVERSE DRUG REACTION R... Visualizza
2151 Palleria C. VILDAGLIPTIN IMPROVES ANIMAL BEH... Visualizza
2152 Palleria C. MONITORING SAFETY AND USE OF OLD... Visualizza
3355 Palleria C. ADVERSE DRUG REACTIONS BY BIOLOG... Visualizza
2153 Pallio G. Activation of the EPOR-b common ... Visualizza
2154 Pallio G. CURCUMIN POTENTIATES THE ANTI-IN... Visualizza
2155 Pallio G. WHITE-TO-BROWN ADIPOSE TRANSDIFF... Visualizza
2156 Pallio G. Cadmium and its role in brain dy... Visualizza
2157 Pallio G. Survivin and NAIP in Human Benig... Visualizza
3356 Pallio G. HIGH VARIABILITY IN TACROLIMUS B... Visualizza
3857 Pallio G. LACK OF THE NLRP3 INFLAMMASOME I... Visualizza
3858 Pallio G. FLAVONOIDS CONTAINED IN FLAVOCOX... Visualizza
2158 Pallotta L. EFFECT OF CARBACHOL AND VIP IN H... Visualizza
3859 Pallotta M. REINSTALLING IMMUNE REGULATORY T... Visualizza
3860 Pallotta M. IMMUNOREGULATORY SYNERGISM BETWE... Visualizza
4077 Pallotta M.T. The proteasome inhibitor bortezo... Visualizza
2159 Pallottini V. CHANGES IN THE ENDOCANNABINOID S... Visualizza
2160 Palma E. BERGAMOT POLYPHENOLS PROTECT AGA... Visualizza
2161 Palma E. HYPERCHOLESTEROLEMIA MODULATES M... Visualizza
2163 Palma PE. Sildenafil improves cardiac func... Visualizza
2164 Palmeri A. cGMP MODULATES LONG-TERM POTENTI... Visualizza
3861 Palmisano M. N/OFQ and CRF systems dysregulat... Visualizza
2165 Palumbo G. The ABCB1 pharmacogenetics of R-... Visualizza
2166 Pandolfi A. CM554, A NEW POTENT AND SELECTIV... Visualizza
2167 Pani A. The importance of Integrated Car... Visualizza
2168 Pani A. OBSERVATIONAL, PROSPECTIVE CLINI... Visualizza
3862 Pani A. Insulin analogue glargine 300 U/... Visualizza
3357 Pani AP. SAFETY AND EFFICACY OF GLP-1 REC... Visualizza
2169 Pannini S. Evaluation of salivary catalase ... Visualizza
2170 Pannunzio A. IRREVERSIBLE BK CHANNEL BLOCKING... Visualizza
2171 Pannuti A. CROSSTALK BETWEEN ADENOSINE AND ... Visualizza
2172 Pantaleo MA. MIR-139-5P AND MIR-455-5P AS POT... Visualizza
2173 Panuccio G. MENINGEAL NEURAL PRECURSORS CONT... Visualizza
2174 Panza E. ACETYL DEACYLASADISULFIDE, A NAT... Visualizza
2175 Panza E. Modulation of the inflammatory r... Visualizza
3358 Panza E. COX-2 EXPRESSION IN MALIGNANT ME... Visualizza
3863 Panza EP. KEY PATHWAYS AND EMERGING PLAYER... Visualizza
2176 Paolini M. The chemopreventive effects of i... Visualizza
2177 Paolini M. Effects of electronic cigarette ... Visualizza
2178 Paolini M. Development of microparticles fo... Visualizza
2179 Paolo tonin PT. SYNERGISTIC ASSOCIATION OF VALPR... Visualizza
2180 Paolone G. Sestrin 3 as a regulator of pro-... Visualizza
2181 Paone S. BERGAMOT POLYPHENOLS PROTECT AGA... Visualizza
2182 Papaleo F. CANNABINOID INVOLVMENT IN THE DE... Visualizza
2183 Papaleo F. Effect of amphetamine on choroid... Visualizza
2184 Papaleo F. Involvement of catechol-O-methyl... Visualizza
3864 Papaleo F. Dopamine D3 receptors control dy... Visualizza
4173 Papaleo F. A precision medicine genetic mar... Visualizza
2185 Papapetropoulos A. 3-Mercaptopyruvate relaxes aorta... Visualizza
2186 Papp M. INFLUENCE OF CHRONIC STRESS EXPO... Visualizza
2187 Pardini C. Melanocortin receptor-4 as a nov... Visualizza
2188 Pardu A. INHIBITION OF 5-ALPHA REDUCTASE ... Visualizza
3865 Pardu A. EFFECTS OF THE PPAR-ALPHA AGONIS... Visualizza
2189 Parente L. Effects of Prisma® Skin dermal ... Visualizza
2190 Parente L. Hypoxia regulates ANXA1 expressi... Visualizza
3866 Parente L. ANNEXIN A1 CONTRIBUTES TO PANCRE... Visualizza
3359 Parenti A. Tryptophan 2,3-dioxygenase inhib... Visualizza
3867 Parenti C. Chronic treatment with fluoxetin... Visualizza
2191 Parisi OA. TRPM8 and experimental colorecta... Visualizza
2192 Parisi OA. A COMPARISON BETWEEN A CANNABIS ... Visualizza
3360 Parisi OA. ENDOCANNABINOID SYSTEM AND MOUSE... Visualizza
2193 Parolaro D. EPIGENETIC MECHANISMS IN THE DEV... Visualizza
2194 Parolaro D. CHRONIC CANNABIDIVARIN ADMINISTR... Visualizza
2195 Parravicini C. Inhibition of SIRT1 Deacetylase ... Visualizza
1083 parrella E. SYNERGISTIC ASSOCIATION OF VALPR... Visualizza
2196 Parrilli M. FREQUENCY AND CHARACTERISTICS OF... Visualizza
2197 Parrilli M. INTENSIVE MONITORING PROGRAM OF ... Visualizza
2198 Parrilli M. ADVERSE DRUG REACTIONS IN ONCOLO... Visualizza
3868 Parrini M. Intracellular chloride accumulat... Visualizza
2199 Pascale A. Small molecules to treat diabeti... Visualizza
2200 Pascale A. MODULATION OF OXIDATIVE AND INFL... Visualizza
3869 Pasquale V. Intracellular chloride accumulat... Visualizza
2201 Pasqualetti F. Melanocortin receptor-4 as a nov... Visualizza
2202 Pasqualini L. Anti-angiogenic effect of therap... Visualizza
2203 Pasquini S. PULSED ELECTROMAGNETIC FIELDS TR... Visualizza
2204 Pasquini S. ANTI-NOCICEPTIVE EFFECTS OF NOVE... Visualizza
2205 Pasquini S. A2B adenosine receptors stimulat... Visualizza
2206 Passalacqua M. PRESYNAPTIC GLP-1 RECEPTORS ENHA... Visualizza
2207 Passalacqua M. VULNERABILITY TO SEIZURES AND AS... Visualizza
4160 Passani M. B. Histaminergic neurons partake in... Visualizza
2208 Passani MB. THE FAT SENSING MOLECULE OLEOYLE... Visualizza
2209 Passani MB. An Omega-3 PUFA/Vitamin A enrich... Visualizza
2210 Passerini N. Development of microparticles fo... Visualizza
2211 Pastorello M. EVALUATION OF HEALTH DIRECT COST... Visualizza
2212 Pastorello M. Real world data about biosimilar... Visualizza
2213 Pastoris O. AN ALTERNATIVE METHOD FOR EVALUA... Visualizza
2214 Paterniti I. Dimethyl fumarate attenuates neu... Visualizza
2215 Paterniti I. Multiple mechanisms of dimethyl ... Visualizza
2216 Paterniti I. Absence of TLR4 reduces neuroinf... Visualizza
2217 Patrignani P. DEVELOPMENT OF A NOVEL DIRECT BI... Visualizza
2218 Patrignani P. Targeting platelet purinergic si... Visualizza
2219 Patrignani P. PLATELET-DEPENDENT ACTIVATION OF... Visualizza
2220 Patrignani P. Conditioned medium of human peri... Visualizza
2221 Patrignani P. LIPIDOMICS OF EICOSANOIDS GENERA... Visualizza
2222 Patrignani P. OVER-EXPRESSION OF MIR-574-5P IN... Visualizza
2223 Patrignani P. Generation of 12- hydroxyeicosat... Visualizza
3870 Patrignani P. MICRORNA-574-5P MODULATES MICROS... Visualizza
3871 Patrignani P. Platelet-derived microparticles ... Visualizza
3872 Patrignani P. REDUCED VARIABILITY TO ASPIRIN A... Visualizza
4152 Patrignani P. Acetylsalicylic acid and cancer:... Visualizza
3873 Patrono C. POOR RESPONSIVENESS TO LOW-DOSE ... Visualizza
2224 Pattarozzi A. bFGF/FGFR1 SIGNALING IS THE MAIN... Visualizza
2225 Pattarozzi A. Subcutaneous slow-release metfor... Visualizza
3361 Pavanello S. CYP27A1 GENETIC POLYMORPHISM IN ... Visualizza
2226 Pavia M. MONITORING SAFETY AND USE OF OLD... Visualizza
2227 Pea F. CLINICAL PHARMACOLOGICAL ADVICE ... Visualizza
3874 Peana AT. Real-time detection of ethanol i... Visualizza
3362 Pecoraro M. CARDIOTOXIC EFFECTS OF SHORT-TER... Visualizza
2228 Pedata F. THE SELECTIVE HISTAMINE H4 RECEP... Visualizza
2229 Pedata F. THE SELECTIVE ANTAGONISM OF ADEN... Visualizza
2230 Pedata F. THE SELECTIVE HISTAMINE H4 RECEP... Visualizza
3875 Pedata F. Molecular basis of adenosine A3 ... Visualizza
2231 Peeters G. On the possible relationship bet... Visualizza
2232 Pelaia G. Therapeutic benefits of methylxa... Visualizza
2233 Pelin M. CHARACTERIZATION OF THE MECHANIS... Visualizza
2234 Pelin M. Surfaced-enhanced Raman spectros... Visualizza
3363 Pelin M. GENETIC IDENTIFICATION OF Na+/K+... Visualizza
2235 Pellegatta F. Apolipoprotein E modulates adapt... Visualizza
2236 Pellegrini C. Enteric glia is involved in colo... Visualizza
2237 Pellegrini C. APIGENIN SUPPLEMENTATION PREVENT... Visualizza
2238 Pellegrini C. Bifidobacterium Longum and Lacto... Visualizza
3364 Pellegrini C. EFFECTS OF L-DOPA/BENSERAZIDE CO... Visualizza
3876 Pellegrini C. COMPARATIVE PRE-CLINICAL STUDY O... Visualizza
2239 Pellegrini-gampietro DE. Central effects induced by syste... Visualizza
3877 Pellegrini-giampietro DE. METAPLASTIC TREATMENTS WITH KETA... Visualizza
3365 Penco I. HOSPICE PALLIATIVE CARE MEDICATI... Visualizza
3366 Penna F. EPIGENETIC MECHANISMS IN THE DEV... Visualizza
3367 Pepe G. ESTROGEN PROMOTES MACROPHAGE PRO... Visualizza
3368 Pepe G. STUDY OF MICROGLIA PROLIFERATION... Visualizza
3878 Perego C. PCSK9 (PROPROTEIN CONVERTASE SUB... Visualizza
3879 Pericolini E. GLUCOCORTICOID-INDUCED LEUCINE Z... Visualizza
2240 Perluigi M. BEHAVIOURAL AND NEUROPATHOLOGICA... Visualizza
2241 Perone M. PHYTO.VIG.GEST: "VIGILANCE ON US... Visualizza
2242 Perrella M. Characterization of adipokines s... Visualizza
2243 Perretti M. MODULATION OF DIABETIC RETINOPAT... Visualizza
2244 Perri M. Myotrophin and miR-375 as pharma... Visualizza
2245 Perri MR. Therapeutic benefits of methylxa... Visualizza
2246 Perrone G. SELECTION AND CHARACTERIZATION O... Visualizza
3369 Perrone V. Healthcare resources use in pati... Visualizza
3370 Perrone V. Burden of comorbidities in HCV p... Visualizza
2247 Perucca E. OVERTREATMENT IN PHARMACORESISTA... Visualizza
2248 Pescara T. Prevention of diabetes in NOD mi... Visualizza
2249 Pesce M. TARGETING S100B-P53WT PROTEIN-PR... Visualizza
2250 Pesce M. Rifaximin induces a PXR-mediated... Visualizza
2251 Pesce V. GROWTH HORMONE SECRETAGOGUES PRE... Visualizza
2252 Petragnani N. Conditioned medium of human peri... Visualizza
2253 Petragnani N. Targeting platelet purinergic si... Visualizza
2254 Petrella A. Hypoxia regulates ANXA1 expressi... Visualizza
3371 Petrella A. Effects of Prisma® Skin dermal ... Visualizza
3880 Petrella A. ANNEXIN A1 CONTRIBUTES TO PANCRE... Visualizza
3372 Petrella C. Involvement of bradykinin B2 rec... Visualizza
2255 Petrella M. PPARγ Acti vati on reduces alco... Visualizza
2256 Petretto E. Sestrin 3 as a regulator of pro-... Visualizza
2257 Petrillo MG. Prevention of diabetes in NOD mi... Visualizza
4078 Petrillo MG. A NOVEL INTERACTION BETWEEN GLUC... Visualizza
2258 Petrini M. The ABCB1 pharmacogenetics of R-... Visualizza
2259 Petrocchi passeri P. Involvement of bradykinin B2 rec... Visualizza
2260 Petrocelli A. ATYPICAL SYMPTOMS OF TRAMADOL WI... Visualizza
2261 Petrolini VM. Analytically confirmed post-inje... Visualizza
2262 Petrolini VM. Gamma-hydroxybutyrate intoxicati... Visualizza
4079 Petrucci G. POOR RESPONSIVENESS TO LOW-DOSE ... Visualizza
2263 Petti LP. TRANSIENT RECEPTOR POTENTIAL VAN... Visualizza
2264 Pezzolla F. EFFECT OF CARBACHOL AND VIP IN H... Visualizza
2265 Piano I. MYOCARDIAL ANTI-AGEING EFFECTS O... Visualizza
2266 Piano I. THE H2S-DONOR, 4-CPI, PROMOTES A... Visualizza
3480 Piano I. NARINGENIN PROTECTS MYOCARDIUM A... Visualizza
3881 Piazza C. Retinal bioavailability of curcu... Visualizza
3373 Piazza S. Cutaneous hypoxia: effect of oxy... Visualizza
3882 Piazza S. EVALUATION OF GASTRIC ANTI-INFLA... Visualizza
2267 Piccinin S. Involvement of bradykinin B2 rec... Visualizza
2268 Piccirillo S. INVOLVEMENT OF NCX IN GLUTAMATE-... Visualizza
3883 Piccirillo S. PIVOTAL ROLE OF NCX1 IN GLUTAMAT... Visualizza
2269 Piccolo M. DOWN REGULATION OF PRO-INFLAMMAT... Visualizza
2270 Piegari E. Ranolazine attenuates adverse my... Visualizza
2271 Piegari E. Effects of lung resident mesench... Visualizza
3884 Piegari E. Cardio-renal positive effects of... Visualizza
3374 Piemontese DR. ANTI-ATHEROSCLEROTIC EFFECTS OF ... Visualizza
2273 Pierno S. SKELETAL MUSCLE CLC-1 CHANNEL: F... Visualizza
2274 Pierno S. STATIN THERAPY: CLC-1 CHLORIDE C... Visualizza
2275 Pierno S. GROWTH HORMONE SECRETAGOGUES PRE... Visualizza
2276 Pierno S. NEW BIOMARKERS IN ALS ETIOLOGY: ... Visualizza
2277 Pieroni S. A CLINICIAN NETWORK FOR SHARING ... Visualizza
1377 pignataro G. SYNERGISTIC ASSOCIATION OF VALPR... Visualizza
2278 Pignatello R. PALMITOYLETHANOLAMIDE LOADED IN ... Visualizza
2279 Pignatiello S. TRPM8 and experimental colorecta... Visualizza
25 Pingeon M. A novel methodology for the dosa... Visualizza
3375 Pingeon M. Health status and concomitant pr... Visualizza
2280 Pini A. HISTAMINE H3 RECEPTOR ANTAGONISM... Visualizza
3885 Pini A. Megalin and Sodium-Hydrogen Exch... Visualizza
2281 Pino A. TRANSPLANTATION OF MENINGEAL-DER... Visualizza
3376 Pino A. MENINGEAL NEURAL PRECURSORS CONT... Visualizza
2282 Pino MS. LIQUID BIOPSY: A REAL CLINICAL P... Visualizza
35 Pinto A. LEVELS OF SOLUBLE CD73 IN MELANO... Visualizza
60 pinto A. NOCICEPTIN REDUCES THE INFLAMMAT... Visualizza
2283 Pinto A. CARDIOTOXIC EFFECTS OF SHORT-TER... Visualizza
2284 Pinto A. Intestine as a Source of Inflamm... Visualizza
2285 Pinto A. TLR4 IS INVOLVED IN S1P/S1P1 PAT... Visualizza
2286 Pinto A. EFFECT OF ULTRAFINE PARTICLE MAT... Visualizza
3886 Pinto A. SEX-DEPENDENT ROLE OF LEUKOTRIEN... Visualizza
3887 Pinto AP. Human Peripheral blood mononucle... Visualizza
2287 Pinzani P. SELECTION AND CHARACTERIZATION O... Visualizza
2288 Piontini AP. TRANSIENT RECEPTOR POTENTIAL VAN... Visualizza
3377 Piragine E. MYOCARDIAL ANTI-AGEING EFFECTS O... Visualizza
3478 Piragine E. NARINGENIN PROTECTS MYOCARDIUM A... Visualizza
3888 Piragine E. ANTI-CANCER PROPERTIES OF ERUCIN... Visualizza
3889 Piragine E. ANTICANCER EFFECTS OF NOVEL LDH-... Visualizza
2289 Piro B. TREND OF ADVERSE DRUG REACTION R... Visualizza
2290 Piro R. MONITORING SAFETY AND USE OF OLD... Visualizza
2291 Pirolo R. MANAGING CHRONIC MYELOID LEUKEMI... Visualizza
2292 Pirolo R. HEPATITIS C VIRUS (HCV) INFECTIO... Visualizza
2293 Pirozzi C. PALMITOYLETAHNOLAMIDE ATTENUATES... Visualizza
2294 Pirozzi C. N-(1-CARBAMOYL-2-PHENYLETHYL) BU... Visualizza
4080 Pirozzi C. BUTYRATE REDUCES VALPROATE-INDUC... Visualizza
2295 Pirro M. Aryl hydrocarbon receptor: a nov... Visualizza
2296 Pirro MP. CpG type-A induction of an early... Visualizza
2297 Pisanu C. SPRUE-LIKE ENTEROPATHY ASSOCIATE... Visualizza
3378 Pisanu C. CONVERGENT ANALYSIS OF GENOME-WI... Visualizza
2298 Piscitelli A. ATYPICAL SYMPTOMS OF TRAMADOL WI... Visualizza
2299 Piscitelli F. A COMPARISON BETWEEN A CANNABIS ... Visualizza
2300 Piscitelli F. Hedonic eating in Prader-Willi s... Visualizza
2301 Piscitelli F. ENDOCANNABINOID SYSTEM AND MOUSE... Visualizza
2302 Piscitelli F. CHRONIC CANNABIDIVARIN ADMINISTR... Visualizza
2303 Piscopo C. RIMONABANT KILLS COLON CANCER ST... Visualizza
2304 Pistelli L. APIGENIN SUPPLEMENTATION PREVENT... Visualizza
4081 Pistis M. EFFECTS OF THE PPAR-ALPHA AGONIS... Visualizza
2305 Pittal V. Small molecules to treat diabeti... Visualizza
2306 Pittaluga A. Functional interaction between n... Visualizza
2307 Pittaluga A. PHARMACOLOGICAL CHARACTERIZATION... Visualizza
2308 Pittaluga A. ENVIRONMENTAL TRAINING AMELIORAT... Visualizza
2309 Pittaluga A. Prophylactic versus Therapeutic ... Visualizza
4129 Pittaluga A. M. Environmental enrichment modulat... Visualizza
3890 Piva A. POST-SYNAPTIC GLUTAMATE DYSFUNCT... Visualizza
3891 Piva A. METAPLASTIC TREATMENTS WITH KETA... Visualizza
1796 pizzi M. SYNERGISTIC ASSOCIATION OF VALPR... Visualizza
4210 Pizzi M. Epigenetic regulation of apoptos... Visualizza
3379 Pizzimenti V. Access to the market of medicine... Visualizza
2310 Pizzino CG. HIGH VARIABILITY IN TACROLIMUS B... Visualizza
2311 Pizzino G. CURCUMIN POTENTIATES THE ANTI-IN... Visualizza
2312 Pizzino G. Activation of the EPOR-b common ... Visualizza
2313 Pizzino G. WHITE-TO-BROWN ADIPOSE TRANSDIFF... Visualizza
2314 Pizzino G. Cadmium and its role in brain dy... Visualizza
2315 Pizzino G. Survivin and NAIP in Human Benig... Visualizza
3380 Pizzino G. MODELING ROS1 TRANSLOCATION IN L... Visualizza
3892 Pizzino G. FLAVONOIDS CONTAINED IN FLAVOCOX... Visualizza
3893 Pizzino G. LACK OF THE NLRP3 INFLAMMASOME I... Visualizza
2316 Pizzoferrato M. Interactions between antiretrovi... Visualizza
2317 Platania C. PALMITOYLETHANOLAMIDE LOADED IN ... Visualizza
2318 Platania CB. Small molecules to treat diabeti... Visualizza
2319 Platania CB. Role of P2X7 receptor in early d... Visualizza
2320 Platania CB. Effects of Taurine in dry eye mo... Visualizza
2321 Platania CB. Role of TGF-_1 in age-related ma... Visualizza
3381 Platania CB. Structure based approach for sea... Visualizza
3894 Platania CB. Retinal bioavailability of curcu... Visualizza
2138 Pòalazzo E. Palmitoylethanolamide Reduces Ne... Visualizza
2322 Poeta L. The loss of Aristaless related h... Visualizza
2323 Polesel J. COST-EVALUATION OF FLUOROPYRIMID... Visualizza
2324 Polesel J. GENETIC MARKERS IN NUCLEAR RECEP... Visualizza
2325 Polidori C. OLFACTORY RECEPTOR 984 A NEW TAR... Visualizza
2326 Polini B. Role of miR-34a as biomarker and... Visualizza
3382 Polini B. Potential relationship between t... Visualizza
2327 Pollastro F. The antimigraine butterbur ingre... Visualizza
2328 Pollina addario SW. Intravitreal anti-VEGF injection... Visualizza
2329 Poluzzi E. Occurrence of Liver Injury with ... Visualizza
2330 Poluzzi E. MYOPERICARDITIS AND VACCINES: GA... Visualizza
2331 Poluzzi E. DRUG-INDUCED KOUNIS SYNDROME: IN... Visualizza
2332 Poluzzi E. Renal impairment in very low bir... Visualizza
2333 Poma P. MDA-9/SYNTENIN AS A POTENTIAL DR... Visualizza
2334 Pompili B. Development of hyaluronan/mannit... Visualizza
2335 Pons N. SCREENING OF HUMAN SULFOTRANSFER... Visualizza
3383 Ponzoni L. PROSOCIAL AND ANXIOLYTIC EFFECT ... Visualizza
2336 Popoli M. Environmental Chronic Stress Ind... Visualizza
2337 Popoli M. MODELLING ANHEDONIA TO STUDY MEC... Visualizza
2338 Popoli M. Altered Mechanisms Underlying th... Visualizza
4167 Popoli M. Maladaptive plasticity induced b... Visualizza
4170 Popoli P. Innovation in orphan drugs: the ... Visualizza
2339 Popolo A. CARDIOTOXIC EFFECTS OF SHORT-TER... Visualizza
2340 Porciatti V. Autoregulation of retinal gangli... Visualizza
3895 Porreca E. REDUCED VARIABILITY TO ASPIRIN A... Visualizza
2917 porrini V. SYNERGISTIC ASSOCIATION OF VALPR... Visualizza
2341 Porro B. Fluoroscopy-associated oxidative... Visualizza
3896 Porro B. POOR RESPONSIVENESS TO LOW-DOSE ... Visualizza
2342 Possenti R. Involvement of bradykinin B2 rec... Visualizza
2343 Potenza MA. POTENTIAL MECHANISMS LINKING DEF... Visualizza
3384 Potenza MA. CM554, A NEW POTENT AND SELECTIV... Visualizza
3385 Potenza MA. INTERMITTENT ANTAGONISM OF BK2-R... Visualizza
4083 Potenza MA. ACTIVATION OF AMPK/SIRT-1 AXIS I... Visualizza
2344 Potenzieri A. Understanding the pathogenesis o... Visualizza
4082 Pot“ F. Sphingosine 1-Phosphate And Athe... Visualizza
2345 Pozzessere D. LIQUID BIOPSY: A REAL CLINICAL P... Visualizza
2346 Pozzi M. On the possible relationship bet... Visualizza
2347 Pozzo L. Evaluation of protective effect ... Visualizza
2348 Pratesi A. SELECTION AND CHARACTERIZATION O... Visualizza
2349 Prato M. Cutaneous hypoxia: effect of oxy... Visualizza
2350 Prato M. CHARACTERIZATION OF THE MECHANIS... Visualizza
2351 Prickaerts J. GEBR-32A, A NEW PROMISING PDE4D ... Visualizza
2352 Prini P. EPIGENETIC MECHANISMS IN THE DEV... Visualizza
4116 Prini P. Role of the endocannabinoid syst... Visualizza
2353 Proli E. HOSPICE PALLIATIVE CARE MEDICATI... Visualizza
2354 Proto MC. RIMONABANT KILLS COLON CANCER ST... Visualizza
2355 Provensi G. TAGATOSE BENEFICIAL EFFECTS IN A... Visualizza
2356 Provensi G. THE FAT SENSING MOLECULE OLEOYLE... Visualizza
3386 Provensi G. An Omega-3 PUFA/Vitamin A enrich... Visualizza
1447 provensi P. DIFFERENTIAL CONTRIBUTION OF IH ... Visualizza
2357 Provenzano F. THE DOWN REGULATION OF MGLUR5 AT... Visualizza
3387 Provenzano F. IN-VIVO EFFECTS OF KNOCKING-DOWN... Visualizza
3388 Pruccoli L. NEUROPROTECTIVE EFFECTS OF THE N... Visualizza
2358 Pruneri G. Inhibition of SIRT1 Deacetylase ... Visualizza
2359 Puccetti P. PROTECTIVE ROLE OF CONVENTIONAL ... Visualizza
3897 Puccetti P. IMMUNOREGULATORY SYNERGISM BETWE... Visualizza
3898 Puccetti P. IDO1 activity in selected immune... Visualizza
3899 Puccetti P. INTERLEUKIN 4-INDUCED GENE-1 AS ... Visualizza
3900 Puccetti P. REINSTALLING IMMUNE REGULATORY T... Visualizza
3901 Puccetti P. The proteasome inhibitor bortezo... Visualizza
2360 Puccetti PP. CpG type-A induction of an early... Visualizza
2361 Puglia C. PALMITOYLETHANOLAMIDE LOADED IN ... Visualizza
4146 Pugliese A. M. Adenosine A2B receptors and sphi... Visualizza
2362 Pugliese AM. THE SELECTIVE ANTAGONISM OF ADEN... Visualizza
3902 Pugliese AM. Molecular basis of adenosine A3 ... Visualizza
2363 Pugliese G. SEDENTARY-TIME: EFFECT ON PRO- A... Visualizza
2364 Puligheddu M. INHIBITION OF 5-ALPHA REDUCTASE ... Visualizza
2365 Puliti A. IN-VIVO EFFECTS OF KNOCKING-DOWN... Visualizza
3903 Purvis GS. THE ANTI-INFLAMMATORY PROTEIN AN... Visualizza
2366 Puzo MR. Intravitreal anti-VEGF injection... Visualizza
2367 Puzzo D. cGMP MODULATES LONG-TERM POTENTI... Visualizza
2368 Puzzolo D. Cadmium and its role in brain dy... Visualizza
2369 Puzzolo D. Survivin and NAIP in Human Benig... Visualizza
2370 Quaglia F. Development of hyaluronan/mannit... Visualizza
4184 Quaini F. Cardiotoxicity by Tyrosine Kinas... Visualizza
2371 Quaroni A. NIVALENOL AND DEOXYNIVALENOL IND... Visualizza
3389 Quattrone D. NABILONE AND THC/CBD FOR THE TRE... Visualizza
2372 Querio G. TOXICOLOGICAL IMPACT OF HIGH FRU... Visualizza
2373 Quintieri L. SCREENING OF HUMAN SULFOTRANSFER... Visualizza
2374 Racagni G. INFLUENCE OF CHRONIC STRESS EXPO... Visualizza
2375 Racagni G. Acute behavioral and molecular e... Visualizza
2376 Racagni G. REPEATED EXPOSURE TO COCAINE DUR... Visualizza
2377 Racchi M. MODULATION OF OXIDATIVE AND INFL... Visualizza
2378 Radice S. On the possible relationship bet... Visualizza
2379 Radice S. MARKAR survey: influence of dire... Visualizza
2380 Rafaniello C. ROSACEA DURING FINGOLIMOD THERAP... Visualizza
2381 Rafaniello C. ESTIMATING INCIDENCE RATES OF AD... Visualizza
4208 Rafaniello C. The Future of Pharmacovigilance:... Visualizza
2382 Raffaeli W. HYDRA VULGARIS AS A MODEL TO STU... Visualizza
2383 Ragazzi E. GLUCOSE-6-PHOSPHATE DEHYDROGENAS... Visualizza
2384 Ragazzi E. ROLE OF MITOCHONDRIA IN CISPLATI... Visualizza
2385 Ragusa S. Evaluation of protective effect ... Visualizza
2386 Raimondi L. Enhancement of cardiac different... Visualizza
2387 Raimondi L. Angiotensin-II activates p-38 an... Visualizza
2388 Raimondi L. Central effects induced by syste... Visualizza
3390 Raiteri L. RELEASE OF [3H]GABA EVOKED BY HI... Visualizza
2389 Ramesh P. RIMONABANT KILLS COLON CANCER ST... Visualizza
2390 Rana F. A LONG TERM TREATMENT WITH TAURI... Visualizza
2391 Rana F. Gender-dependent involvement of ... Visualizza
2392 Rana F. GROWTH HORMONE SECRETAGOGUES PRE... Visualizza
3904 Ranalli P. POOR RESPONSIVENESS TO LOW-DOSE ... Visualizza
2393 Rani B. An Omega-3 PUFA/Vitamin A enrich... Visualizza
2394 Rantsiou K. TOXICOLOGICAL IMPACT OF HIGH FRU... Visualizza
2395 Raouf J. OVER-EXPRESSION OF MIR-574-5P IN... Visualizza
2396 Raschi E. Occurrence of Liver Injury with ... Visualizza
2397 Raschi E. MYOPERICARDITIS AND VACCINES: GA... Visualizza
2398 Raschi E. Renal impairment in very low bir... Visualizza
3391 Raschi E. SAFETY OF FOOD SUPPLEMENTS CONTA... Visualizza
3392 Raschi E. DRUG-INDUCED KOUNIS SYNDROME: IN... Visualizza
2399 Rascle A. The chemopreventive effects of i... Visualizza
2400 Rasola A. GLUCOSE-6-PHOSPHATE DEHYDROGENAS... Visualizza
2401 Rastelli ML. Chronic Oleoylethanolamide Treat... Visualizza
2402 Ratano P. Involvement of the Prokineticin ... Visualizza
3393 Ratano P. ROLE OF DORSOMEDIAL STRIATUM NEU... Visualizza
2403 Ravani A. CAROTID PLAQUE-THICKNESS AND COM... Visualizza
2404 Ravani A. PULSED ELECTROMAGNETIC FIELDS TR... Visualizza
2405 Ravani A. ANTI-NOCICEPTIVE EFFECTS OF NOVE... Visualizza
2406 Ravani A. A PRIORI-DEFINED MEDITERRANEAN-L... Visualizza
2407 Ravani A. A2B adenosine receptors stimulat... Visualizza
2408 Ravegnini G. DNA METHYLATION: GENE PROFILING ... Visualizza
3394 Ravegnini G. MIR-139-5P AND MIR-455-5P AS POT... Visualizza
2409 Ray S. IN VITRO AND IN VIVO MODELING OF... Visualizza
2410 Re N. CM554, A NEW POTENT AND SELECTIV... Visualizza
1126 rea F. ALPHA-1 ANTITRYPSIN (AAT) POLYME... Visualizza
2411 Rea F. NSAIDs utilization in a large co... Visualizza
2412 Rebosio C. cGMP MODULATES LONG-TERM POTENTI... Visualizza
2413 Rebosio C. GEBR-32A, A NEW PROMISING PDE4D ... Visualizza
3395 Rebosio C. PRESYNAPTIC GLP-1 RECEPTORS ENHA... Visualizza
2414 Recinella L. Peripheral RVD-hemopressin(_) ad... Visualizza
2415 Recinella L. HARPAGOPHYTUM PROCUMBENS AQUEOUS... Visualizza
3396 Recinella L. Effects of Growth Hormone-Releas... Visualizza
3905 Recinella L. Emotional Disorders Induced by H... Visualizza
2417 Renesto A. HEPATITIS C VIRUS GENOTYPE 3H: T... Visualizza
1101 Resta F. Isoform-selective blockade of HC... Visualizza
2418 Resta F. Central effects induced by syste... Visualizza
4162 Restani P. Adverse reactions to botanicals ... Visualizza
3397 Restante G. Monitoring of Epidermal Growth F... Visualizza
2419 Ribatti V. Fluoroscopy-associated oxidative... Visualizza
2420 Riccardi C. Structure based approach for sea... Visualizza
2421 Riccardi C. THE EFFECT OF ARA-C TREATMENT ON... Visualizza
2422 Riccardi C. Stimulation of CB2 receptor affe... Visualizza
2423 Riccardi C. GLUCOCORTICOID-INDUCED LEUCINE Z... Visualizza
2424 Riccardi C. Prevention of diabetes in NOD mi... Visualizza
3906 Riccardi C. GLUCOCORTICOID-INDUCED LEUCINE Z... Visualizza
3907 Riccardi C. GLUCOCORTICOID-INDUCED LEUCINE Z... Visualizza
4209 Riccardi C. Glucocorticoi-Induced Leucine Zi... Visualizza
2425 Ricci E. Stimulation of CB2 receptor affe... Visualizza
2426 Ricci E. Prevention of diabetes in NOD mi... Visualizza
3908 Ricci E. GLUCOCORTICOID-INDUCED LEUCINE Z... Visualizza
2427 Ricci G. Gamma-hydroxybutyrate intoxicati... Visualizza
2428 Ricciarelli R. PRESYNAPTIC GLP-1 RECEPTORS ENHA... Visualizza
2429 Ricciarelli R. cGMP MODULATES LONG-TERM POTENTI... Visualizza
2430 Ricciarelli R. GEBR-32A, A NEW PROMISING PDE4D ... Visualizza
3909 Ridolfi L. Nutraceutical properties of Arth... Visualizza
3398 Riemma MA. TLR4 IS INVOLVED IN S1P/S1P1 PAT... Visualizza
2431 Rigamonti AE. DRUGS PRESCRIPTION AS A MEASURE ... Visualizza
3399 Rigamonti AE. Hedonic eating in Prader-Willi s... Visualizza
3400 Rigamonti AE. Six-month levetiracetam treatmen... Visualizza
2432 Riganti C. IN VITRO CARDIOVASCULAR TOXICITY... Visualizza
2433 Riganti C. Effects of NO and H2S releasing ... Visualizza
3910 Riganti L. EFFECTS OF THROMBIN CLEAVAGE OF ... Visualizza
631 rigobello C. ALPHA-1 ANTITRYPSIN (AAT) POLYME... Visualizza
2434 Rimondini R. Cross-Disease Analysis of Alzhei... Visualizza
2435 Rinaldi M. SALMETEROL, A SELECTIVE AND LONG... Visualizza
2436 Rinaldi M. Survivin and NAIP in Human Benig... Visualizza
3401 Rinaldi M. Cadmium and its role in brain dy... Visualizza
2437 Rinaldi MG. HIGH VARIABILITY IN TACROLIMUS B... Visualizza
2438 Riozzi B. PHARMACOLOGICAL CHARACTERIZATION... Visualizza
3402 Riva B. Understanding the pathogenesis o... Visualizza
4219 Riva M. Stress, Epigenetic Changes and V... Visualizza
2440 Riva MA. LONG-LASTING EFFECTS OF STRESS I... Visualizza
2441 Riva MA. INFLUENCE OF CHRONIC STRESS EXPO... Visualizza
2442 Rizza R. SEX BIAS IN LIPID MEDIATOR BIOSY... Visualizza
2443 Rizzardini G. MARKAR survey: influence of dire... Visualizza
2444 Rizzi A. PHARMACOLOGICAL CHARACTERIZATION... Visualizza
3911 Rizzi A. NOP RECEPTOR AND FUNCTIONAL SELE... Visualizza
2445 Rizzi L. miRNA-218 TARGETS LIPIN-1 AND GL... Visualizza
2446 Rizzi L. GROWTH HORMONE SECRETAGOGUES PRE... Visualizza
3403 Rizzi L. EFFECTS OF HEXARELIN IN A MODEL ... Visualizza
2447 Rizzi N. Inhibition of SIRT1 Deacetylase ... Visualizza
3404 Roberto G. NSAIDs utilization in a large co... Visualizza
3405 Roberto G. Utilization of biological drugs ... Visualizza
3912 Rocca B. POOR RESPONSIVENESS TO LOW-DOSE ... Visualizza
4211 Rocca B. Pharmacokinetic/Pharmacodynamic ... Visualizza
4084 Rocchitta G. Real-time detection of ethanol i... Visualizza
2449 Rodinò S. ADVERSE DRUG REACTIONS BY BIOLOG... Visualizza
2450 Rodrigues M. STARGAZIN REGULATES THE BIOCHEMI... Visualizza
2451 Rodriguez FJ. TRANSPLANTATION OF MENINGEAL-DER... Visualizza
2452 Rodriguez PC. CROSSTALK BETWEEN ADENOSINE AND ... Visualizza
2453 Rodriguez-estrada MT. E-CIGARETTES INDUCE TOXICOLOGICA... Visualizza
2454 Rofi E. LIQUID BIOPSY: A REAL CLINICAL P... Visualizza
2455 Rofi E. DETECTION OF AR-V7 IN PLASMA-DER... Visualizza
2456 Rofi E. Monitoring of Epidermal Growth F... Visualizza
3406 Rofi E. EARLY VARIATIONS OF KRAS MUTATIO... Visualizza
2457 Rolando B. UNRAVELING THE MECHANISM OF ACTI... Visualizza
2458 Rolli FR. Retrospective study on ItaliaN A... Visualizza
3913 Romagnoli A. INHIBITION OF SPONTANEOUS COLON ... Visualizza
3914 Romagnoli A. Potential of a flavonoid-rich ex... Visualizza
2459 Romain DR. ANTI-ATHEROSCLEROTIC EFFECTS OF ... Visualizza
92 Romanelli MN. Isoform-selective blockade of HC... Visualizza
2460 Romani RR. CpG type-A induction of an early... Visualizza
2461 Romanini A. Role of miR-34a as biomarker and... Visualizza
2462 Romano A. ROLE OF THE AREA POSTREMA IN THE... Visualizza
2463 Romano A. EFFECTS OF SUBDIAPHRAGMATIC DEAF... Visualizza
2464 Romano A. OBSERVATIONAL, PROSPECTIVE CLINI... Visualizza
3407 Romano A. Chronic Oleoylethanolamide Treat... Visualizza
2465 Romano AR. SAFETY AND EFFICACY OF GLP-1 REC... Visualizza
2466 Romano B. A COMPARISON BETWEEN A CANNABIS ... Visualizza
3408 Romano BR. TRANSIENT RECEPTOR POTENTIAL VAN... Visualizza
2467 Romano E. Hypoxia regulates ANXA1 expressi... Visualizza
2468 Romano G. PALMITOYLETHANOLAMIDE LOADED IN ... Visualizza
3409 Romano GL. Autoregulation of retinal gangli... Visualizza
26 Romano M. A novel methodology for the dosa... Visualizza
2469 Romano R. Palmitoylethanolamide Reduces Ne... Visualizza
2470 Romano R. PALMITOYLETHANOLAMIDE, VIA PPAR-... Visualizza
2471 Romei C. RELEASE OF [3H]GABA EVOKED BY HI... Visualizza
3915 Romoli B. Rat Nicotine Sensitization Modul... Visualizza
2472 Romualdi P. Selective dynorphin and nocicept... Visualizza
3916 Romualdi P. Rat Nicotine Sensitization Modul... Visualizza
4113 Romualdi P. Molecular mechanisms and rationa... Visualizza
3917 Romuladi P. N/OFQ and CRF systems dysregulat... Visualizza
2473 Roncada P. INHIBITION OF 5-ALPHA REDUCTASE ... Visualizza
2474 Roncato R. Next generation sequencing for i... Visualizza
2475 Roncato R. GENETIC MARKERS IN NUCLEAR RECEP... Visualizza
3410 Roncato R. COST-EVALUATION OF FLUOROPYRIMID... Visualizza
2476 Ronchetti S. Stimulation of CB2 receptor affe... Visualizza
4085 Ronchetti S. GLUCOCORTICOID-INDUCED LEUCINE Z... Visualizza
2477 Roncon P. Sestrin 3 as a regulator of pro-... Visualizza
2478 Ronda N. Vitamin D replacement in pre-men... Visualizza
3918 Ronzitti G. Intracellular chloride accumulat... Visualizza
4086 Rosa AC. Megalin and Sodium-Hydrogen Exch... Visualizza
2480 Rosaria R. D-ASPARTIC ACID AMELIORATES COGN... Visualizza
2481 Rosati E. OVERTREATMENT IN PHARMACORESISTA... Visualizza
3919 Roselletti E. GLUCOCORTICOID-INDUCED LEUCINE Z... Visualizza
2482 Rosini M. MODULATION OF OXIDATIVE AND INFL... Visualizza
2483 Rossetti AC. Multiple sclerosis and depressio... Visualizza
3920 Rossetti L. Vitamin D levels and Tissue Fact... Visualizza
4087 Rossetti L. Shedding light on PCSK9 function... Visualizza
2484 Rossetti T. Sestrin 3 as a regulator of pro-... Visualizza
2485 Rossi A. SEX BIAS IN LIPID MEDIATOR BIOSY... Visualizza
2486 Rossi A. ENDOCANNABINOID SYSTEM AND MOUSE... Visualizza
2487 Rossi A. TLR4 IS INVOLVED IN S1P/S1P1 PAT... Visualizza
4088 Rossi A. SEX-DEPENDENT ROLE OF LEUKOTRIEN... Visualizza
4179 Rossi D. Astrocytes as cell targets for t... Visualizza
1210 rossi F. NOCICEPTIN/ORPHANINFQ (N/OFQ) CO... Visualizza
1211 rossi F. NOCICEPTIN REDUCES THE INFLAMMAT... Visualizza
2488 Rossi F. ANALYSIS OF THE ADVERSE DRUG REA... Visualizza
2489 Rossi F. ESTIMATING INCIDENCE RATES OF AD... Visualizza
2490 Rossi F. SAFETY OF NEW DIRECT-ACTING ANTI... Visualizza
2491 Rossi F. LONG TERM DRUG SAFETY IN CHILDRE... Visualizza
2492 Rossi F. Ranolazine attenuates adverse my... Visualizza
2493 Rossi F. Stimulation of CB2 receptor affe... Visualizza
2494 Rossi F. Palmitoylethanolamide Reduces Ne... Visualizza
2495 Rossi F. GENDER SPECIFIC DRUG USE IN PEDI... Visualizza
3921 Rossi F. Cardio-renal positive effects of... Visualizza
2496 Rossi L. DRUGS - INDUCED DISSEMINATED INT... Visualizza
2497 Rossi S. MODULATION OF DIABETIC RETINOPAT... Visualizza
2498 Rossini E. IN VITRO ASSESSMENT OF CABAZITAX... Visualizza
3411 Rossini E. In vitro identification of molec... Visualizza
4144 Rossini M. Denosumab: not only postmenopaus... Visualizza
2499 Rostami AR. CpG type-A induction of an early... Visualizza
2500 Rota F. CYP27A1 GENETIC POLYMORPHISM IN ... Visualizza
2501 Rouanet DR. ANTI-ATHEROSCLEROTIC EFFECTS OF ... Visualizza
2502 Roussel G. Hypothalamic Circuit Mediates Th... Visualizza
2503 Rovati GE. BIVALENT LIGANDS DISCLOSE GPCR D... Visualizza
2504 Rovati LC. Characterization of adipokines s... Visualizza
1169 roviezzo F. NOCICEPTIN REDUCES THE INFLAMMAT... Visualizza
2505 Roviezzo F. TLR4 IS INVOLVED IN S1P/S1P1 PAT... Visualizza
3922 Roviezzo F. SEX-DEPENDENT ROLE OF LEUKOTRIEN... Visualizza
2506 Rozza FR. LEAF EXTRACT OF MORUS ALBA, A CO... Visualizza
2507 Ruberto G. Phytochemical Profile and Photot... Visualizza
2508 Rubino T. CHRONIC CANNABIDIVARIN ADMINISTR... Visualizza
2509 Rubino T. EPIGENETIC MECHANISMS IN THE DEV... Visualizza
2510 Rucci F. The importance of Integrated Car... Visualizza
3923 Rucci F. Insulin analogue glargine 300 U/... Visualizza
2511 Rucci FR. SAFETY AND EFFICACY OF GLP-1 REC... Visualizza
2512 Rugge M. Involvement of catechol-O-methyl... Visualizza
2513 Ruggeri M. Retrospective study on ItaliaN A... Visualizza
3412 Rullo L. Selective dynorphin and nocicept... Visualizza
3924 Rullo L. N/OFQ and CRF systems dysregulat... Visualizza
3925 Ruscica M. PCSK9 (PROPROTEIN CONVERTASE SUB... Visualizza
4089 Ruscica M. High density lipoproteins inhibi... Visualizza
2514 Rusconi S. Pharmacokinetics of darunavir/co... Visualizza
3926 Rusnati M. DUAL TARGETING OF EPH-EPHRIN SYS... Visualizza
2515 Russo A. ROSMARINUS OFFICINALIS EXTRACT P... Visualizza
2516 Russo D. Anti-proliferative effects of Cy... Visualizza
2517 Russo D. Evaluation of protective effect ... Visualizza
2518 Russo E. PHARMACOLOGICAL EFFECT OF PERAMP... Visualizza
2519 Russo E. Fluoroscopy-associated oxidative... Visualizza
2520 Russo E. EFFECTS OF HISTONE DEACETYLASE I... Visualizza
2521 Russo E. VILDAGLIPTIN IMPROVES ANIMAL BEH... Visualizza
2522 Russo E. ADVERSE DRUG REACTIONS WITH BIOL... Visualizza
2523 Russo E. TREND OF ADVERSE DRUG REACTION R... Visualizza
2524 Russo E. ADVERSE DRUG REACTIONS BY BIOLOG... Visualizza
2525 Russo E. MONITORING SAFETY AND USE OF OLD... Visualizza
3413 Russo E. TOCILIZUMAB'S EFFECT ON EPILEPTO... Visualizza
2526 Russo GI. Survivin and NAIP in Human Benig... Visualizza
2527 Russo M. THE ROLE OF SIRT3 PATHWAY IN NEU... Visualizza
2528 Russo R. BUTYRATE ATTENUATES MOTOR DEFICI... Visualizza
2529 Russo R. Behavioral and Metabolic Charact... Visualizza
2530 Russo R. PHARMACOLOGICAL EFFECT OF PERAMP... Visualizza
3927 Russo R. BUTYRATE REDUCES VALPROATE-INDUC... Visualizza
4190 Russo R. High palatable food exposure and... Visualizza
2531 Russo S. PHARMACOLOGICAL CHARACTERIZATION... Visualizza
2532 Ruzza C. PHARMACOLOGICAL CHARACTERIZATION... Visualizza
4090 Ruzza C. NOP RECEPTOR AND FUNCTIONAL SELE... Visualizza
2533 Sacco A. DEVELOPMENT OF A NOVEL DIRECT BI... Visualizza
2534 Sacco A. Generation of 12- hydroxyeicosat... Visualizza
3417 Sacco A. PLATELET-DEPENDENT ACTIVATION OF... Visualizza
2535 Sacerdote P. THERAPEUTIC EFFECT OF SYSTEMIC I... Visualizza
2536 Sacerdote P. ROLE OF PROKINETICIN SYSTEM IN A... Visualizza
2537 Sadofsky LS. Aromatase inhibitor-evoked pain ... Visualizza
1797 saetta M. ALPHA-1 ANTITRYPSIN (AAT) POLYME... Visualizza
3928 Sagheddu C. EFFECTS OF THE PPAR-ALPHA AGONIS... Visualizza
2538 Sahbani D. SEARCHING FOR NOVEL DRUGS IN MYO... Visualizza
2539 Saija A. Curcumin Potentiates Antitumor A... Visualizza
2540 Saija A. Curcumin Ameliorates the In Vitr... Visualizza
2541 Saija A. In Vitro Protective Effects of C... Visualizza
2542 Saija A. Phytochemical Profile and Photot... Visualizza
3929 Saija A. Alpha-Lipoic Acid, But Not Dihyd... Visualizza
2543 Sala M. PROSOCIAL AND ANXIOLYTIC EFFECT ... Visualizza
2544 Sala ME. BIVALENT LIGANDS DISCLOSE GPCR D... Visualizza
3418 Sala N. MODELLING ANHEDONIA TO STUDY MEC... Visualizza
2545 Saletti C. miRNA-218 TARGETS LIPIN-1 AND GL... Visualizza
2546 Salomone S. Structure based approach for sea... Visualizza
2547 Salomone S. Role of P2X7 receptor in early d... Visualizza
2548 Salomone S. Sulodexide prevents high glucose... Visualizza
3930 Salomone S. VEGF EXACERBATES DAMAGE INDUCED ... Visualizza
3931 Salomone S. Retinal bioavailability of curcu... Visualizza
3932 Salomone S. Buspirone rescues MK-801-induced... Visualizza
3933 Salomone S. Dopamine D3 receptors control dy... Visualizza
3934 Salomone S. Dopamine D3 receptor-dependent c... Visualizza
3419 Salvalai ME. CONTRIBUTION OF ASTROCYTES TO NE... Visualizza
2549 Salvatore T. OVER-EXPRESSION OF MIR-574-5P IN... Visualizza
4183 Salvatorelli E. Anthracyclines and the problem o... Visualizza
2550 Salvatori R. Effects of Growth Hormone-Releas... Visualizza
2551 Salvemini D. THE ROLE OF SIRT3 PATHWAY IN NEU... Visualizza
3423 Salvia C.G. Metronomic vinorelbine is active... Visualizza
2552 Sammarini G. MIR-139-5P AND MIR-455-5P AS POT... Visualizza
3424 Sammarini G. DNA METHYLATION: GENE PROFILING ... Visualizza
2553 Samuelli G. Characterization of adipokines s... Visualizza
2554 Sanarica F. EFFECT OF A LONG TERM TREATMENT ... Visualizza
2555 Sanarica F. A LONG TERM TREATMENT WITH TAURI... Visualizza
3425 Sanarica F. IN VIVO AND IN VITRO PRECLINICAL... Visualizza
2556 Sances G. The pharmacogenetics of the resp... Visualizza
3935 Sanchez-Vicente L. ë_-Caryophyllene oxide as a new... Visualizza
2557 Sanderson J. IN VITRO AND IN VIVO MODELING OF... Visualizza
2558 Sandrini L. Carbaprostacyclin prevents venou... Visualizza
3426 Sandrini L. Environmental Chronic Stress Ind... Visualizza
2559 Sangiorgi D. Healthcare resources use in pati... Visualizza
2560 Sangiorgi D. Burden of comorbidities in HCV p... Visualizza
2561 Sangiovanni E. Cutaneous hypoxia: effect of oxy... Visualizza
4091 Sangiovanni E. EVALUATION OF GASTRIC ANTI-INFLA... Visualizza
2562 Saniere L. THE EPHRIN RECEPTOR KINASE INHIB... Visualizza
2563 Sansaro D. CAROTID PLAQUE-THICKNESS AND COM... Visualizza
2564 Sansaro D. A PRIORI-DEFINED MEDITERRANEAN-L... Visualizza
3936 Sansone A. Results from an e-learning cours... Visualizza
2565 Santamaria A. PHYTO.VIG.GEST: "VIGILANCE ON US... Visualizza
2566 Santanaria R. DOWN REGULATION OF PRO-INFLAMMAT... Visualizza
2567 Santangelo A. ADVERSE DRUG REACTIONS IN EMERGE... Visualizza
2568 Santangelo E. PHARMACOLOGICAL EFFECT OF PERAMP... Visualizza
3937 Santilli F. Shedding light on PCSK9 function... Visualizza
2569 Santini F. BIVALENT LIGANDS DISCLOSE GPCR D... Visualizza
2570 Santori A. AMPHETAMINE AND THE "BATH SALT" ... Visualizza
2571 Santoro A. PALMITOYLETAHNOLAMIDE ATTENUATES... Visualizza
2572 Santoro V. NEWER LONG-ACTING INJECTABLE ANT... Visualizza
2573 Sanvito F. IMMUNOSURVEILLANCE OF TUMORS: IG... Visualizza
2574 Saponara S. Effects of NO and H2S releasing ... Visualizza
2575 Saponara S. IN VITRO CARDIOVASCULAR TOXICITY... Visualizza
2576 Sarnelli G. TARGETING S100B-P53WT PROTEIN-PR... Visualizza
2577 Sarnelli G. Rifaximin induces a PXR-mediated... Visualizza
4092 Sarnelli G. PALMITOYLETHANOLAMIDE IMPROVES H... Visualizza
1533 Sartiani L. Isoform-selective blockade of HC... Visualizza
2578 Sartiani L. Enhancement of cardiac different... Visualizza
2579 Sartiani L. Angiotensin-II activates p-38 an... Visualizza
4093 Sartiani L. EFFECT OF RACEMIC AND LEVO-METHA... Visualizza
4094 Sartiani L. REMODELING OF ATRIAL REPOLARIZAT... Visualizza
2580 Sartorio A. DRUGS PRESCRIPTION AS A MEASURE ... Visualizza
2581 Sartorio A. Hedonic eating in Prader-Willi s... Visualizza
2582 Saul MJ. OVER-EXPRESSION OF MIR-574-5P IN... Visualizza
3938 Saul MJ. MICRORNA-574-5P MODULATES MICROS... Visualizza
2583 Sautebin L. SEX BIAS IN LIPID MEDIATOR BIOSY... Visualizza
3939 Sautebin L. SEX-DEPENDENT ROLE OF LEUKOTRIEN... Visualizza
2584 Sava G. TARGETING THE CANCER RESISTOME T... Visualizza
3940 Sava G. RNA-SEQ ANALYSIS OF DIFFERENTIAL... Visualizza
2585 Savai R. OVER-EXPRESSION OF MIR-574-5P IN... Visualizza
2586 Saverio N. Impaired glucose and lipid metab... Visualizza
2587 Scafuro MA. Palmitoylethanolamide Reduces Ne... Visualizza
2588 Scaglione F. The importance of Integrated Car... Visualizza
2589 Scaglione F. OBSERVATIONAL, PROSPECTIVE CLINI... Visualizza
3941 Scaglione F. Insulin analogue glargine 300 U/... Visualizza
2590 Scaglione FS. SAFETY AND EFFICACY OF GLP-1 REC... Visualizza
2591 Scala R. IN VITRO AND EX-VIVO EFFECTS OF ... Visualizza
2592 Scalisi G. Aryl hydrocarbon receptor: a nov... Visualizza
2593 Scalisi G. PROTECTIVE ROLE OF CONVENTIONAL ... Visualizza
3942 Scalisi G. INTERLEUKIN 4-INDUCED GENE-1 AS ... Visualizza
4095 Scalisi G. IDO1 activity in selected immune... Visualizza
2594 Scalisi GS. CpG type-A induction of an early... Visualizza
2595 Scalorbi S. Reporting of adverse drug reacti... Visualizza
2596 Scarano F. Impaired glucose and lipid metab... Visualizza
2597 Scarano F. Early up-regulation of hepatic m... Visualizza
2598 Scarano F. BERGAMOT POLYPHENOLS PROTECT AGA... Visualizza
2599 Scarano F. HYPERCHOLESTEROLEMIA MODULATES M... Visualizza
2600 Scarano SF. Sildenafil improves cardiac func... Visualizza
2601 Scaravaggi G. Analytically confirmed post-inje... Visualizza
2602 Scaravaggi G. Methotrexate therapeutic error i... Visualizza
2603 Scaravaggi G. Gamma-hydroxybutyrate intoxicati... Visualizza
3427 Scaravaggi G. Antidote treatment in Viper enve... Visualizza
3943 Scarpelli P. The bile acid receptor GPBAR1 re... Visualizza
2604 Scarpignato C. Enteric glia is involved in colo... Visualizza
4096 Scarselli M. Clozapine as the most efficaciou... Visualizza
2605 Scatigna M. The importance of Integrated Car... Visualizza
4202 Scatigna M. Clinical Research of drugs for r... Visualizza
2606 Scavone C. ANALYSIS OF THE ADVERSE DRUG REA... Visualizza
2607 Scheggi S. INHIBITION OF 5-ALPHA REDUCTASE ... Visualizza
2608 Scherz MW. A PRECLINICAL SET UP OF A RAT MO... Visualizza
2609 Schiavi S. CHANGES IN THE ENDOCANNABINOID S... Visualizza
3428 Schiavi S. AUTISTIC-LIKE BEHAVIORAL ABNORMA... Visualizza
2610 Schiavini M. MARKAR survey: influence of dire... Visualizza
2611 Schiavon A. HEPATITIS C VIRUS (HCV) INFECTIO... Visualizza
2612 Schiavone S. LIPIDOMICS OF EICOSANOIDS GENERA... Visualizza
3429 Schiavone S. Generation of 12- hydroxyeicosat... Visualizza
3944 Schiavone S. Platelet-derived microparticles ... Visualizza
4122 Schiavone S. Early blood brain barrier dysfun... Visualizza
2613 Schicchi A. Methotrexate therapeutic error i... Visualizza
2614 Schicchi A. Antidote treatment in Viper enve... Visualizza
2615 Schiffer D. SOLID LIPID NANOPARTICLES CARRYI... Visualizza
2616 Schmidt SD. An Omega-3 PUFA/Vitamin A enrich... Visualizza
2617 Schon M. OLFACTORY RECEPTOR 984 A NEW TAR... Visualizza
2618 Schulze TG. CONVERGENT ANALYSIS OF GENOME-WI... Visualizza
3945 Schwarcz R. Gestational cannabinoid exposure... Visualizza
2619 Scicchitano M. Impaired glucose and lipid metab... Visualizza
2620 Scicchitano M. Early up-regulation of hepatic m... Visualizza
2621 Scicchitano M. HYPERCHOLESTEROLEMIA MODULATES M... Visualizza
2622 Scicchitano SM. Sildenafil improves cardiac func... Visualizza
2623 Scilimati A. DEVELOPMENT OF NOVEL LACTATE-NA2... Visualizza
2624 Scilimati A. IN VITRO AND EX-VIVO EFFECTS OF ... Visualizza